Clinical	JJ	amod	O
,	,	punct	O
laboratory	NN	conj	O
,	,	punct	O
histopathological	JJ	conj	O
,	,	punct	O
and	CC	cc	O
pharmacological	JJ	conj	O
evidence	NN	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
the	DT	det	O
coagulation	NN	compound	O
system	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
biology	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
VASP	NN	nmod	B-Gene_or_gene_product
induces	VBZ	ROOT	O
marked	JJ	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
and	CC	cc	O
formation	NN	conj	O
of	IN	case	O
prominent	JJ	amod	O
stress	NN	compound	B-Cellular_component
fibers	NNS	nmod	I-Cellular_component
in	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
experimental	JJ	amod	O
facts	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
acquisition	NN	nsubj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
coupled	VBN	acl	O
with	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
was	VBD	cop	O
conditional	JJ	ccomp	O
in	IN	case	O
nature	NN	nmod	O
,	,	punct	O
being	VBG	auxpass	O
strongly	RB	advmod	O
affected	VBN	advcl	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
circumstances	NNS	nmod	O
.	.	punct	O

Acetylation	NN	nsubjpass	O
of	IN	case	O
histone	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
histone	NN	conj	B-Gene_or_gene_product
proteins	NNS	dep	O
,	,	punct	O
induction	NN	nsubjpass	O
of	IN	case	O
apoptotic	JJ	amod	O
-	HYPH	punct	O
related	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
de	FW	amod	O
-	HYPH	punct	O
phosphorylation	NN	conj	O
of	IN	case	O
focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
and	CC	cc	O
trafficking	NN	conj	O
is	VBZ	auxpass	O
coordinated	VBN	acl:relcl	O
are	VBP	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

Angiogenesis	NNP	compound	O
-	HYPH	punct	O
-	HYPH	punct	O
one	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
hallmarks	NNS	pobj	O
of	IN	prep	O
cancer	NN	pobj	B-Cancer
-	HYPH	punct	O
-	:	punct	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
valid	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	nmod	O
in	IN	case	O
oncology	NN	nmod	O
.	.	punct	O

This	DT	det	O
prospective	JJ	amod	O
study	NN	ROOT	O
aimed	VBN	acl	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
efficacy	NN	dobj	O
and	CC	cc	O
individual	JJ	amod	O
benefit	NN	conj	O
of	IN	case	O
external	JJ	amod	O
beam	NN	compound	O
radiotherapy	NN	nmod	O
(	-LRB-	punct	O
EBRT	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
perfluorocarbon	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
artificial	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
carriers	NNS	nmod	O
on	IN	case	O
tissue	NN	npadvmod	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
engineered	VBN	amod	I-Multi-tissue_structure
trachea	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
agents	NNS	nsubjpass	O
p	NN	dep	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
benzoic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
potassium	NN	compound	I-Simple_chemical
salt	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DM	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
COOK	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
5	CD	conj	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
imidazole	NN	amod	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carboxamide	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DTIC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
di	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxopiperazin	NN	amod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
yl	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
propane	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
ICRF	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
159	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
markedly	RB	advmod	O
depress	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
s	NNS	dobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O

Hematogenous	JJ	amod	O
metastasis	NN	nsubj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
requires	VBZ	ROOT	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
and	CC	cc	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
uptake	NN	conj	O
of	IN	case	O
the	DT	det	O
brain	NN	compound	B-Cancer
tumours	NNS	nmod	I-Cancer
correlated	VBD	ROOT	O
significantly	RB	advmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
71	CD	nummod	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	ROOT	O
0	CD	nummod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Each	DT	nsubj	O
was	VBD	ROOT	O
legally	RB	advmod	O
blind	JJ	acomp	O
before	IN	case	O
treatment	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
1	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
experienced	VBN	conj	O
little	JJ	dobj	O
to	TO	prep	O
no	DT	neg	O
subjective	JJ	amod	O
improvement	NN	pobj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
was	VBD	cop	O
poorly	RB	advmod	O
compliant	JJ	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
volume	NN	nmod	O
and	CC	cc	O
bone	NN	compound	B-Tissue
volume	NN	compound	O
density	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
in	IN	conj	O
the	DT	det	O
oldest	JJS	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	pobj	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
units	NNS	nmod	O
with	IN	case	O
these	DT	det	O
various	JJ	amod	O
proteins	NNS	nmod	O
allows	VBZ	ROOT	O
the	DT	det	O
uPAR	NN	dobj	B-Gene_or_gene_product
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
focused	JJ	amod	O
proteolysis	NN	dobj	O
required	VBN	acl	O
for	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
and	CC	cc	O
to	TO	mark	O
contribute	VB	conj	O
both	CC	cc:preconj	O
directly	RB	advmod	O
and	CC	advmod	O
indirectly	RB	advmod	O
to	TO	case	O
cell	NN	compound	B-Cell
adhesive	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
proteolytic	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
after	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
increased	VBN	conj	O
further	RB	advmod	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
miRNAs	NN	nsubjpass	O
(	-LRB-	punct	O
angiomiRs	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Brn	RB	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	O
gene	NN	compound	O
family	NN	nmod	O
(	-LRB-	punct	O
so	RB	advmod	O
-	HYPH	punct	O
called	VBN	dep	O
because	IN	prep	O
of	IN	pcomp	O
the	DT	det	O
similarity	NN	pobj	O
with	IN	case	O
the	DT	det	O
group	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
Pit	VBP	dep	B-Gene_or_gene_product
,	,	punct	O
Oct	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Unc	NNP	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
engaged	VBN	acl	O
in	IN	case	O
the	DT	det	O
transcription	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
p1	NN	compound	O
and	CC	cc	O
p2	NN	conj	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
antiapoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
Bcl	NN	npadvmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nsubj	O
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
susceptibility	NN	dobj	O
to	TO	case	O
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
accelerated	VBN	amod	O
and	CC	cc	O
increased	VBN	conj	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
.	.	punct	O

The	DT	det	O
vessels	NNS	nsubjpass	B-Multi-tissue_structure
are	VBP	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
quiescient	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
within	IN	case	O
the	DT	det	O
fat	NN	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
epithelioid	JJ	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
entirely	RB	advmod	O
supported	VBN	ROOT	O
by	IN	case	O
proliferated	VBN	amod	O
capillaries	NNS	nmod	B-Tissue
and	CC	cc	O
arteries	NNS	conj	B-Multi-tissue_structure
together	RB	advmod	O
with	IN	case	O
collagenous	JJ	amod	B-Tissue
stroma	NN	nmod	I-Tissue
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
inhibited	VBD	ROOT	O
the	DT	det	O
NK	NN	compound	B-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
blood	NN	compound	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

Although	IN	mark	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	nmod	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
positivity	NN	nsubj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
for	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	mark	O
reported	VBN	advcl	O
in	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

Breast	NN	compound	B-Tissue
tissue	NN	nsubjpass	I-Tissue
taken	VBN	acl	O
at	IN	case	O
varying	VBG	amod	O
postoperative	JJ	amod	O
times	NNS	nmod	O
(	-LRB-	punct	O
n	NN	nsubjpass	O
=	JJ	amod	O
92	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
during	IN	case	O
surgery	NN	conj	O
(	-LRB-	punct	O
controls	NNS	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	amod	O
17	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
temporal	JJ	amod	O
and	CC	cc	O
spatial	JJ	conj	O
activity	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	conj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
during	IN	case	O
human	JJ	amod	B-Organism
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
support	NN	dobj	O
for	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
2ME2	NN	nmod	B-Simple_chemical
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
advanced	JJ	conj	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	dep	I-Cancer
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
transplanted	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
rats	NNS	nmod	B-Organism
of	IN	case	O
different	JJ	amod	O
ages	NNS	nmod	O
on	IN	case	O
the	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
.	.	punct	O

Serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
valuable	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	ROOT	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

ELISA	NN	nsubj	O
found	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
tested	VBN	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
NOK	NN	conj	B-Cell
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
benefit	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
after	IN	case	O
a	DT	det	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
is	VBZ	auxpass	O
diminished	VBN	ROOT	O
by	IN	case	O
early	JJ	amod	O
cell	NN	compound	B-Cell
losses	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	case	O
coculture	NN	compound	O
conditioned	JJ	amod	O
media	NNS	nmod	O
show	VBP	appos	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
decreased	VBN	amod	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	I-Gene_or_gene_product
levels	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
a	DT	det	O
suitable	JJ	amod	O
donor	NN	compound	B-Cell
cell	NN	compound	I-Cell
population	NN	dobj	I-Cell
for	IN	case	O
gene	NN	compound	O
therapy	NN	compound	O
applications	NNS	nmod	O
to	TO	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
,	,	punct	O
primary	JJ	amod	O
fibroblasts	NNS	nsubjpass	B-Cell
isolated	VBN	acl	O
from	IN	case	O
skin	NN	compound	B-Multi-tissue_structure
biopsies	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
maintained	VBN	conj	O
in	IN	case	O
culture	NN	nmod	B-Cell
are	VBP	auxpass	O
employed	VBN	ROOT	O
as	IN	case	O
autologous	JJ	amod	O
cells	NNS	nmod	B-Cell
for	IN	case	O
intracerebral	JJ	amod	B-Immaterial_anatomical_entity
grafting	VBG	nmod	O
within	IN	case	O
the	DT	det	O
adult	JJ	amod	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
induced	VBN	amod	O
genes	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
whole	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
meaningful	JJ	amod	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
and	CC	cc	O
TH1	NN	compound	B-Gene_or_gene_product
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
received	VBD	ROOT	O
either	CC	cc:preconj	O
0	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
ml	NN	compound	O
linomide	NN	nsubjpass	B-Simple_chemical
in	IN	prep	O
drinking	VBG	pcomp	O
water	NN	dobj	O
or	CC	cc	O
acidified	VBD	amod	O
water	NN	conj	O
and	CC	cc	O
were	VBD	auxpass	O
followed	VBN	ROOT	O
until	IN	case	O
tumor	NN	compound	B-Cancer
diameter	NN	nsubj	O
reached	VBD	ccomp	O
3	CD	nummod	O
cm	NN	dobj	O
or	CC	cc	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
at	IN	case	O
least	JJS	mwe	O
some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
were	VBD	auxpass	O
not	RB	neg	O
methylated	VBN	ROOT	O
in	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
the	DT	det	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

By	IN	prep	O
21	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
,	,	punct	O
all	DT	det	O
activity	NN	nsubj	O
had	VBD	aux	O
returned	VBN	ROOT	O
to	TO	case	O
near	IN	case	O
baseline	NN	compound	O
level	NN	nmod	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

Patients	NNS	poss	B-Organism
'	POS	case	O
reading	VBG	compound	O
vision	NN	nsubjpass	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
saved	VBN	ROOT	O
for	IN	prep	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
run	NN	pobj	O
.	.	punct	O

VEGF165	NN	nsubj	B-Gene_or_gene_product
expressed	VBN	acl	O
by	IN	case	O
a	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
recombinant	JJ	amod	O
adenovirus	NN	compound	B-Organism
vector	NN	nmod	O
induces	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
suppression	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
decreased	VBD	ROOT	O
the	DT	det	O
transcript	NN	compound	O
levels	NNS	dobj	O
and	CC	cc	O
BMP	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
Smad1	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	O
5	CD	conj	B-Gene_or_gene_product
/	SYM	punct	O
8	CD	nummod	B-Gene_or_gene_product
,	,	punct	O
critical	JJ	amod	O
downstream	JJ	amod	O
targets	NNS	conj	O
of	IN	case	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
PC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Under	IN	prep	O
this	DT	det	O
condition	NN	pobj	O
,	,	punct	O
the	DT	det	O
secondary	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
effected	JJ	amod	O
cells	NNS	nmod	B-Cell
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
impaired	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
new	JJ	amod	O
metabolic	JJ	amod	O
equilibrium	NN	nsubjpass	O
is	VBZ	auxpass	O
established	VBN	conj	O
,	,	punct	O
determined	VBN	conj	O
by	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
cross	NN	compound	O
-	HYPH	punct	O
diffusion	NN	nmod	O
and	CC	cc	O
degree	NN	conj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
SREBP	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Cdc42	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	conj	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
therefore	RB	advmod	O
has	VBZ	ROOT	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
culture	NN	nmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	conj	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
to	TO	mark	O
induce	VB	xcomp	O
tumorigenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	B-Cell
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
mice	NNS	nmod	B-Organism
pleiotropic	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
PTHrP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
key	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
-	:	punct	O
it	PRP	nsubj	O
influences	VBZ	parataxis	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
primary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
metastases	NNS	conj	O
.	.	punct	O

Hypoxia	NN	nsubj	O
rapidly	RB	advmod	O
induced	VBD	ROOT	O
both	CC	cc:preconj	O
JNK1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
T	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	nmod	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
surface	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
the	DT	det	O
appearance	NN	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
partial	JJ	amod	O
demethylation	NN	conj	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
sequences	NNS	nmod	O
.	.	punct	O

Fibroblasts	NNS	nsubj	B-Cell
of	IN	case	O
the	DT	det	O
host	NN	compound	O
animal	NN	nmod	B-Organism
may	MD	aux	O
thus	RB	advmod	O
have	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
generating	VBG	advcl	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

p53	NN	compound	B-Gene_or_gene_product
targets	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
regulation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ccomp	O
simultaneously	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
group	NN	nsubj	O
seeks	VBZ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
basic	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
ES	NN	compound	O
wound	NN	compound	B-Pathological_formation
therapy	NN	dobj	O
,	,	punct	O
an	DT	det	O
area	NN	appos	O
where	WRB	advmod	O
understanding	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
limited	JJ	acl:relcl	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
study	NN	nsubj	O
provides	VBZ	appos	O
new	JJ	amod	O
candidate	NN	compound	O
genes	NNS	dobj	O
for	IN	case	O
the	DT	det	O
esophageal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
microenvironment	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Immunostaining	NN	nsubj	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	conj	O
revealed	VBD	ROOT	O
a	DT	det	O
more	RBR	advmod	O
significant	JJ	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
downregulation	NN	dobj	O
in	IN	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
methylated	VBN	amod	O
CCMs	NNS	nmod	B-Pathological_formation
in	IN	case	O
comparison	NN	nmod	O
to	TO	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
unmethylated	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

In	IN	case	O
pre	JJ	compound	B-Cancer
-	HYPH	punct	I-Cancer
B	NNP	compound	I-Cancer
acute	JJ	amod	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
ALL	NN	appos	B-Cancer
)	-RRB-	punct	O
with	IN	case	O
t	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
;	:	punct	O
19	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
a	DT	det	O
fusion	NN	compound	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
created	VBN	ROOT	O
between	IN	case	O
E2A	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
a	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
PBX	NN	conj	B-Gene_or_gene_product
.	.	punct	O

During	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
proteolytic	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
tumor	NN	nmod	B-Cell
and	CC	cc	O
stromal	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
modify	VBP	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	dobj	I-Cellular_component
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
microenvironment	NN	amod	O
suitable	JJ	dobj	O
for	IN	case	O
their	PRP$	poss	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
we	PRP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
preclinical	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
results	NNS	conj	O
,	,	punct	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
promising	JJ	amod	O
antitubulin	NN	compound	B-Simple_chemical
agents	NNS	nmod	I-Simple_chemical
:	:	punct	O
the	DT	det	O
combretastatin	NN	compound	B-Simple_chemical
A4	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
derivative	NN	dep	I-Simple_chemical
,	,	punct	O
AVE8062A	NN	appos	B-Simple_chemical
.	.	punct	O

Villani	NNP	ROOT	O
et	FW	dep	O
al	FW	conj	O
.	.	punct	O
define	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
regulatory	JJ	amod	O
protein	NN	compound	O
Igfbp2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
basal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinogenesis	NN	nmod	O
driven	VBN	acl	O
by	IN	case	O
targeted	VBN	amod	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
hedgehog	JJ	amod	B-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
and	CC	cc	O
hemodynamic	JJ	amod	O
forces	NNS	conj	O
(	-LRB-	punct	O
and	CC	cc	O
more	RBR	advmod	O
specifically	RB	advmod	O
,	,	punct	O
fluid	NN	compound	O
shear	NN	compound	O
stress	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
flow	NN	nmod	O
of	IN	case	O
blood	NN	nmod	B-Organism_substance
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
and	CC	cc	O
in	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	compound	I-Multi-tissue_structure
formation	NN	conj	O
via	IN	case	O
a	DT	det	O
process	NN	nmod	O
termed	VBN	acl	O
arteriogenesis	NN	xcomp	O
.	.	punct	O

Highly	RB	advmod	O
sensitive	JJ	amod	O
reverse	NN	compound	O
-	HYPH	punct	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
identifies	VBZ	ROOT	O
an	DT	det	O
induction	NN	dobj	O
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
a	DT	det	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
in	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
irrespective	JJ	amod	O
of	IN	case	O
tissue	NN	compound	B-Tissue
origin	NN	nmod	O
.	.	punct	O

Angiostatin	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
thalidomide	NN	conj	B-Simple_chemical
both	CC	conj	O
inhibited	VBD	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	prep	O
about	RB	advmod	O
55	CD	nummod	O
%	NN	pobj	O
.	.	punct	O

Isotype	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
inhibitors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
key	JJ	amod	O
regulator	NN	compound	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
subtype	NN	compound	I-Gene_or_gene_product
M2	NN	nmod	I-Gene_or_gene_product
moderately	RB	advmod	O
decelerate	VBP	ROOT	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
tumorigenesis	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
human	JJ	nmod	B-Organism
and	CC	cc	O
other	JJ	amod	O
mammalian	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
two	CD	nummod	O
inflammatory	JJ	amod	O
agents	NNS	dobj	O
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1beta	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
phorbol	NN	compound	B-Simple_chemical
myristic	JJ	amod	I-Simple_chemical
acetate	NN	conj	I-Simple_chemical
,	,	punct	O
to	TO	mark	O
activate	VB	advcl	O
PKC	NN	compound	B-Gene_or_gene_product
isozymes	NNS	dobj	O
and	CC	cc	O
specific	JJ	amod	O
inhibitors	NNS	conj	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Go6976	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
PKCbeta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
hispidin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
to	TO	mark	O
distinguish	VB	advcl	O
how	WRB	advmod	O
each	DT	nsubj	O
of	IN	case	O
these	DT	det	O
isoform	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
controls	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
.	.	punct	O

The	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
in	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
:	:	punct	O
analysis	NN	dep	O
of	IN	case	O
microsatellite	NN	compound	O
regions	NNS	nmod	O
and	CC	cc	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
treated	VBN	amod	O
tumor	NN	nmod	B-Cancer
xenografts	NNS	advmod	I-Cancer
revealed	VBD	ROOT	O
significantly	RB	advmod	O
decreased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
regulating	VBG	acl	O
glucose	NN	dobj	B-Simple_chemical
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
metabolism	NN	conj	O
and	CC	cc	O
revealed	VBD	conj	O
changes	NNS	dobj	O
in	IN	case	O
apoptotic	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
imaging	VBG	amod	O
tracers	NNS	compound	O
FDG	NN	nsubj	B-Simple_chemical
,	,	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
fluorothymidine	NN	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
annexin	NN	compound	B-Gene_or_gene_product
V	NN	conj	I-Gene_or_gene_product
could	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
potential	JJ	amod	O
imaging	NN	amod	O
biomarkers	NNS	nmod	O
for	IN	case	O
RAF265	NN	compound	B-Simple_chemical
therapy	NN	compound	O
monitoring	NN	nmod	O
.	.	punct	O

No	DT	neg	O
effective	JJ	amod	O
medical	JJ	amod	O
therapies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
sofar	RB	advmod	O
to	TO	mark	O
enhance	VB	xcomp	O
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
in	IN	case	O
the	DT	det	O
legs	NNS	nmod	B-Organism_subdivision
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
(	-LRB-	punct	O
PAD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
well	RB	advmod	O
known	VBN	advcl	O
that	IN	mark	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
dysregulated	VBN	ccomp	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
implications	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
observation	NN	nmod	O
are	VBP	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
LMP1	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ROOT	O
pleiotropic	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	compound	O
arrest	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
background	NN	advcl	O
of	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Calculations	NNS	nsubj	O
of	IN	prep	O
the	DT	det	O
sources	NNS	pobj	O
of	IN	case	O
energy	NN	nmod	O
for	IN	case	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	compound	I-Simple_chemical
synthesis	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
on	IN	case	O
the	DT	det	O
average	NN	nmod	O
about	IN	case	O
one	CD	nummod	O
-	HYPH	punct	O
third	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
respiratory	JJ	amod	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	nmod	I-Simple_chemical
is	VBZ	auxpass	O
generated	VBN	ccomp	O
by	IN	case	O
electron	NN	compound	B-Simple_chemical
flow	NN	compound	O
originating	VBG	nmod	O
from	IN	case	O
cytosolic	JJ	amod	B-Cellular_component
NADH	NN	nmod	B-Simple_chemical
via	IN	case	O
the	DT	det	O
malate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transform	VBP	acl:relcl	O
to	TO	mark	O
overt	VB	xcomp	O
MDS	NN	dobj	O
or	CC	cc	O
AML	NN	conj	B-Cancer
,	,	punct	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
transplantation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
chance	NN	ROOT	O
for	IN	prep	O
cure	NN	pobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
how	WRB	advmod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
trigger	VBP	acl	O
metastasis	NN	dobj	O
by	IN	mark	O
perturbing	VBG	advcl	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
interactions	NNS	dobj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
considerable	JJ	amod	O
debate	NN	attr	O
concerning	VBG	acl	O
where	WRB	pcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
Notch	NN	compound	B-Gene_or_gene_product
functions	NNS	nmod	O
and	CC	cc	O
what	WP	dobj	O
proteins	NNS	nsubj	O
serve	VBP	conj	O
as	IN	prep	O
effectors	NNS	pobj	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
signal	NN	nmod	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
peritoneal	NN	compound	B-Multi-tissue_structure
dialysis	NN	nsubjpass	O
(	-LRB-	punct	O
PD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	prep	O
ultrafiltration	NN	pobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
pellets	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
CLA	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
fed	JJ	amod	O
animals	NNS	nmod	O
contained	VBD	advcl	O
fewer	JJR	amod	O
infiltrating	JJ	amod	O
cells	NNS	dobj	B-Cell
,	,	punct	O
which	WDT	nsubj	O
formed	VBD	acl:relcl	O
limited	JJ	amod	O
branching	VBG	amod	O
cellular	JJ	amod	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
majority	NN	nsubj	O
of	IN	prep	O
which	WDT	pobj	O
had	VBD	aux	O
collapsed	VBN	ROOT	O
lumen	NN	dobj	B-Immaterial_anatomical_entity
and	CC	cc	O
no	DT	neg	O
RBCs	NNS	conj	B-Cell
.	.	punct	O

Aquaporins	NNS	ROOT	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
identification	NN	dep	O
and	CC	cc	O
involvement	NN	conj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	nmod	O
in	IN	case	O
the	DT	det	O
functional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
universal	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	nmod	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
tunicamycin	NN	appos	B-Simple_chemical
,	,	punct	O
on	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-Organism
leukemic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
K562	NN	dep	I-Cell
,	,	punct	O
U937	NN	conj	B-Cell
and	CC	cc	O
HL60	NN	conj	B-Cell
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	prep	O
nu	CC	advmod	B-Organism
/	SYM	punct	I-Organism
nu	PRP	amod	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
nonobese	JJ	amod	B-Organism
diabetic	JJ	amod	I-Organism
-	HYPH	punct	I-Organism
SCID	NN	compound	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
or	CC	cc	O
activated	VBN	ROOT	O
spc	NN	advmod	B-Cell
enriched	VBN	dobj	O
in	IN	case	O
specific	JJ	amod	O
cell	NN	compound	B-Cell
subpopulations	NNS	nmod	O
demonstrated	VBD	conj	O
that	IN	mark	O
CD4	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
CD8	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
NK	NN	compound	B-Cell
cells	NNS	conj	I-Cell
are	VBP	auxpass	O
all	DT	advmod	O
needed	VBN	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
full	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenetic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
only	JJ	amod	O
CD8	NN	nsubj	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
postthymic	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lymphoma	NN	conj	O
also	RB	advmod	O
expressed	VBD	ROOT	O
all	DT	det	O
three	CD	nummod	O
cytolytic	JJ	amod	O
markers	NNS	dobj	O
,	,	punct	O
two	CD	nummod	O
CD8	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ALCL	NN	nsubj	O
expressed	VBD	parataxis	O
TIA1	NN	dobj	B-Gene_or_gene_product
;	:	punct	O
other	JJ	amod	O
postthymic	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
,	,	punct	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
were	VBD	cop	O
consistently	RB	advmod	O
negative	JJ	parataxis	O
.	.	punct	O

Angiogenin	NN	ROOT	B-Gene_or_gene_product
,	,	punct	O
a	DT	quantmod	O
14	CD	appos	O
.	.	punct	O
2	CD	nummod	O
kD	NN	compound	O
polypeptide	NN	nsubjpass	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
originally	RB	advmod	O
noted	VBN	acl:relcl	O
for	IN	case	O
its	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
now	RB	advmod	O
increasingly	RB	advmod	O
recognized	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
multiplicity	NN	dobj	O
of	IN	case	O
biological	JJ	amod	O
roles	NNS	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
conditions	NNS	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
expressed	VBN	ROOT	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
mutant	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
determine	VB	xcomp	O
in	IN	mark	O
what	WDT	det	O
aspects	NNS	nsubj	O
of	IN	prep	O
cytoskeletal	JJ	amod	B-Cellular_component
behavior	NN	pobj	O
this	DT	det	O
protein	NN	nsubj	O
participates	VBZ	advcl	O
.	.	punct	O

Role	NN	nsubj	O
of	IN	case	O
stromal	JJ	amod	B-Cell
myofibroblasts	NNS	nmod	I-Cell
in	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
stromal	JJ	amod	B-Cell
expression	NN	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	JJ	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	nmod	I-Gene_or_gene_product
correlates	VBZ	ROOT	O
with	IN	case	O
worse	JJR	amod	O
clinical	JJ	amod	O
outcome	NN	nmod	O
.	.	punct	O

A	DT	det	O
feasibility	NN	compound	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
develop	VB	xcomp	O
the	DT	det	O
Ahn	NNP	compound	O
/	:	punct	O
Mustoe	NNP	compound	O
lapine	NN	nsubj	B-Organism
wound	NN	conj	B-Pathological_formation
model	NN	dobj	O
for	IN	case	O
systematic	JJ	amod	O
investigation	NN	nmod	O
of	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
electrical	JJ	amod	O
stimulation	NN	nmod	O
on	IN	case	O
ischemic	JJ	amod	O
wound	NN	compound	B-Pathological_formation
therapy	NN	nmod	O
.	.	punct	O

Vasodilator	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulated	VBN	amod	I-Gene_or_gene_product
phosphoprotein	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VASP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
cellular	JJ	amod	B-Cell
reorganization	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
retraction	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
permeability	NN	nmod	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
differential	JJ	amod	O
expression	NN	conj	O
between	IN	case	O
P185neu	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LAR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
PTP1B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
directly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
tumorigenicity	NN	nmod	O
.	.	punct	O

Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

After	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
gluconeogenesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
plasma	NN	compound	B-Organism_substance
glucose	NN	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
and	CC	cc	O
the	DT	det	O
blood	NN	compound	B-Organism_substance
lactate	NN	nsubj	B-Simple_chemical
increased	VBD	conj	O
significantly	RB	advmod	O
more	JJR	advmod	O
in	IN	case	O
TB	NN	nmod	O
than	IN	case	O
NTB	NN	compound	O
animals	NNS	nmod	O
.	.	punct	O

SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

It	PRP	nsubj	O
involves	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	dobj	O
,	,	punct	O
basal	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
degradation	NN	conj	O
,	,	punct	O
leukocyte	NN	compound	B-Cell
invasion	NN	conj	O
,	,	punct	O
proliferation	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
neointima	NN	compound	B-Tissue
formation	NN	appos	O
(	-LRB-	punct	O
in	IN	case	O
most	JJS	amod	O
species	NNS	nmod	O
studied	VBN	acl	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
changes	NNS	conj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
.	.	punct	O

For	IN	ROOT	O
the	DT	det	O
purpose	NN	pobj	O
of	IN	prep	O
investigating	VBG	pcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
for	IN	prep	O
determing	VBG	pcomp	O
the	DT	det	O
location	NN	dobj	O
of	IN	case	O
the	DT	det	O
positive	JJ	amod	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
tumor	NN	compound	B-Cancer
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	nsubjpass	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
and	CC	cc	O
the	DT	det	O
nonneoplastic	JJ	amod	B-Multi-tissue_structure
area	NN	conj	I-Multi-tissue_structure
surrounding	VBG	acl	O
the	DT	det	O
tumor	NN	dobj	B-Cancer
)	-RRB-	punct	O
was	VBD	auxpass	O
detected	VBN	conj	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
using	VBG	acl	O
digoxiginin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
antisense	JJ	amod	O
complementary	JJ	amod	O
RNA	NN	compound	O
probe	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
to	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
chemicals	NNS	nmod	O
:	:	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	dep	I-Simple_chemical
and	CC	cc	O
MnSO4	NN	conj	B-Simple_chemical
.	.	punct	O

Only	RB	advmod	O
a	DT	det	O
subset	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
suitable	JJ	ROOT	O
for	IN	case	O
laser	NN	compound	O
coagulation	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
retroviral	JJ	amod	O
gene	NN	compound	O
transfer	NN	compound	O
approach	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
strongly	RB	advmod	O
inhibits	VBZ	ccomp	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
massive	JJ	amod	O
morphological	JJ	amod	O
changes	NNS	nmod	O
.	.	punct	O

p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
,	,	punct	O
hormone	NN	compound	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
negative	JJ	amod	O
neoplasms	NNS	ROOT	B-Cancer
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
,	,	punct	O
furthermore	RB	advmod	O
,	,	punct	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
heterogeneity	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

In	IN	case	O
nonischemic	JJ	amod	O
hind	NN	amod	B-Tissue
limb	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
injection	NN	nsubjpass	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
comparatively	RB	advmod	O
small	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Cell
lymphocyte	NN	compound	I-Cell
infiltration	NN	nmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
injection	NN	advcl	O
of	IN	case	O
allogeneic	JJ	amod	O
splenic	JJ	amod	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

Apoptosis	NN	nsubjpass	O
is	VBZ	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
TUNEL	NN	compound	O
method	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
and	CC	cc	O
lymphangiogenic	JJ	conj	O
profiles	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
were	VBD	auxpass	O
characterized	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	JJ	nmod	B-Gene_or_gene_product
closely	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
poly	NN	amod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ADP	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ribose	NN	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
polymerase	NN	compound	I-Gene_or_gene_product
cleavage	NN	nmod	O
and	CC	cc	O
CPP32	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
injected	VBN	advcl	O
into	IN	case	O
chicken	NN	compound	B-Organism
embryos	NNS	nmod	B-Developing_anatomical_structure
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
helper	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
both	DT	det	O
viruses	NNS	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
erythroleukemia	NN	dobj	B-Cancer
in	IN	case	O
about	RB	advmod	O
half	NN	nmod	O
of	IN	prep	O
the	DT	det	O
animals	NNS	pobj	O
.	.	punct	O

SVLT	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubjpass	O
,	,	punct	O
defective	JJ	amod	O
either	CC	advmod	O
in	IN	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
site	NN	nmod	O
,	,	punct	O
near	IN	case	O
the	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
end	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
region	NN	nmod	O
that	WDT	nsubj	O
affects	VBZ	acl:relcl	O
binding	VBG	dobj	O
to	TO	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
transport	NN	compound	O
signal	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
employed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
interference	NN	nsubj	O
was	VBD	cop	O
especially	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
these	DT	det	O
functional	JJ	amod	O
domains	NNS	nmod	O
.	.	punct	O

Pathological	JJ	amod	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
generated	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
corresponded	VBD	ccomp	O
to	TO	case	O
well	RB	advmod	O
-	HYPH	punct	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	nmod	B-Cancer
with	IN	case	O
distinct	JJ	amod	O
and	CC	cc	O
intersecting	VBG	conj	O
bundles	NNS	nmod	B-Cell
and	CC	cc	O
spindle	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

MET	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Hyp	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
compound	NN	ccomp	O
with	IN	case	O
therapeutic	JJ	amod	O
potential	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
elucidate	VBP	conj	O
mechanistic	JJ	amod	O
keys	NNS	dobj	O
.	.	punct	O

In	IN	case	O
seven	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
profound	JJ	amod	O
finding	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	ROOT	O
of	IN	case	O
the	DT	det	O
PEDF	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	dep	O
:	:	punct	O
237	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
comparable	JJ	parataxis	O
to	TO	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	nmod	O
:	:	punct	O
3153	CD	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Reconstitution	NN	nsubj	O
of	IN	case	O
MCF	NNP	compound	B-Organism_substance
-	HYPH	punct	I-Organism_substance
7	CD	nummod	I-Organism_substance
cell	NN	compound	I-Organism_substance
extracts	NNS	nmod	I-Organism_substance
with	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
corrects	VBZ	ROOT	O
this	DT	det	O
defect	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
an	DT	det	O
efficient	JJ	amod	O
and	CC	cc	O
complete	JJ	conj	O
processing	NN	nmod	O
of	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
affecting	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	dobj	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
tube	NN	compound	I-Tissue
formation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
EA	NN	nmod	I-Cell
.	.	punct	I-Cell
hy	NN	dep	I-Cell
926	CD	nummod	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
cause	NN	nmod	O
of	IN	case	O
adult	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
ATL	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Their	PRP$	nmod:poss	O
relevance	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
therapeutic	JJ	amod	O
potential	NN	nsubj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
deserves	VBZ	ROOT	O
further	JJ	amod	O
study	NN	dobj	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymphangiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
prevailing	VBG	amod	O
model	NN	nsubj	O
for	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
ligand	NN	nsubj	O
,	,	punct	O
presented	VBN	acl	O
on	IN	case	O
a	DT	det	O
neighboring	JJ	amod	O
cell	NN	nmod	B-Cell
,	,	punct	O
triggers	VBZ	ccomp	O
proteolytic	JJ	amod	O
processing	NN	dobj	O
of	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
antitumor	JJ	compound	B-Cancer
agents	NNS	nmod	O
on	IN	case	O
cytotoxicity	NN	compound	O
induction	NN	nmod	O
by	IN	case	O
sodium	NN	compound	B-Simple_chemical
fluoride	NN	nmod	I-Simple_chemical
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	nsubj	O
by	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
requires	VBZ	ROOT	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
osteoprotegerin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPG	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
osteoclast	JJ	compound	B-Cell
development	NN	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
ITCs	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	nmod	I-Organism_substance
and	CC	cc	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	conj	I-Multi-tissue_structure
even	RB	advmod	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Collagen	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
poly	JJ	amod	B-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
hybrid	NN	compound	O
matrix	NN	nsubj	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
accelerated	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
diabetic	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
an	DT	det	O
animal	NN	compound	O
model	NN	dobj	O
by	IN	mark	O
using	VBG	advcl	O
an	DT	det	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	O
HEC1A	NN	appos	B-Cell
.	.	punct	O

In	IN	case	O
uremic	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
positively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
PD	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
how	WRB	advmod	O
p18	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
genetically	RB	advmod	O
interact	VBP	ccomp	O
with	IN	case	O
Men1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	appos	O
mutated	VBN	acl	O
in	IN	case	O
familial	JJ	amod	O
MEN1	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
p18	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	conj	B-Gene_or_gene_product
double	JJ	amod	O
mutant	JJ	amod	O
mice	NNS	dep	O
.	.	punct	O

When	WRB	advmod	O
a	DT	det	O
confluent	JJ	amod	O
monolayer	NN	nsubjpass	B-Cell
of	IN	case	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
ECV304	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
denuded	VBN	advcl	O
,	,	punct	O
ECV304	NN	nsubj	B-Cell
at	IN	case	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
edge	NN	nmod	I-Pathological_formation
expressed	VBD	ROOT	O
Ets	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Opticin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
discovered	VBN	amod	O
glycoprotein	NN	appos	O
present	JJ	amod	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
vitreous	JJ	amod	B-Organism_substance
humour	NN	nmod	I-Organism_substance
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrate	VBP	ROOT	O
direct	JJ	amod	O
interaction	NN	dobj	O
of	IN	case	O
Egr	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
with	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	IN	case	O
cell	NN	compound	B-Cell
culture	NN	conj	I-Cell
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	appos	I-Gene_or_gene_product
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	B-Tissue
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	B-Organism
shark	NN	pobj	I-Organism
(	-LRB-	punct	O
Prionace	NN	compound	B-Organism
glauca	NN	appos	I-Organism
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
substantial	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
P185neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
led	VBD	acl:relcl	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
progressively	RB	advmod	O
growing	VBG	amod	O
carcinomas	NNS	nmod	B-Cancer
after	IN	case	O
such	JJ	amod	O
cells	NNS	nmod	B-Cell
were	VBD	auxpass	O
inoculated	VBN	conj	O
into	IN	case	O
athymic	JJ	amod	O
nude	JJ	compound	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Plasmid	NN	amod	B-Cellular_component
DNA	NN	nsubjpass	I-Cellular_component
encoding	VBG	acl	O
each	DT	dobj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
principal	JJ	amod	O
human	JJ	amod	B-Organism
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nmod	O
(	-LRB-	punct	O
phVEGF121	NN	dep	B-Gene_or_gene_product
,	,	punct	O
phVEGF165	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
phVEGF189	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
hydrogel	NN	compound	O
polymer	NN	nmod	O
coating	VBG	acl	O
of	IN	case	O
an	DT	det	O
angioplasty	JJ	amod	O
balloon	NN	nmod	O
and	CC	cc	O
delivered	VBN	conj	O
percutaneously	RB	advmod	O
to	IN	case	O
one	CD	nummod	O
iliac	JJ	compound	B-Multi-tissue_structure
artery	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
rabbits	NNS	nmod	B-Organism
with	IN	case	O
operatively	RB	advmod	O
induced	VBN	amod	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

LDH5	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ROOT	O
an	DT	det	O
upregulated	VBN	amod	O
glycolytic	JJ	amod	O
metabolism	NN	dobj	O
and	CC	cc	O
reduced	VBN	amod	O
dependence	NN	conj	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Sema7A	NN	nsubj	B-Gene_or_gene_product
stimulates	VBZ	ccomp	O
cytoskeletal	JJ	amod	B-Cellular_component
reorganization	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
adhesion	NN	nmod	O
and	CC	cc	O
dendrite	NN	compound	B-Cellular_component
formation	NN	conj	O
.	.	punct	O

Because	IN	mark	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	nsubj	O
of	IN	case	O
OPN	NN	compound	B-Gene_or_gene_product
results	VBZ	nmod	O
in	IN	case	O
substantial	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
OPN	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
adhesive	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
because	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	conj	O
increased	VBD	amod	O
microvascular	JJ	amod	B-Tissue
permeability	NN	dobj	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
extrinsic	JJ	amod	O
coagulation	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
investigated	VBD	ROOT	O
whether	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
facilitates	NNS	ccomp	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	dobj	O
of	IN	case	O
OPN	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
tissue	NN	compound	B-Cancer
samples	NNS	nmod	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
risk	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
course	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
MSCs	NNS	nsubjpass	B-Cell
from	IN	case	O
Sprague	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Dawley	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
SD	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rats	NNS	nmod	I-Organism
were	VBD	auxpass	O
isolated	VBN	dep	O
and	CC	cc	O
cultured	VBN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
composition	NN	nmod	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	dobj	O
,	,	punct	O
or	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
other	JJ	amod	O
autophagy	NN	compound	O
genes	NNS	conj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	B-Cancer
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	B-Gene_or_gene_product
/	:	punct	O
Erk	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
PI3K	NN	conj	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
.	.	punct	O

The	DT	det	O
semaphorin	NN	compound	B-Gene_or_gene_product
7A	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
lost	VBN	ROOT	O
during	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

Eleven	CD	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
changed	VBD	ccomp	O
significantly	RB	advmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
carcinogen	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

There	EX	expl	O
have	VBP	aux	O
been	VBN	ROOT	O
no	DT	det	O
reports	NNS	attr	O
showing	VBG	acl	O
the	DT	det	O
relativity	NN	dobj	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	conj	O
by	IN	case	O
a	DT	det	O
quantitative	JJ	amod	O
analysis	NN	nmod	O
of	IN	prep	O
the	DT	det	O
myofibroblasts	NNS	pobj	B-Cell
that	WDT	nsubj	O
were	VBD	relcl	O
an	DT	det	O
important	JJ	amod	O
player	NN	attr	O
in	IN	prep	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	pobj	O
.	.	punct	O

Medical	JJ	amod	O
therapy	NN	ROOT	O
for	IN	case	O
intermittent	JJ	amod	O
claudication	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
adenosine	NN	nsubj	B-Simple_chemical
could	MD	aux	O
modulate	VB	ccomp	O
the	DT	det	O
migration	NN	dobj	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
an	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
/	:	punct	O
IL	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
has	VBZ	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
inhibit	VB	acl	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
Bax	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
Bak	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
rapidly	RB	advmod	O
translocated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
30	CD	nummod	O
min	NN	dep	O
after	IN	case	O
betulin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
either	CC	cc:preconj	O
the	DT	det	O
structural	JJ	nsubjpass	O
or	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
integrity	NN	conj	O
of	IN	case	O
the	DT	det	O
J	NN	compound	O
domain	NN	nmod	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
invasion	NN	nsubjpass	O
,	,	punct	O
apoptosis	NN	conj	O
and	CC	cc	O
levels	NNS	conj	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	dep	O
by	IN	case	O
invasion	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	appos	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
fluorescence	NN	compound	O
quantitative	JJ	amod	O
PCR	NN	conj	O
respectively	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
laboratory	NN	nsubj	O
has	VBZ	aux	O
provided	VBN	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
thrombin	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
a	DT	det	O
process	NN	dobj	O
which	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
were	VBD	cop	O
largely	RB	advmod	O
attributable	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
attenuated	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p19	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Arf	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
proteins	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
generally	RB	advmod	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
by	IN	case	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
young	JJ	amod	O
mice	NNS	nmod	B-Organism
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
acts	VBZ	ccomp	O
only	RB	advmod	O
through	IN	case	O
an	DT	det	O
antiangiogenic	JJ	amod	O
mechanism	NN	nmod	O
or	CC	cc	O
whether	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
also	RB	advmod	O
directly	RB	advmod	O
target	VB	conj	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
expressed	VBN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Normal	JJ	amod	O
and	CC	cc	O
transforming	VBG	conj	O
functions	NNS	ROOT	O
of	IN	case	O
RUNX1	NN	nmod	B-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
perspective	NN	dep	O
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
over	IN	case	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
period	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
gonadotropin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
estrogen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
maintenance	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
could	MD	aux	O
control	VB	ROOT	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
angiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
selective	JJ	amod	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nsubj	O
,	,	punct	O
SC	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
560	CD	appos	I-Simple_chemical
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
serum	NN	compound	B-Organism_substance
progesterone	NN	compound	B-Simple_chemical
concentrations	NNS	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
VAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	nsubj	O
occur	VBP	ROOT	O
in	IN	case	O
certain	JJ	amod	O
diseases	NNS	nmod	O
having	VBG	acl	O
an	DT	det	O
inflammatory	JJ	amod	O
component	NN	dobj	O
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
b	NN	ROOT	B-Cell
.	.	punct	I-Cell
END5	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
the	DT	det	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	ROOT	O
up	RP	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	conj	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
that	WDT	nsubjpass	O
were	VBD	auxpass	O
preincubated	VBN	acl:relcl	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
surgical	JJ	amod	O
specimens	NNS	nmod	O
of	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
69	CD	dep	O
)	-RRB-	punct	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

Tetracyclines	NNS	nsubj	B-Simple_chemical
are	VBP	ROOT	O
antimicrobial	JJ	amod	O
agents	NNS	attr	O
that	WDT	nsubj	O
can	MD	aux	O
suppress	VB	acl:relcl	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
including	VBG	case	O
gingiva	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
bone	NN	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
cartilage	NN	conj	B-Tissue
.	.	punct	O

Differential	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
radiosensitization	NN	nmod	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
monolayers	NNS	nmod	B-Cell
and	CC	cc	O
multicellular	JJ	amod	B-Cell
spheroids	NNS	conj	I-Cell
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

Growth	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
modified	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
was	VBD	auxpass	O
significantly	RB	advmod	O
restricted	JJ	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

ECs	NNS	nsubj	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ROOT	O
highest	JJS	amod	O
speed	NN	dobj	O
,	,	punct	O
particularly	RB	advmod	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
the	DT	det	O
strip	NN	pobj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
enhanced	VBD	ROOT	O
killing	NN	dobj	O
of	IN	case	O
myeloid	JJ	amod	B-Cell
leukemia	NN	compound	I-Cell
U937	NN	nmod	I-Cell
,	,	punct	O
cervical	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
HeLa	NN	conj	I-Cell
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
upon	IN	case	O
death	NN	compound	O
receptor	NN	compound	O
ligation	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	B-Simple_chemical
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
serine	NN	nmod	B-Amino_acid
392	CD	nummod	I-Amino_acid
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Untransformed	JJ	amod	O
CEF	NN	nsubj	B-Cell
and	CC	cc	O
CEF	NN	conj	B-Cell
transformed	VBN	acl	O
with	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
also	RB	advmod	O
migrated	VBD	ROOT	O
to	TO	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Boyden	NNP	compound	O
single	JJ	amod	O
-	HYPH	punct	O
membrane	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
high	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
and	CC	cc	O
H	NN	conj	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
infection	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
closely	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
carcinogenesis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RSC	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
these	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
samples	NNS	conj	B-Tissue
from	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
for	IN	case	O
the	DT	det	O
expressions	NNS	nmod	O
of	IN	case	O
OPG	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
RANKL	NN	conj	B-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Non	NNP	compound	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	nsubj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	pobj	B-Cancer
tumours	NNS	ROOT	I-Cancer
:	:	punct	O
results	NNS	dep	O
of	IN	case	O
a	DT	det	O
comparative	JJ	amod	O
study	NN	nmod	O
between	IN	case	O
SPET	NN	nmod	O
with	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alpha	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
tyrosine	NN	nmod	I-Simple_chemical
and	CC	cc	O
PET	NN	conj	O
with	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	nmod	I-Simple_chemical
.	.	punct	O

HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
quantification	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	conj	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
after	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
metronomic	JJ	amod	O
CPT	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	dep	I-Simple_chemical
,	,	punct	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
,	,	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	dep	I-Simple_chemical
and	CC	cc	O
their	PRP$	nmod:poss	O
simultaneous	JJ	amod	O
combination	NN	conj	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
clones	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
showed	VBD	ROOT	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
and	CC	cc	O
exhibited	VBD	conj	O
little	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
amplification	NN	dobj	O
with	IN	case	O
correspondingly	RB	advmod	O
low	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Oxygent	JJ	amod	B-Simple_chemical
perfusion	NN	compound	O
medium	NN	nsubj	O
increased	VBD	ROOT	O
the	DT	det	O
TET	NN	compound	B-Tissue
epithelial	JJ	amod	I-Tissue
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
51	CD	dep	O
.	.	punct	O
2	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	appos	O
.	.	punct	O
3	CD	nummod	O
mm	NN	ROOT	O
Hg	NNP	dep	O
vs	CC	cc	O
.	.	punct	O
33	CD	nummod	O
.	.	punct	O
4	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
200	CD	nummod	O
microm	NN	compound	O
thickness	NN	nmod	O
;	:	punct	O
12	CD	dep	O
.	.	punct	O
5	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NNP	ROOT	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
1	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
400	CD	nummod	O
microm	JJ	compound	O
thickness	NN	nmod	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nummod	O
.	.	punct	O
01	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
decreased	VBD	conj	O
the	DT	det	O
lactate	NN	compound	B-Simple_chemical
concentration	NN	dobj	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
63	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
08	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
80	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
06	CD	nummod	O
mmol	NN	compound	O
/	:	punct	O
L	NN	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
pyruvate	NN	dep	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	O
.	.	punct	O
87	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
26	CD	dep	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
36	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
.	.	punct	O
13	CD	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
glucose	NN	compound	B-Simple_chemical
ratios	NNS	ROOT	O
(	-LRB-	punct	O
0	CD	dep	O
.	.	punct	O
10	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
29	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
14	CD	dep	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
or	CC	cc	O
mutant	JJ	amod	O
survivin	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
investigated	VBN	ROOT	O
on	IN	case	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
stability	NN	nmod	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
viability	NN	conj	O
,	,	punct	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
on	IN	case	O
kinetics	NNS	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
a	DT	det	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
intense	JJ	amod	O
staining	NN	nsubj	O
for	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
basolateral	JJ	amod	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
intestinal	JJ	amod	B-Cancer
metaplasia	NN	nmod	I-Cancer
(	-LRB-	punct	O
22	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
91	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	O
situ	FW	advmod	O
(	-LRB-	punct	O
9	CD	nummod	O
/	SYM	punct	O
10	CD	dep	O
;	:	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
lesions	NNS	attr	B-Pathological_formation
that	WDT	nsubj	O
displayed	VBD	acl:relcl	O
a	DT	det	O
significantly	RB	advmod	O
high	JJ	amod	O
proliferation	NN	compound	O
index	NN	dobj	O
.	.	punct	O

Alpha	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
melanocyte	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	VBG	amod	I-Gene_or_gene_product
hormone	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
evolved	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
mediator	NN	nmod	O
of	IN	case	O
diverse	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nmod	O
in	IN	case	O
an	DT	det	O
ever	RB	advmod	O
-	HYPH	punct	O
growing	VBG	amod	O
number	NN	nmod	O
of	IN	prep	O
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
melanocytic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
types	NNS	pobj	O
.	.	punct	O

To	TO	mark	O
confirm	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
lymphangiogenesis	NN	nmod	O
in	IN	mark	O
mediating	VBG	advcl	O
metastasis	NN	dobj	O
,	,	punct	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
LAPC	NN	compound	B-Cell
-	:	punct	I-Cell
9	CD	nummod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
engineered	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
metastases	NNS	nmod	B-Cancer
was	VBD	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
will	MD	aux	O
also	RB	advmod	O
discuss	VB	ROOT	O
several	JJ	amod	O
patents	NNS	dobj	O
regarding	VBG	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
review	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
during	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Prognostic	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
27	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HSP27	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
MYC	NN	conj	B-Gene_or_gene_product
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O

Thalidomide	NN	compound	B-Simple_chemical
[	-LRB-	punct	O
alpha	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phthalimido	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glutarimide	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
action	NN	nmod	O
remains	VBZ	conj	O
unclear	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
oxidative	JJ	amod	O
burst	NN	nsubjpass	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
stimulated	VBN	acl	O
by	IN	case	O
Annexin	NN	compound	B-Gene_or_gene_product
V	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
saline	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
MTX	NN	compound	B-Simple_chemical
group	NN	nmod	O
,	,	punct	O
while	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
abolished	VBD	advcl	O
this	DT	det	O
inhibition	NN	dobj	O
.	.	punct	O

Immunostaining	NN	amod	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
interpreted	VBN	ROOT	O
with	IN	case	O
computer	NN	compound	O
image	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
reported	VBN	conj	O
as	IN	case	O
stain	NN	compound	O
index	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
and	CC	cc	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	conj	O
techniques	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
detect	VB	xcomp	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
exon	NN	compound	O
11	CD	nummod	O
mutation	NN	conj	O
in	IN	case	O
82	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
GIST	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
transport	NN	conj	O
is	VBZ	cop	O
due	JJ	ROOT	O
to	TO	prep	O
the	DT	det	O
exchange	NN	pobj	O
of	IN	prep	O
protons	NNS	pobj	B-Simple_chemical
formed	VBN	acl	O
via	IN	prep	O
glucose	NN	compound	B-Simple_chemical
conversion	NN	pobj	O
into	IN	prep	O
lactate	NN	pobj	B-Simple_chemical
for	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	ROOT	O
.	.	punct	O
,	,	punct	O
to	TO	prep	O
the	DT	det	O
stimulation	NN	pobj	O
of	IN	prep	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
H	NN	compound	B-Simple_chemical
+	CC	cc	I-Simple_chemical
-	HYPH	punct	O
antiport	NN	pobj	O
.	.	punct	O

In	IN	case	O
damaged	VBN	nmod	O
and	CC	cc	O
inflamed	JJ	conj	O
tissue	NN	conj	B-Tissue
,	,	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	dep	I-Gene_or_gene_product
functions	NNS	nsubj	O
as	IN	case	O
a	DT	det	O
chemoattractant	NN	nmod	O
,	,	punct	O
mitogen	NN	conj	O
and	CC	cc	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
factor	NN	conj	O
suggesting	VBG	ROOT	O
that	IN	mark	O
the	DT	det	O
peptide	NN	nsubj	O
may	MD	aux	O
potentiate	VB	ccomp	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Bovine	JJ	amod	B-Organism
lactoferrin	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
multifunctional	JJ	amod	O
glycoprotein	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
strongly	RB	advmod	O
inhibit	VB	xcomp	O
development	NN	dobj	O
of	IN	case	O
azoxymethane	NN	nmod:npmod	B-Simple_chemical
(	-LRB-	punct	O
AOM	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
rat	NN	compound	B-Organism
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

When	WRB	advmod	O
genetic	JJ	amod	O
ablation	NN	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
or	CC	cc	O
2	CD	conj	O
alleles	NNS	nmod	O
of	IN	case	O
fur	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
the	DT	det	O
PLAG1	NN	compound	B-Gene_or_gene_product
transgene	NN	nmod	O
were	VBD	auxpass	O
simultaneously	RB	advmod	O
achieved	VBN	advcl	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nsubjpass	O
in	IN	case	O
tumorigenesis	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
most	RBS	amod	O
fundamental	JJ	pobj	O
is	VBZ	ROOT	O
the	DT	det	O
ability	NN	attr	O
to	TO	aux	O
act	VB	acl	O
as	IN	case	O
essential	JJ	amod	O
growth	NN	compound	O
checkpoint	NN	nmod	O
that	WDT	nsubj	O
protects	VBZ	acl:relcl	O
cells	NNS	dobj	B-Cell
against	IN	case	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
region	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-Cellular_component
identified	VBN	acl	O
here	RB	advmod	O
as	IN	mark	O
being	VBG	cop	O
important	JJ	advcl	O
in	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	xcomp	O
of	IN	case	O
the	DT	det	O
leukemogenicity	NN	nmod	O
and	CC	cc	O
latency	NN	conj	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Opinions	NNS	nsubjpass	O
on	IN	case	O
3	CD	nummod	O
areas	NNS	nmod	O
were	VBD	auxpass	O
sought	VBN	ROOT	O
:	:	punct	O
pulp	JJ	amod	B-Tissue
therapy	NN	dobj	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
primary	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
indirect	JJ	amod	O
pulp	JJ	amod	B-Tissue
treatment	NN	parataxis	O
(	-LRB-	punct	O
IPT	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
immature	JJ	amod	O
permanent	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
and	CC	cc	O
innovative	JJ	amod	O
treatment	NN	compound	O
options	NNS	conj	O
including	VBG	case	O
pulpal	JJ	amod	B-Tissue
revascularization	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
may	MD	aux	O
provide	VB	ROOT	O
clinical	JJ	amod	O
benefits	NNS	dobj	O
to	TO	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Assays	NNS	nsubj	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
antigenicity	NN	conj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
STAT	NN	compound	B-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	B-Gene_or_gene_product
oncoprotein	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
confirm	VBP	ROOT	O
a	DT	det	O
close	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
metabolic	JJ	amod	O
enzymes	NNS	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
an	DT	det	O
alteration	NN	dobj	O
in	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Vimentin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
preferentially	RB	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
with	IN	case	O
high	JJ	amod	O
GF	NN	nmod	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	advmod	O
15	CD	nummod	O
%	NN	dep	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
positive	JJ	nmod	O
by	IN	case	O
immunoperoxidase	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	amod	O
ER	NN	compound	B-Gene_or_gene_product
levels	NNS	conj	O
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	advmod	O
60	CD	nummod	O
fmols	NNS	dep	O
/	:	punct	O
mg	NN	compound	O
protein	NN	dep	O
by	IN	case	O
a	DT	det	O
monoclonal	JJ	amod	O
enzyme	NN	compound	O
immunoassay	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
PET	NN	compound	O
studies	NNS	conj	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
complementary	JJ	amod	O
technologies	NNS	nmod	O
in	IN	case	O
drug	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Genes	NNS	nsubj	O
most	RBS	advmod	O
significantly	RB	advmod	O
represented	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
program	NN	nmod	O
are	VBP	cop	O
those	DT	nmod	O
with	IN	case	O
roles	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
>	NN	dep	O
protein	NN	compound	O
synthesis	NN	dep	O
>	NN	dep	O
gene	NN	compound	O
expression	NN	nmod	O
>	NN	dep	O
cell	NN	compound	B-Cell
death	NN	compound	O
>	NN	amod	O
cell	NN	compound	B-Cell
cycle	NN	dep	O
.	.	punct	O

After	IN	case	O
incubation	NN	nmod	O
for	IN	case	O
4	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
the	DT	det	O
medium	NN	nsubjpass	O
from	IN	prep	O
the	DT	det	O
coculture	NN	compound	O
system	NN	pobj	O
is	VBZ	auxpass	O
collected	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
drugs	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibit	VBP	ROOT	O
severe	JJ	amod	O
side	JJ	amod	O
effects	NNS	dobj	O
and	CC	cc	O
are	VBP	cop	O
expensive	JJ	conj	O
.	.	punct	O

In	IN	case	O
spite	NN	dep	O
of	IN	case	O
uncertainties	NNS	nmod	O
regarding	VBG	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
vitamins	NNS	appos	B-Simple_chemical
such	JJ	case	O
as	IN	mwe	O
beta	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carotene	NN	nmod	I-Simple_chemical
and	CC	cc	O
vitamins	NNS	compound	B-Simple_chemical
A	NN	conj	I-Simple_chemical
,	,	punct	O
C	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
E	NN	conj	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
reduce	VB	acl:relcl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
animal	NN	dobj	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	conj	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Insulin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	appos	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
and	CC	cc	O
secreted	VBN	amod	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
carcinogen	NN	compound	O
exposure	NN	nsubj	O
exerts	VBZ	ROOT	O
continuous	JJ	amod	O
pressure	NN	dobj	O
on	IN	case	O
key	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
repair	VBP	acl:relcl	O
or	CC	cc	O
eliminate	VB	conj	O
carcinogen	NN	npadvmod	O
-	HYPH	punct	O
damaged	VBN	amod	O
cells	NNS	dobj	B-Cell
giving	VBG	acl	O
rise	NN	dobj	O
to	TO	case	O
selective	JJ	amod	O
failures	NNS	nmod	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	B-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	conj	O
.	.	punct	O

Caspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
procaspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	nmod	O
and	CC	cc	O
cisplatin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	conj	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Telomere	RB	compound	B-Cellular_component
/	SYM	punct	O
telomerase	NN	compound	B-Gene_or_gene_product
interplay	NN	ROOT	O
in	IN	case	O
virus	NN	compound	O
-	HYPH	punct	O
driven	VBN	amod	O
and	CC	cc	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
lymphomagenesis	NN	nmod	O
:	:	punct	O
pathogenic	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
implications	NNS	dep	O
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeat	NN	nsubj	I-Cellular_component
(	-LRB-	punct	O
LTR	NN	appos	B-Cellular_component
)	-RRB-	punct	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
encodes	VBZ	ccomp	O
a	DT	det	O
trans	JJ	amod	O
activator	NN	dobj	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
transcription	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
class	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
major	JJ	amod	I-Gene_or_gene_product
histocompatibility	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
genes	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
cytokine	NN	compound	B-Gene_or_gene_product
genes	NNS	conj	O
.	.	punct	O

Metastatic	JJ	amod	B-Cancer
lesions	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

Cell	NNP	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
adhesion	NN	compound	O
assay	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	dobj	O
the	DT	det	O
adhesive	JJ	amod	O
ability	NN	intj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	:	punct	I-Cell
GL	NN	nmod	I-Cell
with	IN	case	O
the	DT	det	O
matrix	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
1	CD	dep	O
.	.	punct	O
2508	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
0711	CD	nsubj	O
)	-RRB-	punct	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cell	NN	nmod	I-Cell
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
0	CD	dep	O
.	.	punct	O
9519	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
068	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Deleted	VBN	ROOT	B-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
split	JJ	amod	I-Gene_or_gene_product
hand	NN	nmod	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
split	VBD	amod	I-Gene_or_gene_product
foot	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Dss1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
gene	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
a	DT	det	O
heterogeneous	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
developmental	JJ	amod	O
disorder	NN	nmod	O
called	VBN	acl	O
split	JJ	amod	O
hand	NN	dobj	B-Organism_subdivision
/	SYM	punct	O
split	VBD	amod	O
foot	NN	compound	B-Organism_subdivision
malformation	NN	nmod	O
.	.	punct	O

Immunoblotting	NN	amod	O
and	CC	cc	O
immunostaining	JJ	conj	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
mostly	RB	advmod	O
along	IN	case	O
the	DT	det	O
endothelium	NN	compound	B-Tissue
lining	JJ	compound	O
peritoneal	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Radiation	NN	compound	O
retinopathy	NN	nsubj	O
is	VBZ	cop	O
treatable	JJ	ROOT	O
with	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
vascular	JJ	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
bevacizumab	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Avastin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
collection	NN	nsubj	O
of	IN	prep	O
reviews	NNS	pobj	O
at	IN	prep	O
the	DT	det	O
front	NN	amod	O
-	HYPH	punct	O
edge	NN	pobj	O
of	IN	prep	O
scientific	JJ	amod	O
knowledge	NN	pobj	O
focuses	VBZ	ROOT	O
on	IN	case	O
host	NN	compound	B-Cell
-	HYPH	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
interactions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disastrous	JJ	amod	O
consequences	NNS	nsubj	O
they	PRP	nsubj	O
can	MD	aux	O
produce	VB	relcl	O
and	CC	cc	O
approaches	VBZ	conj	O
the	DT	det	O
ways	NNS	dobj	O
to	TO	aux	O
break	VB	acl	O
up	RP	prt	O
these	DT	det	O
cellular	JJ	amod	B-Cell
conspiracies	NNS	dobj	O
,	,	punct	O
to	TO	aux	O
leave	VB	parataxis	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
unattended	VBD	conj	O
and	CC	cc	O
vulnerable	JJ	conj	O
.	.	punct	O

Invasion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
BLM	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
attenuated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
PAI	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
monoclonal	JJ	amod	O
antibody	NN	compound	O
MAI	NNP	nmod	O
-	:	punct	O
12	CD	nummod	O
.	.	punct	O

The	DT	det	O
INK4	NN	compound	B-Gene_or_gene_product
family	NN	nsubj	O
of	IN	case	O
proteins	NNS	nmod	O
negatively	RB	advmod	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	dobj	O
at	IN	case	O
the	DT	det	O
G	NN	compound	O
(	-LRB-	punct	O
1	CD	dep	O
)	-RRB-	punct	O
-	:	punct	O
S	NN	compound	O
transition	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinases	NNS	dobj	I-Gene_or_gene_product
.	.	punct	O

Experiments	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
tsA	NN	compound	B-Gene_or_gene_product
58	CD	nummod	I-Gene_or_gene_product
allele	NN	dobj	O
of	IN	case	O
the	DT	det	O
SV	NNP	compound	B-Organism
40	CD	compound	I-Organism
-	HYPH	punct	O
A	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
SV	NN	compound	B-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
strictly	RB	advmod	O
required	VBN	ccomp	O
both	CC	cc:preconj	O
for	IN	case	O
immortalization	NN	nmod	O
and	CC	cc	O
induction	NN	compound	O
anchorage	VBP	compound	O
independence	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	B-Multi-tissue_structure
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	B-Organ
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
knock	NN	compound	O
-	HYPH	punct	O
out	RP	intj	O
mice	NNS	nsubjpass	B-Organism
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
by	IN	case	O
targeted	VBN	amod	O
disruption	NN	nmod	O
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
their	PRP$	nmod:poss	O
hematological	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
although	IN	mark	O
LMP1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
promotes	VBZ	advcl	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
the	DT	det	O
eventual	JJ	amod	O
onset	NN	dobj	O
of	IN	case	O
senescence	NN	nmod	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
method	NN	nsubj	O
of	IN	mark	O
assessing	VBG	acl	O
vascular	JJ	amod	B-Tissue
endothelial	JJ	amod	I-Tissue
function	NN	dobj	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
is	VBZ	cop	O
via	IN	case	O
the	DT	det	O
quantification	NN	ROOT	O
of	IN	case	O
circulating	VBG	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

(	-LRB-	punct	O
2	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
cancer	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
osteoclastogenesis	NN	nmod	O
,	,	punct	O
cells	NNS	conj	B-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
line	NN	nmod	O
,	,	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	appos	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
,	,	punct	O
were	VBD	auxpass	O
directly	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
cultured	VBN	ROOT	O
with	IN	case	O
ST2	NN	nmod	B-Cell
,	,	punct	O
MC3T3	NN	compound	B-Cell
-	HYPH	punct	I-Cell
E1	NN	conj	I-Cell
,	,	punct	O
or	CC	cc	O
with	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
calvarial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

[	-LRB-	ROOT	O
Autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cell	NN	intj	I-Cell
or	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cell	NN	compound	I-Cell
therapy	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
ischaemia	NN	nmod	O
]	-RRB-	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
apoptosis	NN	nsubjpass	O
caused	VBN	acl	O
by	IN	case	O
elevated	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
chemoprevention	NN	nmod	O
by	IN	case	O
lactoferrin	NN	nmod	B-Gene_or_gene_product
of	IN	case	O
colon	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

BAG	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
regulates	VBZ	ROOT	O
cellular	JJ	amod	B-Cell
growth	NN	dobj	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
through	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
diverse	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
vitamin	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VDR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
keratinocyte	NN	nmod	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
associations	NNS	nmod	O
among	IN	case	O
studied	VBN	amod	O
proteins	NNS	nmod	O
revealed	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
in	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
03	CD	dep	O
,	,	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
307	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Cytokines	NNS	nsubj	B-Gene_or_gene_product
and	CC	cc	O
growth	NN	compound	B-Gene_or_gene_product
factors	NNS	conj	I-Gene_or_gene_product
induce	VBP	ROOT	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	B-Gene_or_gene_product
transducers	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activators	NNS	compound	I-Gene_or_gene_product
of	IN	amod	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
STATs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
higher	JJR	amod	O
mortality	NN	compound	O
rate	NN	ROOT	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
other	JJ	amod	O
two	CD	nummod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
25	CD	nummod	O
%	NN	dep	O
versus	CC	cc	O
6	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
5	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	nsubj	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0	CD	nummod	O
.	.	punct	O
02	CD	appos	O
)	-RRB-	punct	O
partially	RB	advmod	O
accounted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
low	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
this	DT	det	O
group	NN	nmod	O
.	.	punct	O

Hyperforin	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	O
Hyp	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
polyphenol	NN	compound	B-Simple_chemical
-	HYPH	punct	O
derivative	NN	appos	O
of	IN	prep	O
St	NN	pobj	B-Organism
.	.	punct	I-Organism

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
furin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PLAG1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
by	IN	case	O
NBD	NN	compound	B-Simple_chemical
peptide	NN	nmod	I-Simple_chemical
may	MD	aux	O
provide	VB	ccomp	O
an	DT	det	O
effective	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
highly	RB	advmod	O
metastatic	JJ	amod	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
level	NN	compound	O
(	-LRB-	punct	O
s	NNS	compound	O
-	:	punct	O
VEGF	NN	dobj	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
RCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Vitamins	NNS	nsubj	B-Simple_chemical
regulate	VBP	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
essential	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
for	IN	case	O
protection	NN	nmod	O
from	IN	case	O
bacterial	JJ	amod	O
infection	NN	nmod	O
and	CC	cc	O
for	IN	case	O
immune	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
binding	NN	compound	O
region	NN	nsubj	O
nor	CC	cc	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
homology	NN	compound	O
region	NN	conj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
cell	NN	compound	B-Cell
death	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	NN	amod	O
agent	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
maximum	NN	amod	O
tolerated	JJ	amod	O
dose	NN	nsubjpass	O
of	IN	case	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
was	VBD	auxpass	O
determined	VBN	dep	O
to	TO	mark	O
be	VB	cop	O
>	NN	advmod	O
125	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	xcomp	O
without	IN	case	O
overt	JJ	amod	O
adverse	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
elicits	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
documented	VBN	ROOT	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
An	DT	det	O
Affymetrix	NNP	compound	O
expression	NN	compound	O
microarray	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
compare	VB	xcomp	O
gene	NN	compound	O
expression	NN	compound	O
profiles	NNS	dobj	O
between	IN	case	O
six	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
TFs	NN	nmod	B-Cell
and	CC	cc	O
normal	JJ	amod	O
fibroblasts	NNS	conj	B-Cell
from	IN	case	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
ESCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Concordance	NN	nsubjpass	O
in	IN	prep	O
topo	IN	pobj	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
staining	VBG	nmod	O
between	IN	case	O
primary	JJ	amod	B-Cancer
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
33	CD	compound	O
of	IN	advmod	O
42	CD	nummod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	acl:relcl	O
.	.	punct	O
029	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
As	IN	prep	O
of	IN	prep	O
November	NNP	pobj	O
30	CD	nummod	O
,	,	punct	O
1994	CD	nummod	O
,	,	punct	O
the	DT	det	O
median	JJ	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	cc	O
period	NN	nsubj	O
was	VBD	dep	O
12	CD	nummod	O
years	NNS	attr	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	B-Gene_or_gene_product
and	CC	cc	O
Ras	NN	conj	B-Gene_or_gene_product
.	.	punct	O

NIH3T3	NN	compound	B-Cell
transfectant	NN	nsubj	I-Cell
containing	VBG	acl	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	dobj	O
shows	VBZ	ROOT	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
or	CC	cc	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	conj	O
with	IN	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGFR2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
function	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
different	JJ	amod	O
but	CC	cc	O
specific	JJ	conj	O
Rab	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
GTP	NN	compound	B-Simple_chemical
hydrolysis	NN	compound	O
activity	NN	nmod	O
required	VBN	acl	O
for	IN	case	O
endosomal	JJ	amod	B-Cellular_component
trafficking	NN	nmod	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
this	DT	det	O
observation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
the	DT	det	O
first	JJ	amod	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
with	IN	case	O
a	DT	det	O
targeted	VBN	amod	O
overexpression	NN	nmod	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
to	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
exogenous	JJ	amod	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
initiating	VBG	advcl	O
tumorigenesis	NN	dobj	O
.	.	punct	O

Tumors	NNS	ROOT	B-Cancer
of	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Tissue
pigment	NN	amod	I-Tissue
epithelium	NN	compound	I-Tissue
metastasize	NN	nmod	O
to	TO	case	O
inguinal	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
spleen	NN	conj	B-Organ
in	IN	case	O
tyrosinase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
SV40	NN	compound	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
estimated	VBD	ROOT	O
the	DT	det	O
threshold	NN	dobj	O
of	IN	case	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nmod	O
that	WDT	nsubj	O
forms	VBZ	acl:relcl	O
one	CD	nummod	O
polyp	RB	dobj	B-Pathological_formation
per	IN	case	O
mouse	NN	nmod	B-Organism
as	IN	case	O
approximately	RB	advmod	O
15	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
type	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
purpose	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
for	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
candidate	NN	compound	O
metastasis	NN	compound	O
suppressor	NN	compound	O
genes	NNS	nmod	O
,	,	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
,	,	punct	O
either	CC	cc:preconj	O
by	IN	case	O
mutation	NN	nmod	O
or	CC	cc	O
by	IN	case	O
loss	NN	conj	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Media	NNS	nsubj	O
supplemented	VBD	ROOT	O
with	IN	prep	O
and	CC	cc	O
without	IN	conj	O
10	CD	nummod	O
%	NN	compound	O
Oxygent	NNP	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	conj	O
in	IN	prep	O
all	DT	det	O
assessments	NNS	pobj	O
.	.	punct	O

Prolonged	JJ	amod	O
silencing	NN	nsubj	O
of	IN	case	O
both	DT	det	O
MCTs	NNS	nmod	B-Gene_or_gene_product
reduced	VBD	ROOT	O
viability	NN	dobj	O
by	IN	case	O
75	CD	nummod	O
%	NN	nmod	O
individually	RB	advmod	O
and	CC	cc	O
92	CD	nummod	O
%	NN	conj	O
in	IN	case	O
combination	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
both	CC	cc:preconj	O
phenotypic	JJ	intj	O
and	CC	cc	O
flow	NN	compound	O
cytometric	JJ	amod	O
analyses	NNS	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubjpass	I-Multi-tissue_structure
and	CC	cc	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
samples	NNS	conj	I-Organism_substance
from	IN	case	O
810	CD	nummod	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
collected	VBN	dep	O
at	IN	case	O
the	DT	det	O
Central	NNP	compound	O
Hospital	NNP	nmod	O
,	,	punct	O
National	NNP	compound	O
Cancer	NNP	compound	O
Center	NNP	appos	O
(	-LRB-	punct	O
Tokyo	NNP	appos	O
,	,	punct	O
Japan	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
FBS	NN	conj	B-Organism_substance
,	,	punct	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
upon	IN	case	O
addition	NN	nmod	O
of	IN	case	O
CHX	NN	nmod	B-Simple_chemical
or	CC	cc	O
Act	NNP	compound	B-Simple_chemical
D	NN	conj	I-Simple_chemical
.	.	punct	O

L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyribose	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dR	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
phosphorylase	NN	compound	I-Simple_chemical
inhibitor	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
TPI	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
can	MD	aux	O
reverse	VB	ROOT	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	dobj	O
involved	VBN	acl	O
in	IN	case	O
such	JJ	amod	O
growth	NN	compound	O
-	HYPH	punct	O
factor	NN	nmod:npmod	O
/	:	punct	O
serum	NN	nmod:npmod	B-Organism_substance
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	nmod	B-Cell
,	,	punct	O
we	PRP	nsubj	O
carried	VBD	ROOT	O
out	RP	prt	O
a	DT	det	O
two	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
differential	JJ	amod	O
proteome	NN	compound	O
analysis	NN	dobj	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
cells	NNS	conj	B-Cell
expressing	VBG	acl	O
vector	NN	compound	O
control	NN	dobj	O
.	.	punct	O

As	IN	case	O
with	IN	case	O
duplication	NN	nmod	O
of	IN	case	O
the	DT	det	O
entire	JJ	amod	O
TK	NN	nmod	O
/	:	punct	O
CAIN	NN	compound	O
region	NN	conj	O
(	-LRB-	punct	O
exons	NNS	dep	O
18	CD	nummod	O
-	SYM	punct	O
26	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
172	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
duplication	NN	nsubjpass	O
of	IN	case	O
exons	NNS	nmod	O
18	CD	nummod	O
-	SYM	punct	O
25	CD	dep	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
genomic	JJ	amod	O
rearrangement	NN	nmod	O
between	IN	case	O
flanking	JJ	amod	O
introns	NNS	nmod	O
.	.	punct	O

Statistical	JJ	amod	O
analysis	NN	nsubjpass	O
is	VBZ	auxpass	O
performed	VBN	ROOT	O
and	CC	cc	O
P	NN	compound	O
<	ADD	conj	O
0	CD	nummod	O
.	.	punct	O
05	CD	nsubj	O
considered	VBN	ROOT	O
significant	JJ	xcomp	O
.	.	punct	O

Nineteen	NNP	nsubj	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
expressed	VBD	ROOT	O
perforin	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
all	DT	det	O
24	CD	nummod	O
cases	NNS	nsubj	O
expressed	VBD	conj	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
TIA1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
proapoptotic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
HDACi	NN	nmod	O
was	VBD	auxpass	O
robustly	RB	advmod	O
enhanced	VBN	ccomp	O
by	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
multiple	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	conj	B-Cell
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
revealed	VBD	ROOT	O
cystic	JJ	amod	O
or	CC	cc	O
angiomatoid	NN	conj	O
spaces	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
sizes	NNS	nmod	O
lined	VBN	acl	O
by	IN	case	O
cuboidal	JJ	nmod	O
,	,	punct	O
low	JJ	amod	O
-	HYPH	punct	O
columnar	NN	conj	O
,	,	punct	O
or	CC	cc	O
flattened	VBN	amod	O
epithelioid	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
vacuolated	VBN	amod	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
round	RB	conj	O
to	TO	case	O
oval	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
.	.	punct	O

Although	IN	mark	O
both	CC	det	O
hypomorphic	JJ	amod	O
heterozygotes	NNS	nsubj	O
developed	VBD	advcl	O
intestinal	JJ	amod	B-Pathological_formation
polyps	NN	dobj	I-Pathological_formation
,	,	punct	O
tumor	NN	compound	B-Cancer
multiplicities	NNS	nsubj	O
were	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Delta716	JJ	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mice	NNS	nmod	O
,	,	punct	O
heterozygotes	NNS	xcomp	O
of	IN	case	O
an	DT	det	O
Apc	NN	compound	B-Gene_or_gene_product
null	JJ	amod	O
allele	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
retroviral	JJ	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
delivery	NN	dobj	O
to	TO	mark	O
effect	VB	advcl	O
sustained	JJ	amod	O
autocrine	JJ	compound	O
expression	NN	dobj	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
murine	JJ	amod	B-Organism
neuroblastoma	NN	nmod	B-Cell
and	CC	cc	O
melanoma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
further	RB	advmod	O
examine	VB	advcl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
TIMPs	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
inhibit	VB	acl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
malignant	JJ	amod	I-Pathological_formation
tumor	NN	compound	I-Pathological_formation
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Since	IN	mark	O
both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
remained	VBD	advcl	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	dobj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
these	DT	det	O
properties	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
attained	VBD	ccomp	O
a	DT	det	O
premalignant	JJ	amod	O
phenotype	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
metastatic	JJ	amod	O
tumors	NNS	nsubjpass	B-Cancer
in	IN	case	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
were	VBD	auxpass	O
markedly	RB	advmod	O
decreased	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
acute	JJ	amod	O
lung	NN	compound	B-Organ
injury	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
B16F10	NN	compound	B-Cancer
melanoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
was	VBD	auxpass	O
diminished	VBN	conj	O
by	IN	case	O
systemic	JJ	amod	O
rk	IN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
treatment	NN	nmod	O
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
Rab7a	NN	nmod	B-Gene_or_gene_product
decreased	VBD	ROOT	O
VEGFR2	NN	compound	B-Gene_or_gene_product
Y1175	NN	compound	O
phosphorylation	NN	dobj	O
but	CC	cc	O
increased	VBN	amod	O
p42	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
44	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
pERK1	NN	appos	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	conj	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
rate	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
pp60src	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Clinical	JJ	amod	O
results	NNS	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
angiogenic	JJ	amod	O
growth	NN	compound	O
/	:	punct	O
differentiation	NN	compound	O
factors	NNS	conj	O
in	IN	case	O
end	NN	compound	O
-	HYPH	punct	O
stage	NN	compound	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PAD	NN	nmod	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
responsible	JJ	amod	O
for	IN	prep	O
hyperinvasiveness	NN	pobj	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	prep	O
anti	VB	npadvmod	O
-	HYPH	punct	O
invasive	JJ	amod	O
action	NN	pobj	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Increased	VBN	amod	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
many	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubjpass	O
(	-LRB-	punct	O
DFS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
overall	JJ	amod	O
survival	NN	conj	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
different	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
method	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
&	CC	cc	O
#	$	advmod	O
38	CD	conj	O
;	:	punct	O
OBJECTIVE	NN	appos	O
:	:	punct	O
It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proved	VBN	ROOT	O
that	IN	mark	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
further	RB	advmod	O
establish	VBP	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
stimulate	VB	ccomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
motility	NN	dobj	O
by	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
filopodia	NN	nmod	B-Cellular_component
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Although	IN	mark	O
many	JJ	amod	O
children	NNS	nsubj	B-Organism
with	IN	case	O
CHD	NN	nmod	O
develop	VBP	advcl	O
pulmonary	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
disease	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	dep	O
why	WRB	advmod	O
this	DT	det	O
complication	NN	nsubj	O
is	VBZ	cop	O
reversible	JJ	ccomp	O
after	IN	prep	O
complete	JJ	amod	O
repair	NN	pobj	O
in	IN	prep	O
some	DT	det	O
cases	NNS	pobj	O
but	CC	cc	O
irreversible	JJ	conj	O
in	IN	case	O
others	NNS	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
organ	NN	compound	B-Organ
vascularization	NN	nmod	O
and	CC	cc	O
lipoplex	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
serum	NN	nmod:npmod	B-Organism_substance
initial	JJ	amod	O
contact	NN	conj	O
in	IN	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
murine	JJ	amod	B-Organism
lipofection	NN	nmod	O
.	.	punct	O

These	DT	det	O
functions	NNS	nsubj	O
include	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
stages	NNS	dobj	O
of	IN	prep	O
sprouting	NN	pcomp	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
following	VBG	case	O
wounding	NN	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	conj	O
.	.	punct	O

Intracerebral	JJ	amod	O
grafting	NN	ROOT	O
of	IN	case	O
cultured	VBN	amod	O
autologous	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
into	IN	case	O
the	DT	det	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
:	:	punct	O
an	DT	det	O
assessment	NN	appos	O
of	IN	prep	O
graft	NN	compound	B-Tissue
size	NN	pobj	O
and	CC	cc	O
ultrastructure	NN	conj	O
.	.	punct	O

Nerve	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
NGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
support	VB	xcomp	O
survival	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
neuroblastoma	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
NB	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
TrkA	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PCNA	NN	conj	B-Gene_or_gene_product
status	NN	dep	O
do	VBP	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
topo	IN	compound	B-Gene_or_gene_product
I	NN	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
topo	NN	nsubj	B-Gene_or_gene_product
I	PRP	nsubj	I-Gene_or_gene_product
has	VBZ	conj	O
no	DT	neg	O
apparent	JJ	amod	O
association	NN	dobj	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
a	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	B-Organism
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nmod	O
.	.	punct	O

The	DT	det	O
alternative	JJ	amod	O
splicing	NN	nsubj	O
of	IN	case	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
produces	VBZ	ROOT	O
two	CD	nummod	O
molecular	JJ	amod	O
forms	NNS	dobj	O
:	:	punct	O
a	DT	det	O
longer	RBR	amod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
transactivating	NN	compound	O
form	NN	dep	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
shorter	JJR	amod	O
inactive	JJ	amod	O
form	NN	conj	O
,	,	punct	O
lacking	VBG	acl	O
84	CD	nummod	O
AA	NN	dobj	O
in	IN	prep	O
the	DT	det	O
aminoterminus	NN	pobj	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
largest	JJS	amod	O
study	NN	attr	O
to	TO	prep	O
date	NN	pobj	O
evaluating	VBG	acl	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitors	NNS	dobj	O
as	IN	case	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
in	IN	case	O
haemophilia	NN	nmod	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
these	DT	det	O
agents	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
adjunctive	JJ	amod	O
therapy	NN	ccomp	O
in	IN	case	O
the	DT	det	O
management	NN	nmod	O
of	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O

After	IN	case	O
removal	NN	nmod	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
by	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
G	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
418	CD	nummod	I-Simple_chemical
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
increased	VBN	amod	O
metastatic	JJ	amod	O
ability	NN	dobj	O
and	CC	cc	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
mRNA	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
intimate	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
influencing	VBG	acl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
transfected	VBN	amod	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
Hoxa9	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	conj	O
,	,	punct	O
retroviral	JJ	amod	B-Organism
insertional	JJ	amod	O
mutagenesis	NN	nsubjpass	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
using	VBG	xcomp	O
retrovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
supplementation	NN	nsubj	O
with	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Carnitine	NNP	nmod	I-Simple_chemical
as	IN	case	O
an	DT	det	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
may	MD	aux	O
be	VB	aux	O
promising	JJ	ROOT	O
in	IN	prep	O
alleviating	VBG	pcomp	O
the	DT	det	O
systemic	JJ	amod	O
side	NN	compound	O
-	HYPH	punct	O
effects	NNS	dobj	O
of	IN	prep	O
chemotherapeutics	NNS	pobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Galpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
readily	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
SET	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
/	:	punct	O
tissue	NN	compound	O
inhibitors	NNS	nsubj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
phenotype	NN	nmod	O
identifies	VBZ	ROOT	O
poor	JJ	amod	O
prognosis	NN	compound	O
colorectal	JJ	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

No	DT	neg	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
glycolytic	JJ	amod	O
rates	NNS	nmod	O
and	CC	cc	O
pAkt	JJ	compound	B-Gene_or_gene_product
levels	NNS	conj	O
.	.	punct	O

This	DT	det	O
protein	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
protein	NN	compound	O
kinase	NN	xcomp	O
that	WDT	nsubj	O
phosphorylates	VBZ	acl:relcl	O
on	IN	case	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
function	NN	nmod	O
by	IN	case	O
either	CC	cc:preconj	O
targeted	VBN	amod	O
allele	NN	compound	O
deletion	NN	nmod	O
or	CC	cc	O
use	NN	conj	O
of	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
Dll4	NN	compound	B-Gene_or_gene_product
extracellular	JJ	amod	B-Immaterial_anatomical_entity
domain	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
increased	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
proliferation	NN	nmod	O
but	CC	cc	O
defective	JJ	amod	O
maturation	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
neutralizing	VBG	amod	O
Abs	NNS	dobj	O
to	TO	mark	O
show	VB	xcomp	O
that	IN	mark	O
the	DT	det	O
IFN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
monokine	NN	conj	O
-	,	punct	O
induced	VBN	acl	O
by	IN	case	O
IFN	NN	compound	O
-	HYPH	punct	O
gamma	NN	compound	O
chemokines	NNS	nmod	O
are	VBP	cop	O
pivotal	JJ	ccomp	O
in	IN	mark	O
inducing	VBG	advcl	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
and	CC	cc	O
consistent	JJ	conj	O
induction	NN	nsubjpass	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
was	VBD	auxpass	O
seen	VBN	ROOT	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
alterations	NNS	nmod	O
in	IN	case	O
Bax	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
cdk2	NN	conj	B-Gene_or_gene_product
as	IN	mark	O
observed	VBN	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
define	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Azacytidine	NNP	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
DNA	NN	compound	B-Cellular_component
methylation	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
induced	VBD	ROOT	O
growth	NN	dobj	O
of	IN	prep	O
large	JJ	amod	O
colonies	NNS	pobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	compound	O
cultures	NNS	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
or	CC	cc	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	conj	I-Gene_or_gene_product
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
switch	NN	nsubj	O
from	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
to	IN	case	O
oncogene	NN	nmod	O
reflects	VBZ	ccomp	O
genetic	JJ	amod	O
or	CC	cc	O
epigenetic	JJ	conj	O
alterations	NNS	dobj	O
in	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
alter	VBP	acl:relcl	O
the	DT	det	O
readout	NN	dobj	O
from	IN	case	O
the	DT	det	O
TGFbeta1	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

sVAP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
predictive	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
sex	NN	conj	O
,	,	punct	O
Dukes	NNP	nmod:poss	O
'	POS	case	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	compound	O
grade	NN	conj	O
,	,	punct	O
survival	NN	compound	O
status	NN	conj	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
PCNA	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
MCT	NN	nsubj	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
the	DT	det	O
predominantly	RB	advmod	O
expressed	VBN	amod	O
isoform	NN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
brain	NN	nmod	B-Organ
.	.	punct	O

Gliomas	NNS	nsubj	B-Cancer
are	VBP	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
primary	JJ	amod	O
tumours	NNS	attr	B-Cancer
of	IN	prep	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	pobj	I-Anatomical_system
,	,	punct	O
with	IN	prep	O
nearly	RB	advmod	O
15	CD	nummod	O
,	,	punct	O
000	CD	nsubj	O
diagnosed	VBN	pcomp	O
annually	RB	advmod	O
in	IN	prep	O
the	DT	det	O
United	NNP	compound	O
States	NNP	pobj	O
and	CC	cc	O
a	DT	det	O
lethality	NN	conj	O
approaching	VBG	acl	O
80	CD	nummod	O
%	NN	dobj	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
year	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	B-Cancer
diagnosis	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	compound	O
muscle	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ROOT	O
only	RB	advmod	O
a	DT	det	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcript	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
therapeutic	JJ	amod	O
approach	NN	nsubj	O
markedly	RB	advmod	O
promotes	VBZ	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
other	JJ	amod	O
conditions	NNS	nmod	O
14	CD	nummod	O
days	NNS	dobj	O
after	IN	case	O
wounding	NN	pobj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
.	.	punct	O

All	DT	det	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
reported	VBN	ROOT	O
as	IN	case	O
means	NNS	compound	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SEM	NNP	nmod	O
.	.	punct	O

The	DT	det	O
dynamic	JJ	amod	O
uptake	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
analogue	NN	nmod	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
diseased	JJ	amod	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
upper	JJ	amod	B-Organism_subdivision
arm	NN	compound	I-Organism_subdivision
skeletal	JJ	amod	B-Tissue
muscle	NN	conj	I-Tissue
in	IN	case	O
both	DT	det	O
metabolic	JJ	amod	O
states	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
anabolic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	appos	O
for	IN	case	O
use	NN	nmod	O
to	TO	mark	O
reverse	VB	acl	O
malnutrition	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
recruits	VBZ	appos	O
mononuclear	JJ	amod	B-Cell
phagocytes	NNS	dobj	I-Cell
which	WDT	nsubj	O
regulate	VBP	acl:relcl	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
angiogenesis	NN	nmod	O
and	CC	cc	O
metastases	NNS	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	DT	mark	O
hCAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
overexpressed	VBN	acl:relcl	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
ovarian	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
through	IN	case	O
direct	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
initiation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	case	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
filopodia	NN	compound	B-Cellular_component
formation	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
feature	NN	appos	O
of	IN	case	O
motile	JJ	compound	O
cells	NNS	nmod	B-Cell
,	,	punct	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
treated	VBN	acl	O
with	IN	case	O
either	DT	cc:preconj	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
siRNA	NN	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
cultured	VBN	acl	O
in	IN	case	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	nmod	O
.	.	punct	O

M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	ROOT	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
of	IN	case	O
Sp1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
ERK	NN	compound	B-Gene_or_gene_product
inhibition	NN	nmod	O
.	.	punct	O

Hypoxic	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
head	NN	amod	B-Cell
and	CC	cc	I-Cell
neck	NN	conj	I-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
stress	NN	compound	O
activated	JJ	amod	O
protein	NN	compound	O
kinases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
pomegranate	NN	amod	B-Organism
tree	NN	nsubj	B-Organism_subdivision
,	,	punct	O
Punica	NNP	compound	B-Organism
granatum	NN	appos	I-Organism
,	,	punct	O
especially	RB	advmod	O
its	PRP$	poss	O
fruit	NN	appos	O
,	,	punct	O
possesses	VBZ	ROOT	O
a	DT	det	O
vast	JJ	amod	O
ethnomedical	JJ	amod	O
history	NN	dobj	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
phytochemical	JJ	amod	O
reservoir	NN	dobj	O
of	IN	case	O
heuristic	JJ	amod	O
medicinal	JJ	amod	O
value	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
(	-LRB-	punct	O
wt	NN	appos	O
)	-RRB-	punct	O
SVLT	NN	nsubj	B-Gene_or_gene_product
strongly	RB	advmod	O
inhibited	VBD	ccomp	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	dobj	O
of	IN	case	O
mouse	NN	compound	B-Organism
C2	NN	compound	B-Cell
myoblasts	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
this	DT	det	O
arrest	NN	nsubj	O
occurred	VBD	conj	O
only	RB	advmod	O
after	IN	case	O
the	DT	det	O
synthesis	NN	nmod	O
of	IN	case	O
myogenin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
initial	JJ	amod	O
step	NN	appos	O
in	IN	case	O
biochemical	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
in	IN	case	O
several	JJ	amod	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
were	VBD	cop	O
subject	JJ	ROOT	O
to	TO	mark	O
down	JJ	advcl	O
modulation	NN	dobj	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
growth	NN	compound	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

35	CD	nummod	O
%	NN	nsubj	O
of	IN	prep	O
eyes	NNS	pobj	B-Organ
improved	VBD	ccomp	O
their	PRP$	nmod:poss	O
BCVA	NN	dobj	O
by	IN	case	O
2	CD	nummod	O
lines	NNS	nmod	O
or	CC	cc	O
more	JJR	conj	O
,	,	punct	O
45	CD	nummod	O
%	NN	nsubj	O
remained	VBD	ROOT	O
stable	JJ	acomp	O
and	CC	cc	O
18	CD	nummod	O
%	NN	nsubj	O
lost	VBD	conj	O
2	CD	nummod	O
lines	NNS	dobj	O
or	CC	cc	O
more	JJR	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Inflammation	NN	nsubj	O
followed	VBN	acl	O
by	IN	case	O
fibrosis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
component	NN	dep	O
of	IN	case	O
islet	NN	compound	B-Multi-tissue_structure
dysfunction	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
rodent	JJ	nmod	O
and	CC	cc	O
human	JJ	conj	B-Organism
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	dep	O
.	.	punct	O

Positron	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
imaging	NN	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
a	DT	det	O
useful	JJ	amod	O
tool	NN	nsubj	O
for	IN	mark	O
assessing	VBG	acl	O
early	JJ	amod	O
biologic	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
particularly	RB	advmod	O
useful	JJ	conj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
cancer	NN	compound	B-Cancer
therapeutics	NNS	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
a	DT	det	O
striking	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
PTPases	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
LAR	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
PTP1B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
3	CD	nummod	O
independently	RB	advmod	O
neu	NN	compound	B-Gene_or_gene_product
transformed	VBD	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
their	PRP$	nmod:poss	O
derived	VBN	amod	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	compound	I-Gene_or_gene_product
deficiency	NN	nsubj	O
inhibits	VBZ	ROOT	O
small	JJ	amod	B-Organ
intestinal	JJ	amod	I-Organ
tumorigenesis	NN	dobj	O
in	IN	case	O
ApcMin	NN	nmod	B-Gene_or_gene_product
/	,	punct	O
+	CC	cc	O
mice	NNS	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
MnSO4	NN	compound	B-Simple_chemical
co	NN	compound	O
-	:	punct	O
operates	VBZ	ccomp	O
with	IN	case	O
overexpressed	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
in	IN	prep	O
inducing	VBG	pcomp	O
transformation	NN	dobj	O
,	,	punct	O
while	IN	mark	O
5	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	compound	I-Simple_chemical
transformation	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	advcl	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
overexpression	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
involve	VB	conj	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Anagen	NNP	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nsubj	O
offers	VBZ	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
the	DT	det	O
physiologic	JJ	amod	O
controls	NNS	dobj	O
of	IN	case	O
cutaneous	JJ	amod	B-Organism_subdivision
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
interesting	JJ	amod	O
system	NN	conj	O
for	IN	mark	O
screening	VBG	acl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
potential	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
an	DT	det	O
ECAT	NN	compound	O
EXACT	NN	dep	O
47	CD	nummod	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
camera	NN	dobj	O
and	CC	cc	O
fluorine	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
fluorodeoxyglucose	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
;	:	punct	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	parataxis	O
with	IN	case	O
the	DT	det	O
triple	NN	npadvmod	O
-	HYPH	punct	O
headed	VBN	amod	O
single	JJ	amod	O
-	HYPH	punct	O
photon	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
SPET	NN	appos	O
)	-RRB-	punct	O
camera	NNS	nmod	O
,	,	punct	O
MULTISPECT	NN	appos	O
3	CD	nummod	O
.	.	punct	O

Tumors	NNS	nsubj	B-Cancer
greater	JJR	advmod	O
than	IN	advmod	O
35	CD	nummod	O
mm3	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
IR	NN	compound	O
24	CD	nummod	O
hours	NNS	nmod	O
previously	RB	advmod	O
or	CC	cc	O
with	IN	case	O
TEMF	NN	conj	O
had	VBD	aux	O
decreased	VBN	ROOT	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
subcortex	JJ	nmod	B-Cancer
and	CC	cc	O
more	RBR	conj	O
endothelial	JJ	amod	B-Cellular_component
pseudopods	NNS	dep	I-Cellular_component
projecting	VBG	acl	O
into	IN	case	O
hypoxic	JJ	nmod	O
,	,	punct	O
HIF	NN	compound	B-Gene_or_gene_product
positive	JJ	amod	O
areas	NNS	conj	O
than	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

Topo	IN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
in	IN	case	O
paired	JJ	amod	O
primary	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
for	IN	case	O
concordance	NN	nmod	O
.	.	punct	O

Forced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
SEMA3F	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SEMA3B	NN	conj	B-Gene_or_gene_product
in	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
endothelial	JJ	amod	B-Tissue
cell	NN	compound	I-Tissue
tube	NN	compound	I-Tissue
formation	NN	dobj	O
.	.	punct	O

Dietary	NNP	nsubj	O
conjugated	VBD	ROOT	B-Simple_chemical
linoleic	JJ	amod	I-Simple_chemical
acid	NN	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
CLA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	dep	O
previously	RB	advmod	O
to	TO	mark	O
inhibit	VB	xcomp	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
carcinogenesis	NN	dobj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	compound	I-Gene_or_gene_product
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
activities	NNS	nsubjpass	O
are	VBP	auxpass	O
both	CC	dep	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

No	DT	det	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
lung	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

Transformation	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	O
cells	NNS	nmod	B-Cell
in	IN	case	O
cultures	NNS	nmod	O
requires	VBZ	ROOT	O
both	CC	det	O
overcoming	VBG	amod	O
growth	NN	compound	O
arrest	NN	dobj	O
by	IN	mark	O
stimulating	VBG	advcl	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	dobj	O
and	CC	cc	O
blocking	VBG	conj	O
cell	NN	compound	B-Cell
death	NN	compound	O
activities	NNS	dobj	O
presumably	RB	advmod	O
activated	VBN	acl	O
by	IN	case	O
oncogene	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
hyperproliferation	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

Interestingly	RB	ROOT	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-Organism
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
lymphoblastoid	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
SKW6	NN	intj	I-Cell
.	.	punct	I-Cell
4	LS	nsubjpass	I-Cell
,	,	punct	O
a	DT	det	O
prototype	NN	appos	O
for	IN	case	O
mitochondria	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
independent	JJ	amod	O
death	NN	compound	O
receptor	NN	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
sensitized	VBN	ROOT	O
to	TO	case	O
anti	VB	compound	O
-	HYPH	punct	O
CD95	NN	nmod:npmod	B-Gene_or_gene_product
and	CC	cc	O
TRAIL	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
under	IN	case	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
free	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
stage	NN	ROOT	O
specific	JJ	amod	O
duality	NN	nsubj	O
of	IN	case	O
function	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
emerging	VBG	amod	O
paradigm	NN	dobj	O
for	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
TGFbeta1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
are	VBP	auxpass	O
measured	VBN	ROOT	O
with	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

Erbb2	NN	nsubj	B-Gene_or_gene_product
suppresses	VBZ	ROOT	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	B-Organism
skin	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
soluble	JJ	amod	O
factors	NNS	nsubj	O
they	PRP	nsubj	O
release	VBP	ROOT	O
in	IN	case	O
its	PRP$	nmod:poss	O
presence	NN	compound	O
arrest	VBP	ccomp	O
the	DT	det	O
cycle	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
inhibit	VBP	conj	O
in	FW	amod	O
vitro	FW	dep	O
angiogenesis	NN	dobj	O
,	,	punct	O
negatively	RB	advmod	O
modulate	VB	parataxis	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
EC	NN	nmod	B-Cell
to	TO	mark	O
adhere	VB	acl	O
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	conj	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
VCAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
expression	NN	dep	O
.	.	punct	O

Relationship	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
Helicobacter	NNP	conj	B-Organism
pylori	NNS	nmod	I-Organism
to	TO	case	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
remnant	JJ	amod	B-Cancer
stomach	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
after	IN	case	O
gastric	JJ	amod	B-Organ
surgery	NN	nmod	O
for	IN	case	O
primary	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	compound	O
levels	NNS	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
fibronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	conj	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	:	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
14	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
highly	RB	advmod	O
metastatic	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
suppose	VBP	ROOT	O
that	DT	mark	O
knowledge	NN	nsubj	O
about	IN	case	O
heterogeneity	NN	nmod	O
between	IN	case	O
primary	JJ	nmod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumor	NN	dep	B-Cancer
might	MD	aux	O
help	VB	ccomp	O
to	TO	mark	O
understand	VB	xcomp	O
mechanisms	NNS	dobj	O
of	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
The	DT	det	O
matrix	NN	compound	O
metalloproteinases	NNS	nsubj	O
(	-LRB-	punct	O
MMPs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
a	DT	det	O
family	NN	dep	O
of	IN	case	O
proteolytic	JJ	amod	O
enzymes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
;	:	punct	O
several	JJ	amod	O
individual	JJ	amod	O
members	NNS	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
prognosis	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
doxycycline	NN	nsubj	B-Simple_chemical
diminishes	VBZ	ROOT	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
this	DT	det	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
also	RB	advmod	O
decreases	VBZ	conj	O
its	PRP$	nmod:poss	O
gelatinolytic	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
gel	NN	compound	O
zymography	NN	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
of	IN	case	O
the	DT	det	O
cytotoxic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
in	IN	case	O
human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Galpha	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
alpha	NN	compound	O
-	HYPH	punct	O
subunit	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
G12	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
heterotrimeric	JJ	amod	B-Gene_or_gene_product
G	NN	compound	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
neoplastic	JJ	amod	O
transformation	NN	conj	O
.	.	punct	O

A	DT	det	O
role	NN	nsubj	O
for	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
appears	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
control	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
promotion	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
/	:	punct	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
threshold	NN	compound	O
level	NN	ROOT	O
of	IN	case	O
adenomatous	JJ	amod	B-Gene_or_gene_product
polyposis	NN	compound	I-Gene_or_gene_product
coli	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
for	IN	case	O
mouse	NN	compound	B-Organism
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
differential	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
in	IN	case	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
clinically	RB	advmod	O
more	RBR	advmod	O
aggressive	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
these	DT	det	O
neoplasms	NNS	nmod	B-Cancer
.	.	punct	O

Accumulating	NN	amod	O
evidences	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
receptor	NN	compound	B-Gene_or_gene_product
activator	NN	nsubj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
NF	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kB	NN	compound	I-Gene_or_gene_product
ligand	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
RANKL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
ultimate	JJ	amod	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	ccomp	O
that	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
osteoclast	JJ	compound	B-Cell
differentiation	NN	dobj	O
into	IN	case	O
mature	JJ	amod	O
osteoclasts	NNS	nmod	B-Cell
.	.	punct	O

This	DT	det	O
hypothesis	NN	nsubjpass	O
in	IN	case	O
humans	NNS	nmod	B-Organism
can	MD	aux	O
be	VB	auxpass	O
tested	VBN	ROOT	O
only	RB	advmod	O
by	IN	case	O
intervention	NN	compound	O
trials	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	acl:relcl	O
in	IN	prep	O
progress	NN	pobj	O
.	.	punct	O

SAHA	NN	nsubj	B-Simple_chemical
enhanced	VBD	ROOT	O
acetylation	NN	dobj	O
of	IN	case	O
histone	NN	compound	B-Gene_or_gene_product
H3	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
Bim	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	nmod	O
,	,	punct	O
while	IN	mark	O
E1A	NN	nsubj	B-Gene_or_gene_product
upregulated	VBD	advcl	O
Egr	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	dobj	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
directly	RB	advmod	O
involved	VBN	ccomp	O
in	IN	case	O
Bim	NN	compound	B-Gene_or_gene_product
transactivation	NN	nmod	O
.	.	punct	O

The	DT	det	O
sensitivity	NN	nsubj	O
and	CC	cc	O
specificity	NN	conj	O
of	IN	case	O
s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nmod	B-Gene_or_gene_product
at	IN	prep	O
the	DT	det	O
cut	NN	pobj	O
-	HYPH	punct	O
off	RP	prep	O
level	NN	conj	O
of	IN	case	O
100	CD	nummod	O
pg	CC	compound	O
/	SYM	punct	O
ml	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	acl	O
by	IN	case	O
the	DT	det	O
receiver	NN	compound	O
-	HYPH	punct	O
operating	NN	compound	O
-	HYPH	punct	O
characteristics	NNS	compound	O
curve	NN	nmod	O
,	,	punct	O
were	VBD	ROOT	O
80	CD	attr	O
.	.	punct	O
0	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
72	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

No	DT	neg	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
19	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
initiation	NN	dep	O
.	.	punct	O

The	DT	det	O
subsequent	JJ	amod	O
identification	NN	nsubj	O
of	IN	case	O
germline	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
gene	NN	compound	O
encoding	NN	compound	O
fumarase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
-	:	punct	O
another	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	compound	O
enzyme	NN	conj	O
-	:	punct	O
-	:	punct	O
in	IN	case	O
a	DT	det	O
new	JJ	amod	O
hereditary	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
susceptibility	NN	nmod	O
to	TO	case	O
renal	JJ	amod	B-Cancer
,	,	punct	O
uterine	JJ	conj	B-Cancer
and	CC	cc	O
cutaneous	JJ	conj	B-Cancer
tumors	NNS	nmod	I-Cancer
has	VBZ	aux	O
highlighted	VBN	ROOT	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	nmod	O
and	CC	cc	O
,	,	punct	O
more	RBR	advmod	O
generally	RB	advmod	O
,	,	punct	O
of	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
glycogen	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
depleted	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
low	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
medium	NN	nmod	O
,	,	punct	O
but	CC	cc	O
conserved	VBN	conj	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

BMP	NN	compound	O
expression	NN	nsubjpass	O
and	CC	cc	O
activation	NN	conj	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
PCR	NN	nmod	O
and	CC	cc	O
reporter	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

AIM	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
whether	IN	mark	O
a	DT	det	O
variety	NN	nsubj	O
of	IN	case	O
ciliary	JJ	amod	B-Cancer
body	NN	nmod	I-Cancer
tumours	NNS	ccomp	I-Cancer
synthesise	JJ	amod	O
opticin	NN	dobj	B-Gene_or_gene_product
to	TO	aux	O
characterise	VB	xcomp	O
further	RB	advmod	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
ciliary	JJ	amod	B-Multi-tissue_structure
body	NN	compound	I-Multi-tissue_structure
health	NN	nmod	O
and	CC	cc	O
disease	NN	conj	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
believe	VBP	ROOT	O
that	IN	mark	O
pulp	JJ	amod	B-Tissue
revascularization	NN	nsubj	O
and	CC	cc	O
regeneration	NN	conj	O
will	MD	aux	O
be	VB	ccomp	O
viable	JJ	amod	O
treatment	NN	compound	O
modalities	NNS	attr	O
in	IN	prep	O
the	DT	det	O
future	NN	pobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
therapeutic	JJ	amod	O
implications	NNS	dobj	O
concerning	VBG	case	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
inhibitors	NNS	nmod	O
.	.	punct	O

A	DT	det	O
series	NN	nsubj	O
of	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
invasion	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
prerequisite	JJ	ccomp	O
that	IN	mark	O
Arf6	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
AMAP1	NN	conj	B-Gene_or_gene_product
both	DT	nsubjpass	O
are	VBP	auxpass	O
highly	RB	advmod	O
overexpressed	VBN	ccomp	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
EGFR	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	conj	O
by	IN	case	O
ligands	NNS	nmod	O
.	.	punct	O

Cyclin	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	nsubjpass	O
,	,	punct	O
p107	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
cyclin	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
phosphorylation	NN	nsubjpass	O
are	VBP	auxpass	O
markedly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
peptides	NNS	conj	O
derived	VBN	acl	O
from	IN	case	O
specific	JJ	amod	O
domains	NNS	nmod	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Angiogenesis	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Extensive	JJ	amod	O
regulation	NN	nsubj	O
contributes	VBZ	ROOT	O
to	TO	case	O
normal	JJ	amod	O
growth	NN	compound	O
control	NN	nmod	O
,	,	punct	O
abrogation	NN	nsubj	O
of	IN	case	O
regulatory	JJ	amod	O
controls	NNS	nmod	O
contributes	VBZ	parataxis	O
to	TO	case	O
uncontrolled	JJ	amod	O
growth	NN	nmod	O
as	IN	mark	O
seen	VBN	advcl	O
with	IN	case	O
erb	NN	compound	B-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
transformation	NN	nmod	O
and	CC	cc	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
amplification	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	ROOT	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	conj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	ROOT	O
whether	IN	mark	O
bee	NN	compound	B-Organism
venom	NN	nsubj	B-Organism_substance
(	-LRB-	punct	O
BV	NN	appos	B-Organism_substance
)	-RRB-	punct	O
induces	VBZ	ccomp	O
apoptosis	NN	dobj	O
,	,	punct	O
the	DT	det	O
3	CD	nummod	B-Simple_chemical
-	CD	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylthiazol	NN	conj	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
yl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diphenyltetrazolium	NN	compound	I-Simple_chemical
bromide	NN	compound	I-Simple_chemical
assay	NN	conj	O
,	,	punct	O
terminal	JJ	amod	B-Gene_or_gene_product
deoxynucleotidyl	NN	compound	I-Gene_or_gene_product
transferase	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
dUTP	NN	compound	B-Simple_chemical
nick	NNS	compound	O
end	NN	compound	O
-	HYPH	punct	O
labeling	NN	compound	O
assay	NN	conj	O
,	,	punct	O
4	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diamidino	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylindole	NN	amod	I-Simple_chemical
staining	NN	appos	O
,	,	punct	O
flow	NN	compound	O
cytometric	JJ	amod	O
analysis	NN	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	compound	O
assay	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	parataxis	O
on	IN	case	O
NCI	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
H1299	NN	compound	I-Cell
lung	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
treated	VBN	acl	O
with	IN	case	O
BV	NN	nmod	B-Organism_substance
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
immunohistochemically	RB	advmod	O
investigate	VB	xcomp	O
the	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinicopathology	NN	conj	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
present	JJ	amod	O
series	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
theory	NN	dobj	O
that	IN	mark	O
opticin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
produced	VBN	acl	O
by	IN	agent	O
the	DT	det	O
non	JJ	npadvmod	B-Tissue
-	HYPH	punct	I-Tissue
pigmented	VBN	amod	I-Tissue
CBE	NN	pobj	I-Tissue
throughout	IN	prep	O
adult	JJ	amod	O
life	NN	pobj	O
.	.	punct	O

TF	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
,	,	punct	O
embryogenesis	NN	conj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Phosphatase	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tension	NN	conj	I-Gene_or_gene_product
homolog	NN	dep	I-Gene_or_gene_product
deleted	VBN	acl	I-Gene_or_gene_product
on	IN	case	I-Gene_or_gene_product
chromosome	NN	nmod	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PTEN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
frequently	RB	advmod	O
deficient	JJ	ROOT	O
in	IN	case	O
various	JJ	amod	O
pathologies	NNS	nmod	O
due	JJ	case	O
to	TO	mwe	O
mutation	NN	nmod	O
or	CC	cc	O
epigenetic	JJ	amod	O
alterations	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
380	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
were	VBD	cop	O
ITC	NN	nmod:npmod	B-Cell
negative	JJ	acl:relcl	O
and	CC	cc	O
showed	VBD	conj	O
low	JJ	amod	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
synchronous	JJ	amod	O
(	-LRB-	punct	O
at	IN	case	O
the	DT	det	O
time	NN	dep	O
of	IN	case	O
surgery	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
heterochronous	JJ	amod	O
(	-LRB-	punct	O
recurrent	JJ	dep	O
)	-RRB-	punct	O
metastases	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
upregulation	NN	dobj	O
of	IN	case	O
an	DT	det	O
endogenous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
during	IN	case	O
multi	NN	amod	O
step	NN	compound	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
identify	VB	conj	O
enhanced	VBN	amod	O
stromal	JJ	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
host	NN	compound	O
anti	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
defense	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
interaction	NN	nsubj	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
high	JJ	amod	B-Cell
invasive	JJ	amod	I-Cell
melanoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
soluble	JJ	amod	O
recombinant	JJ	amod	O
DC	NN	nmod	O
-	:	punct	O
9	CD	nummod	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
GSAS	NN	nsubj	B-Cell
/	:	punct	I-Cell
N3	NN	conj	I-Cell
and	CC	cc	O
N5	NN	compound	B-Cell
cells	NNS	conj	I-Cell
showed	VBD	ROOT	O
an	DT	det	O
enhanced	VBN	amod	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
contributing	VBG	advcl	O
to	TO	case	O
increased	VBN	amod	O
migration	NN	nmod	O
,	,	punct	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	conj	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
parent	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

This	DT	det	O
decrease	NN	nsubj	O
persisted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
2	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

By	IN	mark	O
modulating	VBG	advcl	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
levels	NNS	dobj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
melanoma	NN	nmod	B-Cancer
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	acl:relcl	O
on	IN	case	O
melanocyte	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
specific	JJ	amod	O
Pten	NNP	compound	B-Gene_or_gene_product
loss	NN	nmod	O
and	CC	cc	O
Braf	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
V600E	NN	appos	B-Amino_acid
)	-RRB-	punct	O
mutation	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
central	JJ	amod	O
mediator	NN	ccomp	O
of	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
to	TO	case	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
lungs	NNS	conj	B-Organ
.	.	punct	O

Results	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
chi2	NN	compound	O
tests	NNS	nmod	O
.	.	punct	O

Numerous	JJ	amod	O
products	NNS	nsubjpass	O
from	IN	prep	O
fruits	NNS	pobj	B-Organism_subdivision
,	,	punct	O
vegetable	JJ	amod	B-Organism_subdivision
and	CC	cc	O
traditional	JJ	amod	O
medicinal	JJ	amod	O
plants	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
which	WDT	nsubj	O
can	MD	aux	O
suppress	VB	ccomp	O
TNF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
TNF	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
but	CC	cc	O
their	PRP$	nmod:poss	O
clinical	JJ	amod	O
potential	NN	nsubj	O
is	VBZ	cop	O
yet	RB	advmod	O
uncertain	JJ	conj	O
.	.	punct	O

[	-LRB-	punct	O
Ambiguity	NN	compound	O
role	NN	ROOT	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O

Convergence	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
signaling	NN	compound	O
networks	NNS	nmod	O
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
stable	JJ	amod	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mouse	NN	compound	B-Organism
-	HYPH	punct	O
melanocytic	JJ	amod	B-Cell
clones	NNS	nmod	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
metabotropic	JJ	amod	O
glutamate	JJ	compound	B-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Grm1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expressing	VBG	acl	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	I-Cell
C8161	NN	conj	I-Cell
,	,	punct	O
stimulation	NN	nsubj	O
of	IN	case	O
Grm1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
its	PRP$	nmod:poss	O
agonist	NN	nmod	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
AKT	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
preincubation	NN	nsubj	O
with	IN	case	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
antagonist	NN	nmod	O
abolished	VBD	advcl	O
Grm1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
agonist	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
AKT	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
.	.	punct	O

Unexpectedly	RB	advmod	O
,	,	punct	O
cells	NNS	nsubj	B-Cell
expressing	VBG	acl	O
both	CC	cc:preconj	O
Ras	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
TEL	NN	conj	B-Gene_or_gene_product
grew	VBD	ROOT	O
as	IN	case	O
aggregates	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
on	IN	case	O
related	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
CNE1	NN	nmod	I-Cell
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
rendered	JJ	ccomp	O
rat	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	dobj	I-Cell
(	-LRB-	punct	O
REF	NN	appos	B-Cell
)	-RRB-	punct	O
sensitive	JJ	amod	O
to	TO	case	O
5	CD	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
may	MD	aux	O
depend	VB	ccomp	O
on	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
repression	NN	compound	O
function	NN	nmod	O
of	IN	case	O
the	DT	det	O
55	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
be	VB	cop	O
phosphorylation	NN	nmod	O
at	IN	case	O
the	DT	det	O
carboxy	NN	compound	O
terminus	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
HTR8	NN	compound	B-Cell
line	NN	nsubj	I-Cell
has	VBZ	advcl	O
a	DT	det	O
limited	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
lifespan	NN	dobj	O
of	IN	case	O
12	CD	compound	O
-	SYM	punct	O
15	CD	nummod	O
passages	NNS	nmod	O
,	,	punct	O
SV40	NN	nmod:npmod	B-Organism
Tag	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
selected	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
extended	VBN	amod	O
lifespan	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
density	NN	conj	O
in	IN	case	O
the	DT	det	O
old	JJ	amod	O
donor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
were	VBD	cop	O
lower	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
young	JJ	amod	O
donor	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
but	CC	cc	O
higher	JJR	conj	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
report	VB	dep	O
on	IN	case	O
bevacizumab	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
for	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
affecting	VBG	acl	O
the	DT	det	O
macula	NN	dobj	B-Tissue
.	.	punct	O

Cancer	NNP	nsubj	B-Cancer
is	VBZ	cop	O
a	DT	det	O
disease	NN	ROOT	O
largely	RB	advmod	O
dependent	JJ	amod	O
on	IN	case	O
neoangiogenesis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Proteomic	JJ	amod	O
findings	NNS	nsubj	O
indicated	VBD	appos	O
that	IN	mark	O
adenosine	NN	compound	B-Gene_or_gene_product
triphosphate	VBP	compound	I-Gene_or_gene_product
synthase	NN	compound	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
chain	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	cop	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
,	,	punct	O
whereas	IN	dep	O
annexin	NN	nsubjpass	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
annexin	NN	compound	B-Gene_or_gene_product
V	NN	compound	I-Gene_or_gene_product
,	,	punct	O
beta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
tubulin	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
profilin	NN	conj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
were	VBD	auxpass	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	advcl	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
study	NN	nsubjpass	O
with	IN	case	O
specific	JJ	amod	O
antisera	NNS	nmod	O
was	VBD	auxpass	O
done	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
members	NNS	nsubj	O
of	IN	case	O
an	DT	det	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
microRNA	NN	compound	O
cluster	NN	nmod	O
cooperate	VBP	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
B	NN	compound	B-Cell
lymphocytes	NNS	dobj	I-Cell
.	.	punct	O

To	IN	case	O
date	NN	nmod	O
,	,	punct	O
the	DT	det	O
potential	JJ	amod	O
oncogenic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
examined	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
owing	VBG	xcomp	O
to	IN	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
appropriate	JJ	amod	O
model	NN	compound	O
systems	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Altered	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

Topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
127	CD	nummod	O
(	-LRB-	punct	O
51	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
samples	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
24	CD	nmod	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
with	IN	case	O
>	NN	amod	O
50	CD	nummod	O
%	NN	amod	O
positive	JJ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Treatment	NN	nsubj	O
involved	VBD	ROOT	O
intravitreal	JJ	amod	O
injection	NN	dobj	O
of	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	O
.	.	punct	O
25	CD	nummod	O
mg	NN	conj	O
in	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	nummod	O
mL	NN	ROOT	O
)	-RRB-	punct	O
every	DT	det	O
6	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
weeks	NNS	appos	O
.	.	punct	O

Tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
isolated	VBN	ROOT	O
two	CD	nummod	O
decades	NNS	nmod:npmod	O
ago	RB	advmod	O
as	IN	case	O
a	DT	det	O
macrophageproduced	JJ	amod	O
protein	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
effectively	RB	advmod	O
kill	VB	acl:relcl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
/	:	punct	O
myb	VBD	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nsubj	O
exhibited	VBD	ROOT	O
a	DT	det	O
5	CD	nummod	O
-	SYM	punct	O
10	CD	nummod	O
-	HYPH	punct	O
fold	VB	dep	O
higher	JJR	amod	O
transformed	VBN	amod	O
colony	NN	dep	O
forming	NN	acl	O
efficiency	NN	dobj	O
than	IN	case	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nmod	O
in	IN	case	O
the	DT	det	O
blastoderm	JJ	amod	B-Cell
assay	NN	dobj	O
.	.	punct	O

Directed	JJ	amod	O
EC	NN	compound	B-Cell
migration	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
central	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
and	CC	cc	O
depends	VBZ	conj	O
on	IN	case	O
cellular	JJ	amod	B-Cell
signaling	NN	compound	O
cascades	NNS	nmod	O
that	WDT	nsubj	O
initiate	VBP	acl:relcl	O
and	CC	cc	O
control	VBP	conj	O
the	DT	det	O
structural	JJ	amod	O
rearrangements	NNS	dobj	O
.	.	punct	O

Cells	NNS	nsubj	B-Cell
which	WDT	nsubjpass	O
were	VBD	auxpass	O
grown	VBN	acl:relcl	O
in	IN	case	O
media	NNS	nmod	O
containing	VBG	acl	O
5	CD	nummod	O
and	CC	cc	O
10	CD	conj	O
ng	NN	compound	O
/	:	punct	O
ml	NN	compound	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	dobj	I-Gene_or_gene_product
demonstrated	VBD	ROOT	O
a	DT	det	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	prep	O
colony	NN	npadvmod	O
-	HYPH	punct	O
forming	VBG	amod	O
efficiency	NN	pobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	compound	O
medium	NN	pobj	O
without	IN	case	O
added	VBN	amod	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
tumorigenicity	NN	conj	O
in	IN	case	O
isogeneic	JJ	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

Immunodetection	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
bFGF	NN	compound	B-Gene_or_gene_product
mouse	NN	compound	B-Organism
monoclonal	JJ	amod	O
antibody	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
react	VB	xcomp	O
with	IN	case	O
recombinant	JJ	amod	O
human	JJ	amod	B-Organism
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
specifically	RB	advmod	O
neutralize	VB	conj	O
the	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
bovine	JJ	amod	B-Organism
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Development	NN	ROOT	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
for	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
with	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
response	NN	nsubj	O
to	TO	case	O
taxol	NN	amod	B-Simple_chemical
and	CC	cc	O
heparin	NN	conj	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
steroid	NN	nmod	I-Simple_chemical
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
HPVAM	NNP	nmod	O
,	,	punct	O
a	DT	det	O
validated	JJ	amod	O
angiogenesis	NN	compound	O
assay	NN	appos	O
.	.	punct	O

As	IN	mark	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
are	VBP	cop	O
devoid	JJ	advcl	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
potentiated	VBN	ROOT	O
by	IN	case	O
EGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Ovarian	JJ	amod	B-Cancer
cancers	NNS	nsubj	I-Cancer
overexpress	VBP	ROOT	O
the	DT	det	O
antimicrobial	JJ	amod	O
protein	NN	dobj	O
hCAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
derivative	JJ	amod	O
LL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nummod	I-Gene_or_gene_product
increases	VBZ	dep	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
heterozygous	JJ	amod	O
disruption	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
increased	VBN	amod	O
cellular	JJ	amod	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
reduced	VBD	amod	O
autophagy	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Abnormal	JJ	amod	O
hemostasis	NN	nsubjpass	O
in	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
described	VBN	dep	O
,	,	punct	O
however	RB	advmod	O
the	DT	det	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
and	CC	cc	O
cancer	NN	compound	B-Cancer
metastasis	NN	conj	O
and	CC	cc	O
prognosis	NN	conj	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
reported	VBN	parataxis	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
-	HYPH	punct	O
scale	NN	amod	O
clinical	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
by	IN	case	O
ectopically	RB	advmod	O
constitutive	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Dss1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
JB6	NN	compound	B-Cell
Cl	NN	compound	I-Cell
41	CD	nummod	I-Cell
-	HYPH	punct	I-Cell
5a	NN	compound	I-Cell
preneoplastic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
strongly	RB	advmod	O
increased	VBD	ROOT	O
focus	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
enhanced	VBN	amod	O
efficiency	NN	conj	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
/	:	punct	O
SIGNIFICANCE	NN	appos	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggested	VBD	dep	O
that	IN	mark	O
intrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathway	NN	nsubj	O
may	MD	aux	O
involve	VB	ccomp	O
in	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
effects	NNS	nmod	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
in	IN	case	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
the	DT	det	O
abilities	NNS	nmod	O
of	IN	case	O
the	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
acting	VBG	acl	O
alone	RB	advmod	O
,	,	punct	O
to	TO	mark	O
effectively	RB	advmod	O
induce	VB	advcl	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
of	IN	case	O
its	PRP$	nmod:poss	O
cooperativity	NN	conj	O
with	IN	case	O
another	DT	det	O
cellular	JJ	amod	B-Cell
oncogene	NN	nmod	O
in	IN	case	O
transforming	VBG	amod	O
primary	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Magnitude	NN	nsubj	O
of	IN	case	O
malate	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nmod	I-Simple_chemical
reduced	VBN	amod	I-Simple_chemical
nicotinamide	NN	compound	I-Simple_chemical
adenine	NN	nsubj	I-Simple_chemical
dinucleotide	NN	ROOT	I-Simple_chemical
shuttle	NN	amod	O
activity	NN	dobj	O
in	IN	case	O
intact	JJ	amod	O
respiring	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Fluorescence	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
cell	NN	compound	B-Cell
sorter	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
isolated	VBN	amod	O
tumor	NN	compound	B-Cell
ECs	NNS	nsubj	I-Cell
have	VBP	aux	O
suppressed	VBN	ccomp	O
levels	NNS	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
ECs	NNS	nmod	B-Cell
from	IN	case	O
normal	JJ	amod	O
mouse	NN	compound	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
identified	VBD	ROOT	O
GEP100	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
BRAG2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
be	VB	cop	O
responsible	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
Arf6	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
by	IN	mark	O
directly	RB	advmod	O
binding	VBG	advcl	O
to	TO	case	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
murine	JJ	amod	B-Organism
models	NNS	nmod	O
,	,	punct	O
the	DT	det	O
latter	JJ	nsubj	O
produces	VBZ	ROOT	O
a	DT	det	O
hyperproliferative	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
confers	VBZ	conj	O
resistance	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
enhances	VBZ	conj	O
cell	NN	compound	B-Cell
survival	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
inhibiting	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
not	RB	neg	O
transformed	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	VBN	amod	O
carcinogens	NNS	compound	O
benzo	NN	nmod	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
pyrene	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
BP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
or	CC	cc	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
MNNG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
shown	VBN	advcl	O
previously	RB	advmod	O
,	,	punct	O
ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Runx2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	B-Organ
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
preneoplastic	JJ	amod	O
state	NN	nmod	O
defined	VBN	acl	O
by	IN	case	O
an	DT	det	O
accumulation	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
phenotype	NN	nmod	O
and	CC	cc	O
a	DT	det	O
low	JJ	amod	O
proliferative	JJ	amod	O
rate	NN	conj	O
.	.	punct	O

Almost	RB	advmod	O
all	DT	det	O
patients	NNS	nsubj	B-Organism
respond	VBP	ROOT	O
to	TO	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
with	IN	case	O
increased	VBN	amod	O
neutrophils	NNS	nmod	B-Cell
,	,	punct	O
reduced	VBN	amod	O
infections	NNS	conj	O
,	,	punct	O
and	CC	cc	O
improved	VBD	conj	O
survival	NN	dobj	O
.	.	punct	O

This	DT	det	O
Review	NNP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
rationale	NN	dobj	O
for	IN	prep	O
using	VBG	pcomp	O
antiangiogenic	JJ	amod	O
compounds	NNS	dobj	O
and	CC	cc	O
will	MD	aux	O
focus	VB	conj	O
on	IN	prep	O
large	JJ	amod	O
molecules	NNS	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
antibodies	NNS	nmod	O
,	,	punct	O
that	WDT	nsubj	O
target	VBP	ccomp	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
system	NN	dobj	O
.	.	punct	O

Mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
platelet	NN	compound	B-Cell
activation	NN	nmod	O
with	IN	case	O
prostaglandin	NN	compound	B-Simple_chemical
E1	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
PGE	NN	appos	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
1	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
attenuated	VBD	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
capacity	NN	dobj	O
of	IN	case	O
SKOV3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
optimize	VB	dep	O
the	DT	det	O
method	NN	dobj	O
of	IN	mark	O
treating	VBG	acl	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	dobj	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
associated	VBN	acl	O
with	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
15	CD	intj	O
and	CC	cc	O
30	CD	conj	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
markedly	RB	advmod	O
inhibited	VBD	dep	O
HUVEC	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
,	,	punct	O
at	IN	case	O
15	CD	compound	O
-	HYPH	punct	O
50	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
decline	NN	dobj	O
in	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-	:	punct	O
thymidine	NN	compound	B-Simple_chemical
incorporation	NN	nmod	O
.	.	punct	O

The	DT	det	O
synthesis	NN	nsubjpass	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
the	DT	det	O
excretion	NN	conj	O
of	IN	case	O
this	DT	det	O
factor	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
medium	NN	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
A	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

30	CD	nummod	O
and	CC	cc	O
50	CD	conj	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
of	IN	prep	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	pobj	I-Gene_or_gene_product
,	,	punct	O
when	WRB	advmod	O
added	VBN	acl	O
to	TO	case	O
TNF	NN	compound	B-Gene_or_gene_product
alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
caused	VBD	ROOT	O
discontinuous	JJ	amod	O
and	CC	cc	O
disrupted	VBN	conj	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

Most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
studies	NNS	nmod	O
focusing	VBG	acl	O
on	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
upon	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
established	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
activating	VBG	compound	O
inputs	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
high	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
radiations	NNS	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	JJ	amod	O
drugs	NNS	conj	O
and	CC	cc	O
activated	VBN	amod	O
oncogenes	NNS	conj	O
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
Using	VBG	dep	O
ICG	NN	compound	B-Simple_chemical
-	HYPH	punct	O
DEP	NN	dobj	O
,	,	punct	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubjpass	I-Multi-tissue_structure
were	VBD	auxpass	O
closed	VBN	ROOT	O
with	IN	prep	O
single	JJ	amod	O
pulse	NN	compound	O
laser	NN	compound	O
energy	NN	pobj	O
,	,	punct	O
delivering	VBG	advcl	O
as	RB	advmod	O
little	JJ	amod	O
as	IN	quantmod	O
0	CD	dobj	O
.	.	punct	O
6	CD	compound	O
to	TO	dep	O
1	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
J	NN	ROOT	O
of	IN	case	O
energy	NN	nmod	O
to	IN	prep	O
the	DT	det	O
fundus	NN	pobj	B-Multi-tissue_structure
,	,	punct	O
producing	VBG	acl	O
no	DT	neg	O
visible	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
the	DT	det	O
fundus	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
using	VBG	acl	O
monolayer	JJ	compound	B-Cell
cultures	NNS	dobj	I-Cell
of	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nsubj	I-Simple_chemical
selectively	RB	advmod	O
inhibits	VBZ	ccomp	O
energy	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
DNA	NN	compound	B-Cellular_component
repair	NN	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
recovery	NN	compound	O
processes	NNS	conj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
annexin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
was	VBD	auxpass	O
positively	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
in	IN	case	O
NPC	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
suppressive	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NN	nmod	I-Organism
in	IN	case	O
subcutaneous	JJ	amod	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
A549	NN	compound	I-Cancer
xenograft	NN	nmod	I-Cancer
correlated	VBD	ROOT	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
vessels	NNS	nmod	I-Tissue
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
cultured	VBN	acl	O
on	IN	case	O
Matrigel	NNP	nmod	O
showed	VBD	ROOT	O
evident	JJ	amod	O
tube	NN	compound	B-Tissue
formation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
coculture	NN	nsubj	O
of	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
A431	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
led	VBD	conj	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
A431	NN	compound	B-Cell
cell	NN	compound	I-Cell
nests	NNS	nmod	O
constantly	RB	advmod	O
surrounded	VBN	acl	O
by	IN	agent	O
tube	NN	pobj	B-Tissue
-	HYPH	punct	O
like	IN	case	O
networks	NNS	nmod	O
consisting	VBG	acl	O
of	IN	prep	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	pobj	I-Cell
.	.	punct	O

RESULTS	NNS	dep	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
SREBP	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
activated	VBN	ROOT	O
during	IN	case	O
ECs	NNS	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	dep	O
the	DT	det	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
AQP0	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
corresponding	VBG	conj	O
normal	JJ	amod	B-Tissue
tissues	NNS	dobj	I-Tissue
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

Using	VBG	csubj	O
vitamin	NN	compound	B-Simple_chemical
K	NN	dobj	I-Simple_chemical
in	IN	case	O
perioperation	NN	compound	O
management	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
reduce	VB	ROOT	O
intraoperative	JJ	amod	O
blood	NN	compound	B-Organism_substance
loss	NN	dobj	O
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
before	RB	case	O
,	,	punct	O
4	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
nephrectomy	NN	nmod	O
in	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
contribution	NN	nsubj	O
of	IN	case	O
ischemia	NN	nmod	O
to	TO	case	O
arteriogenesis	NN	nmod	O
is	VBZ	cop	O
still	RB	advmod	O
unclear	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
arteriogenesis	NN	nsubj	O
clearly	RB	advmod	O
can	MD	aux	O
occur	VB	conj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
any	DT	det	O
significant	JJ	amod	O
ischemia	NN	nmod	O
.	.	punct	O

Caspase	NN	compound	B-Gene_or_gene_product
activation	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
depolarization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	conj	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
review	VBP	ROOT	O
and	CC	cc	O
comment	VB	conj	O
on	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
and	CC	cc	O
on	IN	case	O
their	PRP$	nmod:poss	O
implications	NNS	conj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
biology	NN	nmod	O
.	.	punct	O

These	DT	det	O
HCC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
had	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
genetic	JJ	amod	O
background	NN	dobj	O
but	CC	cc	O
with	IN	case	O
an	DT	det	O
increasing	VBG	amod	O
potential	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

This	DT	det	O
first	JJ	amod	O
analysis	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
73	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
50	CD	nummod	O
women	NNS	dep	B-Organism
,	,	punct	O
23	CD	nummod	O
men	NNS	appos	B-Organism
,	,	punct	O
median	JJ	amod	O
age	NN	appos	O
74	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
years	NNS	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	prep	O
a	DT	det	O
median	JJ	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	NN	pobj	O
of	IN	prep	O
13	CD	pobj	O
.	.	punct	O
3	CD	nummod	O
months	NNS	ROOT	O
and	CC	cc	O
a	DT	det	O
minimum	JJ	amod	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	conj	O
of	IN	prep	O
11	CD	nummod	O
months	NNS	pobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
mechanical	JJ	amod	O
strain	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
involves	VBZ	ccomp	O
signaling	VBG	compound	O
cascades	NNS	dobj	O
through	IN	case	O
RhoA	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
actin	NN	compound	B-Cellular_component
remodeling	NN	nmod	O
and	CC	cc	O
the	DT	det	O
p38	NN	compound	B-Gene_or_gene_product
stress	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
SAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	B-Multi-tissue_structure
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
owing	VBG	advcl	O
to	IN	case	O
the	DT	det	O
long	JJ	amod	O
latency	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
sporadic	JJ	amod	O
occurrence	NN	conj	O
of	IN	case	O
bona	FW	compound	O
fide	FW	compound	O
mammary	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
,	,	punct	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
Tsg101	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
has	VBZ	ccomp	O
only	RB	advmod	O
weak	JJ	amod	O
oncogenic	JJ	amod	O
properties	NNS	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
treatment	NN	nsubj	O
of	IN	case	O
immunocompetent	JJ	amod	O
mice	NNS	nmod	B-Organism
in	IN	case	O
the	DT	det	O
spontaneous	JJ	amod	O
lung	NN	compound	B-Organ
metastases	NNS	compound	O
model	VBP	nmod	O
with	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	nmod	I-Organism
after	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
excision	NN	nmod	O
prolonged	VBD	ROOT	O
their	PRP$	nmod:poss	O
median	JJ	amod	O
survival	NN	dobj	O
from	IN	case	O
21	CD	compound	O
to	TO	dep	O
51	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
days	NNS	ROOT	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
measured	VBN	ROOT	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	nmod	O
and	CC	cc	O
microscope	NN	compound	O
examination	NN	conj	O
.	.	punct	O

Ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
reduced	VBN	amod	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
cord	NN	compound	B-Tissue
formation	NN	nmod	O
on	IN	case	O
collagen	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
reduced	VBD	amod	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
structure	NN	conj	O
on	IN	case	O
Matrigel	NNP	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	B-Organism
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
CDK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4c	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Kip1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	B-Cancer
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
multiple	JJ	amod	B-Cancer
endocrine	JJ	amod	I-Cancer
neoplasia	NN	compound	I-Cancer
(	-LRB-	punct	O
MEN	NN	appos	B-Cancer
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
migration	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
enhance	VBP	ROOT	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
metabolism	NN	dobj	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
and	CC	cc	O
its	PRP$	nmod:poss	O
incorporation	NN	conj	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
of	IN	case	O
leukemic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
leading	VBG	acl	O
to	TO	case	O
a	DT	det	O
higher	JJR	amod	O
antileukemic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
on	IN	case	O
clonogenic	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
CFU	NN	compound	B-Cell
-	HYPH	punct	I-Cell
L	NN	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Angiogenin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	acomp	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
in	IN	case	O
human	JJ	amod	B-Organism
primary	JJ	amod	O
breast	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
markers	NNS	nmod	O
of	IN	case	O
hypoxia	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
survival	NN	conj	O
.	.	punct	O

Different	JJ	amod	O
antiangiogenic	JJ	amod	O
therapeutics	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
improve	VB	xcomp	O
tumor	NN	compound	B-Cancer
control	NN	dobj	O
through	IN	case	O
vascular	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
targeting	VBG	dep	I-Simple_chemical
agents	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
VTA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
osteoprotegerin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
RANK	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
bone	NN	compound	B-Tissue
metastasis	NN	nmod	O
.	.	punct	O

This	DT	det	O
correlation	NN	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
a	DT	det	O
higher	JJR	amod	O
number	NN	ROOT	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
rather	RB	cc	O
than	IN	mwe	O
to	IN	case	O
a	DT	det	O
larger	JJR	amod	O
size	NN	conj	O
of	IN	case	O
the	DT	det	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activation	NN	nsubj	O
by	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
implicates	VBZ	ROOT	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

FOXO3a	NN	nsubj	B-Gene_or_gene_product
elicits	VBZ	ROOT	O
a	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
transcription	NN	compound	O
program	NN	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
response	NN	conj	O
to	TO	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Organ
carcinogen	NN	compound	O
nicotine	NN	nmod:npmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
derived	VBN	amod	I-Simple_chemical
nitrosaminoketone	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
NNK	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Proof	NN	nsubj	O
of	IN	case	O
principle	NN	nmod	O
of	IN	case	O
the	DT	det	O
combined	JJ	amod	O
diagnosis	NN	compound	O
/	:	punct	O
treatment	NN	compound	O
system	NN	compound	O
design	NN	nsubjpass	O
for	IN	prep	O
performing	VBG	pcomp	O
dye	NN	npadvmod	O
-	HYPH	punct	O
enhanced	VBN	amod	O
photocoagulation	NN	dobj	O
(	-LRB-	punct	O
DEP	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
setting	NN	nmod	O
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
minimum	JJ	amod	O
DEP	NN	compound	O
laser	NN	compound	O
energy	NN	nmod	O
needed	VBD	acl	O
to	TO	case	O
close	VB	amod	O
CNV	NN	compound	O
FVs	NNS	nmod	B-Multi-tissue_structure
was	VBD	auxpass	O
made	VBN	ROOT	O
in	IN	case	O
11	CD	nummod	O
AMD	NN	compound	O
patients	NNS	nmod	B-Organism
requiring	VBG	acl	O
treatment	NN	dobj	O
of	IN	case	O
CNV	NN	nmod	O
,	,	punct	O
but	CC	cc	O
for	IN	case	O
whom	WP	nmod	O
other	JJ	amod	O
treatment	NN	nsubj	O
was	VBD	conj	O
not	RB	neg	O
appropriate	JJ	acomp	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
pituitary	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
pancreatic	JJ	conj	B-Multi-tissue_structure
islets	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Rb	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
protein	NN	nmod	O
at	IN	case	O
both	CC	cc:preconj	O
CDK2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CDK4	NN	conj	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
sites	NNS	dep	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
p18	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
Men1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
further	RB	advmod	O
increased	VBN	conj	O
in	IN	case	O
p18	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
;	:	punct	O
Men1	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	parataxis	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubjpass	O
nor	CC	cc	O
secreted	VBN	amod	O
protein	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
uninfected	JJ	amod	O
HUVECs	NNS	nmod	B-Cell
or	CC	cc	O
RASMCs	NNS	conj	B-Cell
or	CC	cc	O
in	IN	case	O
cells	NNS	conj	B-Cell
infected	VBN	acl	O
with	IN	case	O
the	DT	det	O
control	JJ	compound	O
vector	NN	compound	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	ROOT	I-Gene_or_gene_product
(	-LRB-	punct	O
where	WRB	advmod	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ccomp	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
galactosidase	NN	attr	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Hence	RB	advmod	O
orally	RB	advmod	O
active	JJ	amod	O
blockers	NNS	nsubj	O
of	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
that	WDT	nsubj	O
are	VBP	cop	O
safe	JJ	ROOT	O
,	,	punct	O
efficacious	JJ	nsubjpass	O
and	CC	cc	O
inexpensive	JJ	conj	O
are	VBP	auxpass	O
urgently	RB	advmod	O
needed	VBN	conj	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
delivery	NN	nsubj	O
of	IN	case	O
an	DT	det	O
appropriate	JJ	amod	O
combination	NN	nmod	O
of	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
from	IN	case	O
an	DT	det	O
injectable	JJ	amod	O
alginate	JJ	compound	O
hydrogel	NN	compound	O
system	NN	nmod	O
into	IN	case	O
ischemic	JJ	amod	O
hindlimbs	NN	nmod	B-Organism_subdivision
led	VBD	ROOT	O
to	IN	case	O
a	DT	det	O
faster	JJR	amod	O
recovery	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Organism_substance
flow	NN	nmod	O
than	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
DAPT	NN	conj	B-Simple_chemical
alone	RB	advmod	O
;	:	punct	O
perfusion	NN	compound	O
levels	NNS	nsubj	O
reached	VBD	parataxis	O
80	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
with	IN	case	O
combined	JJ	amod	O
DAPT	NN	nmod	B-Simple_chemical
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
delivery	NN	conj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
transfection	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
can	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
CNE1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

This	DT	det	O
reduction	NN	nsubj	O
disappeared	VBD	ROOT	O
with	IN	prep	O
increasing	VBG	amod	O
distance	NN	pobj	O
from	IN	prep	O
the	DT	det	O
tumor	NN	pobj	B-Cancer
.	.	punct	O

Human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
CaSki	NN	dep	B-Cell
and	CC	cc	O
SiHa	NN	conj	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
flanks	NNS	nmod	B-Organism_subdivision
of	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Growth	NN	compound	O
inhibition	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
cellular	JJ	amod	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
extensive	JJ	amod	O
necrosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
mean	NN	compound	O
vessel	NN	compound	B-Multi-tissue_structure
density	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
reduction	NN	conj	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
expression	NN	nmod	O
of	IN	case	O
angioproliferative	JJ	amod	O
cytokines	NNS	nmod	O
.	.	punct	O

Prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
dissemination	NN	nsubj	O
is	VBZ	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
and	CC	cc	O
few	JJ	amod	O
treatment	NN	compound	O
options	NNS	nsubj	O
exist	VBP	conj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
advanced	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
.	.	punct	O

These	DT	det	O
models	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
clinically	RB	advmod	O
relevant	JJ	amod	O
implications	NNS	dobj	O
,	,	punct	O
particularly	RB	advmod	O
for	IN	case	O
the	DT	det	O
tailoring	NN	nmod	O
of	IN	case	O
therapeutic	JJ	amod	O
strategies	NNS	nmod	O
targeting	VBG	acl	O
telomerase	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
rapid	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
Tie1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
shear	NN	compound	O
stress	NN	compound	O
changes	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
rapid	JJ	amod	O
binding	NN	conj	O
to	TO	case	O
Tie2	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
destabilization	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
initiate	VB	advcl	O
the	DT	det	O
process	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
restructuring	NN	nmod	O
.	.	punct	O

The	DT	det	O
coagulative	JJ	amod	O
parameters	NNS	nsubj	O
including	VBG	case	O
the	DT	det	O
prothrombin	NN	compound	B-Gene_or_gene_product
time	NN	nmod	O
,	,	punct	O
activated	VBN	ROOT	O
partial	JJ	amod	O
thromboplastin	NN	compound	B-Gene_or_gene_product
time	NN	dobj	O
,	,	punct	O
and	CC	cc	O
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
collected	VBN	conj	O
and	CC	cc	O
studied	VBN	conj	O
retrospectively	RB	advmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
glucose	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
alanine	NN	compound	B-Amino_acid
kinetics	NNS	conj	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
tracer	NN	compound	O
methodology	NN	nmod	O
in	IN	case	O
a	DT	det	O
sarcoma	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
latency	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
transcripts	NNS	nmod	O
that	WDT	nsubj	O
map	VBP	acl:relcl	O
antisense	JJ	dep	O
to	TO	case	O
the	DT	det	O
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
of	IN	case	O
Marek	NNP	nmod:poss	B-Organism
'	POS	case	I-Organism
s	VBZ	compound	I-Organism
disease	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

A	DT	det	O
C	NNP	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	nsubj	O
consisting	VBG	acl	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
amino	NN	compound	B-Amino_acid
acids	NNS	nmod	I-Amino_acid
251	CD	compound	O
to	TO	dep	O
708	CD	nummod	O
(	-LRB-	punct	O
T251	NN	compound	O
-	:	punct	O
708	CD	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
sensitized	VBD	ROOT	O
cells	NNS	dobj	B-Cell
to	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
area	NN	nsubjpass	O
covered	VBN	acl	O
by	IN	agent	O
spread	JJ	amod	O
EC	NN	pobj	B-Cell
was	VBD	auxpass	O
dramatically	RB	advmod	O
enlarged	VBN	ROOT	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
focal	JJ	amod	B-Cellular_component
contacts	NNS	nmod	I-Cellular_component
and	CC	cc	O
altered	JJ	amod	O
organization	NN	conj	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
filaments	NNS	nmod	B-Cellular_component
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
deletion	NN	compound	O
mutants	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
EGFR	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
amplified	VBN	parataxis	O
and	CC	cc	O
rearranged	VBN	conj	O
.	.	punct	O

The	DT	det	O
conclusion	NN	nsubj	O
most	RBS	advmod	O
consistent	JJ	amod	O
with	IN	case	O
the	DT	det	O
data	NNS	nmod	O
is	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
MSRs	NNS	nsubj	B-Gene_or_gene_product
are	VBP	aux	O
overlapping	VBG	ccomp	O
,	,	punct	O
spliced	VBN	amod	O
RNAs	NNS	dobj	O
.	.	punct	O

The	DT	det	O
transition	NN	nsubj	O
between	IN	case	O
both	DT	det	O
conformations	NNS	nmod	O
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
important	JJ	conj	O
for	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
D10S541	NN	nmod	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
was	VBD	auxpass	O
found	VBN	dep	O
in	IN	case	O
37	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
21	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Two	CD	nummod	O
distraction	NN	compound	O
rates	NNS	nsubjpass	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	dep	O
and	CC	cc	O
1	CD	conj	O
mm	NN	dep	O
/	SYM	punct	O
day	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
and	CC	cc	O
for	IN	case	O
each	DT	det	O
group	NN	conj	O
three	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
analyzed	VBN	parataxis	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
allogeneic	JJ	amod	O
injection	NN	nsubj	O
of	IN	case	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
new	JJ	amod	O
therapeutic	JJ	amod	O
strategy	NN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
severe	JJ	amod	O
peripheral	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

On	IN	prep	O
strips	NNS	pobj	O
of	IN	prep	O
all	DT	det	O
widths	NNS	pobj	O
,	,	punct	O
ECs	NNS	nsubj	B-Cell
tended	VBD	ROOT	O
to	TO	aux	O
migrate	VB	xcomp	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
strips	NNS	pobj	O
.	.	punct	O

Six	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
randomly	RB	advmod	O
divided	VBN	ROOT	O
into	IN	case	O
four	CD	nummod	O
treatment	NN	compound	O
groups	NNS	nmod	O
:	:	punct	O
untreated	JJ	amod	O
controls	NNS	dep	O
;	:	punct	O
10	CD	nummod	O
minute	NN	parataxis	O
daily	JJ	amod	O
TEMF	NN	dobj	O
;	:	punct	O
200	CD	nummod	O
cGy	NN	dep	O
of	IN	case	O
IR	NN	nmod	O
every	DT	det	O
other	JJ	amod	O
day	NN	nmod	O
(	-LRB-	punct	O
total	JJ	amod	O
800	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
IR	NN	dep	O
plus	CC	cc	O
daily	RB	conj	O
TEMF	NN	conj	O
.	.	punct	O

S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
also	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	attr	O
.	.	punct	O

VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
induced	VBD	ROOT	O
dermal	JJ	amod	B-Cell
microvascular	JJ	amod	I-Cell
EC	NN	compound	I-Cell
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	B-Gene_or_gene_product
and	CC	cc	O
beta3	NN	compound	B-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
subunits	NNS	conj	I-Gene_or_gene_product
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
ligand	NN	appos	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
endogenous	JJ	amod	O
IL	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
mediator	NN	ccomp	O
of	IN	case	O
ischaemic	JJ	amod	O
and	CC	cc	O
excitotoxic	JJ	conj	O
brain	NN	compound	B-Organ
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
inhibitors	NNS	nsubj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
action	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
value	NN	conj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
or	CC	cc	O
chronic	JJ	conj	O
neuronal	JJ	amod	B-Cell
death	NN	nmod	O
.	.	punct	O

An	DT	det	O
important	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
proprotein	NN	compound	O
convertases	VBZ	nmod	O
in	IN	case	O
tumorigenic	JJ	amod	O
processes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

Electronmicroscopically	RB	advmod	O
,	,	punct	O
thrombus	NN	compound	B-Pathological_formation
formation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nmod	O
prevented	VBD	ROOT	O
tumor	NN	compound	B-Cancer
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	compound	O
formation	NN	conj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
whether	IN	mark	O
ATX	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
affects	VBZ	ccomp	O
motility	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
stably	RB	advmod	O
transfected	VBD	ROOT	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
ATX	NN	compound	B-Gene_or_gene_product
cDNA	NN	dobj	O
into	IN	case	O
two	CD	nummod	O
non	JJ	amod	O
-	HYPH	punct	O
expressing	VBG	dep	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
parental	JJ	amod	O
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	dep	O
NIH3T3	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
clone7	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	appos	I-Cell
.	.	punct	O

Attenuating	NN	csubj	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
by	IN	case	O
siRNA	NN	nmod	O
constrained	VBD	ROOT	O
PTTG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HA	NN	compound	O
/	:	punct	O
EC9706	NN	compound	O
cell	NN	compound	O
motility	NN	dobj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
RAGE	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
structural	JJ	amod	O
damage	NN	compound	O
(	-LRB-	punct	O
e	NN	amod	O
.	.	punct	O
g	NN	nmod	O
.	.	punct	O
inflammation	NN	ROOT	O
,	,	punct	O
neoangiogenesis	NN	conj	O
and	CC	cc	O
fibrosis	NN	conj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Alternatively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
equally	RB	advmod	O
plausible	JJ	conj	O
,	,	punct	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
simply	RB	advmod	O
be	VB	ROOT	O
an	DT	det	O
"	``	punct	O
innocent	JJ	amod	O
bystander	NN	attr	O
"	''	punct	O
that	WDT	nsubj	O
corrects	VBZ	relcl	O
neutropenia	NN	dobj	O
,	,	punct	O
prolongs	NNS	advcl	O
patient	VBP	compound	B-Organism
survival	NN	dobj	O
,	,	punct	O
and	CC	cc	O
allows	VBZ	conj	O
time	NN	dobj	O
for	IN	mark	O
the	DT	det	O
malignant	JJ	amod	O
predisposition	NN	nsubj	O
to	TO	aux	O
declare	VB	advcl	O
itself	PRP	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	B-Gene_or_gene_product
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	B-Cellular_component
.	.	punct	O

OBJECTIVES	NNS	ROOT	O
:	:	punct	O
To	TO	mark	O
compare	VB	dep	O
the	DT	det	O
proteomic	JJ	amod	O
expression	NN	compound	O
profile	NN	dobj	O
between	IN	case	O
an	DT	det	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	nmod:npmod	I-Organism
virus	NN	nmod:npmod	I-Organism
-	HYPH	punct	O
associated	VBN	amod	O
NPC	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
C666	NN	appos	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
normal	JJ	amod	O
NP	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
(	-LRB-	punct	O
NP69	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
targeted	VBN	amod	O
mutant	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
to	TO	mark	O
test	VB	xcomp	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
monoallelic	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ccomp	O
tumorigenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
mode	NN	nsubj	O
of	IN	case	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	conj	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
shape	NN	dobj	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
cohort	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
betel	NN	nmod:npmod	B-Organism_subdivision
-	HYPH	punct	O
associated	VBN	amod	O
OSCC	NN	nmod	B-Cancer
and	CC	cc	O
to	TO	mark	O
evaluate	VB	conj	O
for	IN	case	O
possible	JJ	amod	O
clinicopathologic	JJ	amod	O
correlations	NNS	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	B-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

Attenuation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
effects	NNS	nmod	O
by	IN	mark	O
neutralizing	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
antibodies	NNS	dobj	I-Gene_or_gene_product
suggests	VBZ	ROOT	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
play	VBP	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
phenotype	NN	nmod	O
in	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
normal	JJ	amod	O
gastric	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
gastric	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
and	CC	cc	O
SABC	NN	compound	O
immunohistochemistry	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

VTAs	NNS	nsubjpass	B-Simple_chemical
can	MD	aux	O
be	VB	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
:	:	punct	O
antiangiogenic	JJ	amod	B-Simple_chemical
agents	NNS	dep	I-Simple_chemical
and	CC	cc	O
vascular	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
disrupting	VBG	amod	I-Simple_chemical
agents	NNS	conj	I-Simple_chemical
(	-LRB-	punct	O
VDAs	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

VEGF	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ROOT	O
angiogenesis	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
fundamental	JJ	amod	O
event	NN	acl:relcl	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
dissemination	NN	conj	O
.	.	punct	O

Platelet	NN	compound	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
PECAM	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
;	:	punct	O
additionally	RB	advmod	O
,	,	punct	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibodies	NNS	nsubjpass	I-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	parataxis	O
to	TO	mark	O
inhibit	VB	xcomp	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
NP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
,	,	punct	O
NP	NN	dep	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
plexin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A1	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
surface	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
and	CC	cc	O
ovarian	JJ	conj	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
378	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
296	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
92	CD	nummod	B-Gene_or_gene_product
cluster	NN	nsubj	O
contribute	VBP	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nsubjpass	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod:poss	O
'	POS	case	O
mRNA	NN	conj	O
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
and	CC	cc	O
control	NN	conj	O
tissues	NNS	dep	B-Tissue
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
Ang1	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
mDia	NNS	nmod	B-Gene_or_gene_product
through	IN	case	O
RhoA	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
association	NN	nmod	O
of	IN	case	O
mDia	NNS	nmod	B-Gene_or_gene_product
with	IN	case	O
Src	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
by	IN	case	O
a	DT	det	O
tumorigenicity	NN	compound	O
assay	NN	nmod	O
using	VBG	acl	O
NIH3T3	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
transfected	VBN	acl	O
with	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	compound	O
patient	NN	nmod	B-Organism
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Jun	NN	compound	I-Gene_or_gene_product
amino	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
terminal	JJ	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
JNK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
blocked	VBD	ROOT	O
type	NN	compound	B-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
collagen	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MEFs	NNS	nmod	B-Cell
,	,	punct	O
suggesting	VBG	advcl	O
regulation	NN	dobj	O
of	IN	case	O
JNK	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
as	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
controls	VBZ	acl:relcl	O
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
SAT	NN	nsubj	B-Tissue
and	CC	cc	O
VAT	NN	conj	B-Tissue
expressed	VBD	dep	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
without	IN	case	O
significant	JJ	amod	O
difference	NN	nmod	O
for	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
glucose	NN	nsubj	B-Simple_chemical
potentiated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
failure	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
might	MD	aux	O
lead	VB	advcl	O
to	TO	case	O
intimal	JJ	amod	B-Tissue
proliferation	NN	nmod	O
and	CC	cc	O
lack	NN	conj	O
of	IN	case	O
reversibility	NN	nmod	O
of	IN	case	O
PHT	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
this	DT	dobj	O
and	CC	cc	O
other	JJ	amod	O
key	JJ	amod	O
markers	NNS	conj	O
of	IN	case	O
vasoactivity	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
PHT	NN	nmod	O
and	CC	cc	O
CHD	NN	conj	O
.	.	punct	O

Upon	IN	case	O
HTPB	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
and	CC	cc	O
subsequently	RB	advmod	O
led	VBN	conj	O
to	TO	case	O
mitochondria	VB	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	advcl	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Bax	NN	compound	B-Gene_or_gene_product
ratio	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
monolayers	NNS	nmod	B-Cell
and	CC	cc	O
spheroids	NNS	conj	B-Cell
.	.	punct	O

miRNA	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
126	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
EC	NNP	nmod:npmod	B-Cell
-	HYPH	punct	O
restricted	JJ	amod	O
miRNA	NN	appos	O
,	,	punct	O
regulates	VBZ	ROOT	O
vascular	JJ	amod	B-Multi-tissue_structure
integrity	NN	dobj	O
and	CC	cc	O
developmental	JJ	amod	O
angiogenesis	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
experimental	JJ	amod	O
data	NNS	nsubj	O
confirm	VBP	ROOT	O
previous	JJ	amod	O
studies	NNS	dobj	O
showing	VBG	acl	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
growth	NN	compound	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
bladder	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
HTB9	NN	nmod	I-Cell
and	CC	cc	O
further	RB	advmod	O
showed	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
at	IN	case	O
the	DT	det	O
S	NN	compound	O
/	:	punct	O
G2	NN	compound	O
-	:	punct	O
M	NN	nmod	O
checkpoints	NNS	nmod	O
.	.	punct	O

These	DT	det	O
proliferative	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
release	NN	conj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	acl:relcl	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	compound	I-Simple_chemical
agonist	NN	compound	O
addition	NN	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	compound	B-Cell
invasion	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
transwell	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Antiangiogenesis	NN	compound	O
therapy	NN	nsubj	O
might	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
regional	JJ	amod	O
metastasis	NN	dobj	O
.	.	punct	O

Ablation	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
almost	RB	advmod	O
completely	RB	advmod	O
abolished	VBD	ROOT	O
these	DT	det	O
cellular	JJ	amod	B-Cell
interactions	NNS	dobj	O
and	CC	cc	O
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Binding	NN	amod	O
studies	NNS	nsubj	O
with	IN	case	O
SPARC	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
SPARC	NN	conj	B-Gene_or_gene_product
peptides	NNS	nmod	I-Gene_or_gene_product
indicate	VBP	ROOT	O
specific	JJ	amod	O
and	CC	cc	O
saturable	JJ	conj	O
interaction	NN	dobj	O
with	IN	case	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
involves	VBZ	acl:relcl	O
the	DT	det	O
C	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
Ca2	NN	nmod	O
+	CC	cc	O
-	:	punct	O
binding	NN	compound	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
specific	JJ	amod	O
mitogen	NN	appos	O
,	,	punct	O
can	MD	aux	O
act	VB	ROOT	O
in	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
specific	JJ	amod	O
receptors	NNS	nmod	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	B-Cellular_component
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nsubj	I-Simple_chemical
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
delay	NN	dobj	O
in	IN	case	O
monolayers	NNS	nmod	B-Cell
,	,	punct	O
while	IN	mark	O
a	DT	det	O
transient	JJ	amod	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
delay	NN	nsubj	O
was	VBD	cop	O
apparent	JJ	advcl	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
heterogeneity	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
between	IN	case	O
primary	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
41	CD	nmod	O
.	.	punct	O
3	CD	nummod	O
%	NN	ROOT	O
.	.	punct	O

Some	DT	det	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	B-Gene_or_gene_product
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
tunicamycin	NN	nsubj	B-Simple_chemical
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
viability	NN	nmod	O
and	CC	cc	O
MTT	NN	compound	B-Simple_chemical
responses	NNS	conj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
used	VBN	acl	O
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
CYR61	NN	compound	B-Gene_or_gene_product
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
CREB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
binding	NN	conj	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
histone	NN	compound	I-Gene_or_gene_product
acetyltransferase	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Angiopoietin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
prevents	VBZ	ROOT	O
VEGF	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Tissue
permeability	NN	dobj	O
by	IN	prep	O
sequestering	VBG	pcomp	O
Src	NNP	dobj	B-Gene_or_gene_product
through	IN	prep	O
mDia	NNS	pobj	B-Gene_or_gene_product
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
hypoxic	JJ	amod	O
tumor	NN	compound	B-Cancer
environments	NNS	nsubj	O
induce	VBP	acl:relcl	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

Cobalt	NN	compound	B-Simple_chemical
chloride	NN	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
stimulator	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
stimulated	VBD	ROOT	O
angiogenesis	NN	compound	O
initiation	NN	dobj	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
the	DT	det	O
HPVAM	NNP	conj	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nsubjpass	O
was	VBD	auxpass	O
stimulated	VBN	conj	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	B-Tissue
assay	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
CLA	NN	nsubj	B-Simple_chemical
might	MD	aux	O
inhibit	VB	ccomp	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

After	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
before	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
length	NN	compound	O
density	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubj	O
increased	VBD	ROOT	O
greater	JJR	advmod	O
than	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
fold	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
declined	VBD	conj	O
to	TO	mark	O
control	VB	xcomp	O
levels	NNS	dobj	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
insulin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
conditioned	VBN	amod	O
RPE	NN	compound	B-Cell
cell	NN	compound	I-Cell
media	NNS	nsubj	O
stimulated	VBD	amod	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	ROOT	O
,	,	punct	O
an	DT	det	O
effect	NN	appos	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
completely	RB	advmod	O
blocked	VBN	acl:relcl	O
by	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
neutralizing	VBG	compound	O
antibody	NN	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
by	IN	case	O
adeno	NN	nmod:npmod	B-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
virus	NN	nmod:npmod	I-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
vasostatin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	dep	I-Gene_or_gene_product
in	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
MEFs	NNS	appos	B-Cell
)	-RRB-	punct	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
use	NN	nmod	O
of	IN	case	O
MEFs	NNS	nmod	B-Cell
defective	JJ	amod	O
in	IN	case	O
SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
two	CD	nummod	O
candidate	NN	compound	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
RNA	NN	compound	O
-	HYPH	punct	O
damaging	NN	compound	O
agents	NNS	nsubjpass	O
,	,	punct	O
onconase	NN	conj	B-Simple_chemical
and	CC	cc	O
(	-LRB-	punct	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	LS	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
rhEDN	NN	conj	I-Simple_chemical
,	,	punct	O
were	VBD	auxpass	O
screened	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
using	VBG	xcomp	O
three	CD	nummod	O
distinct	JJ	amod	O
types	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
:	:	punct	O
HPV	NN	compound	B-Organism
-	:	punct	I-Organism
16	CD	nummod	I-Organism
E6	NN	compound	I-Organism
/	:	punct	O
E7	NN	nmod:npmod	B-Organism
-	:	punct	O
immortalized	VBN	amod	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
Kras	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
HPV	NNP	compound	B-Organism
-	:	punct	I-Organism
16	CD	nummod	I-Organism
E6	NN	compound	I-Organism
/	:	punct	O
E7	NN	compound	B-Organism
HUVEC	NN	appos	B-Cell
(	-LRB-	punct	O
Rhim	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
Carcinogenesis	NN	appos	O
4	CD	nummod	O
,	,	punct	O
673	CD	nummod	O
-	SYM	punct	O
681	CD	nummod	O
,	,	punct	O
1998	CD	amod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
primary	JJ	amod	O
HUVECs	NNS	conj	B-Cell
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
landmark	NN	compound	O
feature	NN	appos	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
growth	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
various	JJ	amod	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

TSP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O

1	LS	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Tetradecylpyrrolidine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
TPNO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
immediately	RB	advmod	O
after	IN	case	O
addition	NN	appos	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
over	IN	case	O
the	DT	det	O
whole	JJ	amod	O
concentration	NN	compound	O
range	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
>	NN	dobj	O
2	CD	dep	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	ROOT	O
in	IN	case	O
Fas	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
elevation	NN	conj	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
injection	NN	nsubj	O
or	CC	cc	O
oral	JJ	amod	B-Organism_subdivision
administration	NN	conj	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
efficiently	RB	advmod	O
inhibited	VBD	ROOT	O
A549	NN	compound	B-Cancer
xenograft	NN	compound	I-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
without	IN	case	O
side	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

Malignant	JJ	amod	B-Cancer
melanoma	NN	nsubjpass	I-Cancer
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
frequent	JJ	amod	O
metastasis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
specific	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
this	DT	det	O
process	NN	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
delineated	VBN	parataxis	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
potentiating	NN	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
on	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
synthesis	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
reproduced	VBN	ccomp	O
with	IN	case	O
simple	JJ	amod	O
expression	NN	compound	O
plasmids	NNS	nmod	O
,	,	punct	O
provided	VBD	ccomp	O
that	IN	mark	O
both	DT	det	O
miRNAs	NNS	nsubjpass	O
are	VBP	auxpass	O
processed	VBN	ccomp	O
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
transcript	NN	nmod	O
.	.	punct	O

Curcumin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
metastatic	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	nmod	I-Cell
through	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
urokinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Dose	NNP	compound	O
-	:	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
effects	NNS	ROOT	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
on	IN	case	O
cytotoxicity	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	conj	O
and	CC	cc	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

No	DT	neg	O
harmful	JJ	amod	O
side	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
TEMF	NN	nmod	O
.	.	punct	O

Hepatectomy	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
patient	NN	nsubj	B-Organism
is	VBZ	cop	O
alive	JJ	conj	O
and	CC	cc	O
free	JJ	conj	O
of	IN	case	O
disease	NN	nmod	O
1	CD	nummod	O
year	NN	compound	O
postsurgery	NN	conj	O
.	.	punct	O

In	IN	case	O
spheroids	NNS	ROOT	B-Cell
,	,	punct	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	intj	O
(	-LRB-	punct	O
2	CD	dep	O
.	.	punct	O
1	CD	nummod	O
p	NN	compound	O
mole	NN	nsubj	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
lactate	NN	compound	B-Simple_chemical
production	NN	conj	O
(	-LRB-	punct	O
3	CD	dep	O
.	.	punct	O
67	CD	nummod	O
p	NN	compound	O
mole	NN	dep	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
nearly	RB	advmod	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	ROOT	O
fold	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
in	IN	case	O
monolayer	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
0	CD	dep	O
.	.	punct	O
83	CD	dep	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
43	CD	nummod	O
p	NN	compound	O
mole	NN	compound	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	ROOT	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nsubjpass	O
and	CC	cc	O
western	NN	compound	O
blot	NN	compound	O
techniques	NNS	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
validate	JJ	xcomp	O
target	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Many	JJ	amod	O
observations	NNS	nsubj	O
in	IN	case	O
various	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	B-Organism
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remodeling	NN	nsubj	O
of	IN	prep	O
preexisting	VBG	pcomp	O
collateral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
is	VBZ	cop	O
the	DT	det	O
mechanism	NN	ccomp	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
for	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
a	DT	det	O
novel	JJ	amod	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
underlying	VBG	acl	O
anti	RB	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activity	NN	dobj	O
of	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
a	DT	det	O
rationale	NN	conj	O
for	IN	case	O
the	DT	det	O
combined	JJ	amod	O
HDACi	NN	nmod	O
and	CC	cc	O
E1A	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
therapy	NN	conj	O
in	IN	case	O
future	JJ	amod	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
impact	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
and	CC	cc	O
angiostatin	NN	conj	B-Gene_or_gene_product
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Thalidomide	NNP	nsubj	B-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Patients	NNS	nsubj	B-Organism
whose	WP$	nmod:poss	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
CD40	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
negative	NN	dep	O
showed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
better	JJR	amod	O
N	NN	compound	O
stage	NN	dobj	O
,	,	punct	O
overall	JJ	amod	O
stage	NN	appos	O
at	IN	case	O
presentation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
than	IN	case	O
those	DT	det	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CD40	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
with	IN	case	O
clinical	JJ	amod	O
pathology	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
of	IN	case	O
gastrointestinal	JJ	amod	B-Cancer
stromal	JJ	amod	I-Cancer
tumor	NN	nmod	I-Cancer
(	-LRB-	punct	O
GIST	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
exposed	VBN	advcl	O
to	TO	case	O
step	NN	compound	O
-	HYPH	punct	O
wise	JJ	amod	O
increases	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
concentration	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
resistance	NN	nmod	O
was	VBD	auxpass	O
accelerated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ccomp	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
in	IN	case	O
Hct	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
116	CD	nummod	I-Cell
human	JJ	amod	I-Cell
colon	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
clarify	VB	advcl	O
if	IN	mark	O
a	DT	det	O
time	NN	npadvmod	O
/	,	punct	O
concentration	NN	compound	O
range	NN	nsubj	O
for	IN	case	O
optimal	JJ	amod	O
doxorubicin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
exists	VBZ	ROOT	O
.	.	punct	O

Cell	NNP	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
adhesion	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
adhesive	JJ	amod	O
ability	NN	dobj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	HYPH	punct	I-Cell
GL	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
stromal	JJ	nmod	B-Cell
or	CC	cc	O
osteoblastic	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
induced	VBD	ROOT	O
RANKL	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
decreased	VBD	conj	O
OPG	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
microsatellites	NNS	nmod	O
in	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Continuous	JJ	amod	O
(	-LRB-	punct	O
24h	NN	dep	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
5	CD	compound	O
microM	NN	amod	O
doxorubicin	NN	nmod	B-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
in	IN	case	O
G0	NN	compound	O
/	:	punct	O
G1	NN	compound	O
phase	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
neither	CC	cc:preconj	O
accompanied	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
nor	CC	cc	O
enhanced	VBD	amod	O
expression	NN	conj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
potent	JJ	amod	O
collaboration	NN	nmod	O
is	VBZ	auxpass	O
elucidated	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
of	IN	case	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
term	NN	nmod	O
"	``	punct	O
arteriogenesis	NN	nsubjpass	O
"	''	punct	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
to	TO	mark	O
differentiate	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
arteries	NNS	nmod	I-Multi-tissue_structure
from	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
mainly	RB	advmod	O
occurs	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
ischemic	JJ	amod	O
,	,	punct	O
collateral	JJ	dep	O
flow	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	dep	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

Following	VBG	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
administration	NN	nmod	O
of	IN	case	O
cationic	JJ	amod	O
lipid	NN	compound	O
-	HYPH	punct	O
DNA	NN	compound	B-Cellular_component
complexes	NNS	nmod	O
(	-LRB-	punct	O
lipoplexes	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
into	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
transfection	NN	nsubj	O
(	-LRB-	punct	O
lipofection	NN	appos	O
)	-RRB-	punct	O
occurs	VBZ	ROOT	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
lungs	NNS	nmod	B-Organ
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Six	CD	nummod	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
twice	RB	advmod	O
underwent	VBD	appos	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
-	HYPH	punct	O
PET	NN	dep	O
imaging	NN	xcomp	O
:	:	punct	O
once	RB	advmod	O
after	IN	dep	O
fasting	VBG	pcomp	O
overnight	RB	advmod	O
and	CC	cc	O
once	RB	conj	O
during	IN	conj	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	pobj	O
.	.	punct	O

PROCEDURE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
p75	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
NB	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
transfected	VBD	parataxis	O
the	DT	det	O
p75	NN	compound	B-Gene_or_gene_product
cDNA	NN	dobj	O
into	IN	case	O
SH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
SY5Y	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
an	DT	det	O
NB	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	appos	I-Cell
lacking	VBG	acl	O
expression	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
p75	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TrkA	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Topoisomerase	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	ROOT	O
in	IN	case	O
primary	JJ	amod	B-Cancer
colorectal	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastases	NNS	conj	I-Cancer
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
relationship	NN	nsubj	O
between	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	B-Organism_subdivision
cancers	NNS	nmod	B-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
02	CD	dep	O
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
increased	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
in	IN	case	O
metastatic	JJ	amod	O
sites	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
could	MD	aux	O
indicate	VB	ROOT	O
an	DT	det	O
association	NN	dobj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
with	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

Simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
SV40	NN	compound	B-Organism
Tag	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
first	JJ	amod	O
trimester	NN	compound	O
invasive	JJ	amod	O
EVT	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
HTR8	NN	appos	B-Cell
,	,	punct	O
established	VBN	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
laboratory	NN	nmod	O
.	.	punct	O

Domain	NN	nsubj	O
5	CD	nummod	O
(	-LRB-	punct	O
D5	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
cleaved	VBN	amod	O
high	JJ	amod	B-Gene_or_gene_product
molecular	JJ	amod	I-Gene_or_gene_product
weight	NN	compound	I-Gene_or_gene_product
kininogen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HKa	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
pathways	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
HKa	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibition	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
are	VBP	auxpass	O
incompletely	RB	advmod	O
delineated	VBN	conj	O
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
inhibitors	NNS	nmod	O
,	,	punct	O
p16	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4A	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p15	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4B	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
have	VBP	ROOT	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
activities	NNS	dobj	O
and	CC	cc	O
are	VBP	auxpass	O
inactivated	VBN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	nmod	B-Cancer
.	.	punct	O

Modulating	VBG	ROOT	O
metastasis	NN	dobj	O
by	IN	case	O
a	DT	det	O
lymphangiogenic	JJ	amod	O
switch	NN	nmod	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

A	DT	det	O
connection	NN	nsubjpass	O
between	IN	case	O
CAM	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
adipose	NN	conj	B-Tissue
tissue	NN	compound	I-Tissue
vessels	NNS	conj	I-Tissue
was	VBD	auxpass	O
evidenced	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
with	IN	case	O
recruitment	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
avian	JJ	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Having	VBG	aux	O
identified	VBD	advcl	O
the	DT	det	O
nucleolar	JJ	amod	B-Cellular_component
localisation	NN	compound	O
sequence	NN	dobj	O
in	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
sequence	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1L	NN	dobj	I-Gene_or_gene_product
from	IN	mark	O
potentiating	VBG	advcl	O
VDR	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
comparative	JJ	amod	O
proteomic	JJ	amod	O
and	CC	cc	O
pathway	NN	conj	O
analysis	NN	dobj	O
of	IN	case	O
four	CD	nummod	O
human	JJ	amod	B-Organism
metastatic	JJ	amod	B-Cell
HCC	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
to	TO	mark	O
identify	VB	advcl	O
metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
89	CD	dep	O
.	.	punct	O
5	CD	nummod	O
%	NN	nsubj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
238	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
revealed	VBD	ROOT	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
whereas	IN	mark	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	advcl	O
in	IN	case	O
non	JJ	amod	B-Tissue
neoplastic	JJ	amod	I-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
34	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
0001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
genetics	NNS	ROOT	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
SV	NNP	nmod	B-Organism
40	CD	nummod	I-Organism
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
,	,	punct	O
induced	VBD	amod	O
overexpression	NN	ROOT	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
LAPC	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
enhanced	VBN	amod	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
.	.	punct	O

Under	IN	case	O
similar	JJ	amod	O
conditions	NNS	ROOT	O
,	,	punct	O
both	DT	cc:preconj	O
uninfected	JJ	amod	O
HUVECs	NNS	appos	B-Cell
and	CC	cc	O
HUVECs	NNS	conj	B-Cell
infected	VBN	acl	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	nsubj	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
differentiate	VB	ROOT	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
associated	VBN	amod	O
regulatory	JJ	amod	O
factors	NNS	conj	O
(	-LRB-	punct	O
including	VBG	case	O
IkappaB	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	O
subunits	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
IkappaB	NN	compound	B-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	auxpass	O
strongly	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
hematologic	JJ	amod	B-Cancer
and	CC	cc	O
solid	JJ	conj	B-Cancer
tumor	NN	compound	I-Cancer
malignancies	NNS	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
hypothesize	VBP	ROOT	O
that	IN	mark	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
will	MD	aux	O
interact	VB	ccomp	O
with	IN	case	O
host	NN	compound	O
tissues	NNS	nmod	B-Tissue
to	TO	mark	O
release	VB	xcomp	O
mediators	NNS	dobj	O
that	WDT	nsubj	O
affect	VBP	acl:relcl	O
apoptosis	NN	dobj	O
.	.	punct	O

The	DT	det	O
proliferative	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nmod	I-Simple_chemical
were	VBD	auxpass	O
markedly	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibody	NN	nmod	O
.	.	punct	O

WT1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Wilms	NN	amod	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

HTPB	NN	nsubj	B-Simple_chemical
disrupted	VBD	ROOT	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
dynamics	NNS	dobj	O
via	IN	mark	O
downregulating	VBG	advcl	O
RhoA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
GTP	NN	nmod	B-Simple_chemical
or	CC	cc	O
GDP	NN	conj	B-Simple_chemical
-	:	punct	O
bound	VBN	amod	O
Rab5a	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
block	VBP	ROOT	O
activated	VBN	amod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	NN	dobj	O
and	CC	cc	O
degradation	NN	conj	O
.	.	punct	O

The	DT	det	O
steady	JJ	amod	O
-	HYPH	punct	O
state	NN	compound	O
extraction	NN	compound	O
ratio	NN	nsubj	O
of	IN	case	O
enalapril	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
substrate	NN	appos	O
that	WDT	nsubj	O
enters	VBZ	acl:relcl	O
the	DT	det	O
liver	NN	dobj	B-Organ
rapidly	RB	advmod	O
via	IN	case	O
Oatp1a1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
primarily	RB	advmod	O
undergoes	VBZ	ROOT	O
metabolism	NN	dobj	O
by	IN	case	O
the	DT	det	O
carboxylesterases	NNS	nmod	O
,	,	punct	O
was	VBD	aux	O
unaffected	JJ	conj	O
by	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
at	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
regardless	RB	advmod	O
of	IN	case	O
its	PRP$	poss	O
delivery	NN	nmod	O
via	IN	case	O
the	DT	det	O
portal	JJ	amod	B-Multi-tissue_structure
vein	NN	nmod	I-Multi-tissue_structure
or	CC	cc	O
hepatic	JJ	amod	B-Multi-tissue_structure
artery	NN	conj	I-Multi-tissue_structure
into	IN	case	O
the	DT	det	O
perfused	JJ	amod	O
liver	NN	compound	B-Organ
preparations	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
administration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NAD	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
P	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
H	NN	compound	I-Gene_or_gene_product
oxidase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	compound	O
apocynin	NN	nmod	B-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
to	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NNP	nmod	I-Simple_chemical
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
RASSF1C	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
unlike	IN	case	O
RASSF1A	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	ccomp	O
,	,	punct	O
but	CC	cc	O
instead	RB	advmod	O
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
stimulating	VBG	advcl	O
metastasis	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
these	DT	det	O
breast	NN	compound	B-Cancer
cancers	NNS	nsubj	I-Cancer
activated	VBD	ROOT	O
Akt	NNP	nsubj	B-Gene_or_gene_product
fails	VBZ	ccomp	O
to	TO	mark	O
inactivate	VB	xcomp	O
and	CC	cc	O
re	NN	advmod	O
-	HYPH	punct	O
localize	VB	conj	O
FOXO3a	NN	dobj	B-Gene_or_gene_product
to	TO	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-Cellular_component
-	HYPH	punct	O
targeted	VBN	amod	O
FOXO3a	NN	nsubj	B-Gene_or_gene_product
does	VBZ	aux	O
not	RB	neg	O
induce	VB	conj	O
cell	NN	compound	B-Cell
death	NN	dobj	O
or	CC	cc	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	B-Gene_or_gene_product
arrests	NNS	ccomp	O
monomeric	JJ	amod	O
collagen	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
supported	VBN	dep	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
G1	NN	compound	O
-	HYPH	punct	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
an	DT	det	O
effect	NN	nmod	O
on	IN	case	O
cell	NN	compound	B-Cell
shape	NN	nmod	O
or	CC	cc	O
on	IN	case	O
levels	NNS	conj	O
of	IN	case	O
cyclin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dependent	JJ	amod	I-Simple_chemical
kinase	NN	compound	I-Simple_chemical
inhibitors	NNS	nmod	I-Simple_chemical
.	.	punct	O

The	DT	det	O
collagen	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubjpass	O
,	,	punct	O
uPAR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
AP	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
Endo	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
180	CD	appos	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
LRP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MEFs	NNS	nmod	B-Cell
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
during	IN	case	O
reendothelialization	NN	nmod	O
after	IN	case	O
denuding	VBG	compound	O
injury	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
miRNAs	NN	nmod	O
in	IN	mark	O
regulating	VBG	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
function	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
angiogenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
thus	RB	advmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
element	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	JJ	amod	O
signaling	NN	compound	O
network	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	nmod	B-Cell
proliferation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
reports	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
tumour	VB	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blot	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
uPA	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
PDFs	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
GDPs	NNS	nmod	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	ROOT	O
on	IN	case	O
morphological	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
in	IN	case	O
a	DT	det	O
RAGE	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
/	SYM	punct	O
-	HYPH	punct	O
mouse	NN	compound	O
model	NN	nmod	O
.	.	punct	O

TP	NN	nsubj	B-Gene_or_gene_product
catalyzes	VBZ	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
of	IN	case	O
thymidine	NN	nmod	B-Simple_chemical
to	TO	case	O
thymine	NN	nmod	B-Simple_chemical
and	CC	cc	O
doxyribose	NN	amod	B-Simple_chemical
-	,	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
dR	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
P	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
milder	NN	amod	O
epidermal	JJ	amod	B-Pathological_formation
hyperplasia	NN	nmod	I-Pathological_formation
,	,	punct	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
accumulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
decreased	VBN	amod	O
levels	NNS	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
regulator	NN	nmod	O
Cdc25a	NN	dep	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	xcomp	O
altered	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
regulation	NN	dobj	O
on	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

RASMC	NN	compound	B-Cell
proliferation	NN	nsubj	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	B-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
together	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
initially	RB	advmod	O
exerts	VBZ	ccomp	O
its	PRP$	nmod:poss	O
apoptotic	JJ	amod	O
effect	NN	dobj	O
through	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
,	,	punct	O
when	WRB	advmod	O
followed	VBN	advcl	O
by	IN	case	O
reduction	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
downstream	JJ	amod	O
effectors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
S6K1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
may	MD	aux	O
lead	VB	acl:relcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
molecule	NN	compound	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
proapoptotic	JJ	amod	O
molecule	NN	compound	O
BAD	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PC12	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
tumors	NNS	nsubjpass	B-Cancer
of	IN	case	O
A431	NN	nmod	B-Cell
supplemented	VBN	acl	O
with	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
profoundly	RB	advmod	O
vascularized	VBN	ROOT	O
throughout	IN	case	O
by	IN	case	O
the	DT	det	O
tubular	JJ	amod	B-Tissue
structures	NNS	nmod	I-Tissue
formed	VBN	acl	O
by	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
lumen	NN	nsubj	B-Immaterial_anatomical_entity
of	IN	case	O
which	WDT	nmod	O
contained	VBD	parataxis	O
the	DT	det	O
host	NN	compound	O
rat	NN	compound	B-Organism
blood	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

AQP5	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	ROOT	O
mainly	RB	advmod	O
in	IN	case	O
cell	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
in	IN	case	O
carcinoma	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
almost	RB	advmod	O
absent	JJ	conj	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nsubj	I-Gene_or_gene_product
exerts	VBZ	ccomp	O
modulatory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
regulate	VB	conj	O
chemokine	NN	compound	O
secretion	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

Caspase	NN	nsubjpass	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
mitochondrial	JJ	amod	B-Cellular_component
extrinsic	JJ	amod	O
pathway	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
intrinsic	JJ	amod	O
pathway	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
to	IN	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
revealed	VBD	ROOT	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	dobj	O
in	IN	case	O
15	CD	nmod	O
.	.	punct	O
9	CD	nummod	O
%	NN	amod	O
CCMs	NNS	ROOT	B-Pathological_formation
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
their	PRP$	nmod:poss	O
relation	NN	dobj	O
to	TO	case	O
the	DT	det	O
metastatic	JJ	amod	O
profile	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
pretreatment	NN	amod	O
serum	NN	compound	B-Organism_substance
levels	NNS	nmod	O
of	IN	prep	O
S	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
metastatic	JJ	conj	O
site	NN	dep	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
50	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
advanced	JJ	amod	O
melanoma	NN	nmod	B-Cancer
who	WP	nsubj	O
were	VBD	acl:relcl	O
to	TO	aux	O
receive	VB	xcomp	O
chemoimmunotherapy	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ccomp	O
human	JJ	amod	B-Organism
arterial	JJ	amod	B-Cell
smooth	NN	amod	I-Cell
muscle	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
stimulated	VBN	acl	O
by	IN	case	O
platelet	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
by	IN	case	O
adhesion	NN	conj	O
to	TO	case	O
monomeric	JJ	amod	B-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
collagen	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
triggers	VBZ	ccomp	O
apoptosis	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
intrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
special	JJ	amod	O
attention	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
ambiguity	NN	nmod	O
of	IN	case	O
the	DT	det	O
neutrophil	NN	compound	B-Cell
role	NN	nmod	O
in	IN	case	O
oncogenesis	NN	nmod	O
.	.	punct	O

Actin	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
controls	VBZ	ROOT	O
serum	NN	compound	B-Gene_or_gene_product
response	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
SRF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	dobj	O
via	IN	case	O
SRF	NN	compound	B-Gene_or_gene_product
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
myocardin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
transcriptional	JJ	amod	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MRTF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
tethering	NN	conj	O
to	IN	case	O
a	DT	det	O
single	JJ	amod	O
CArG	NN	compound	O
box	NN	compound	O
sequence	NN	nmod	O
within	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	dobj	O
in	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
abilities	NNS	nmod	O
,	,	punct	O
responses	NNS	dep	O
to	TO	case	O
the	DT	dep	O
invasion	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
-	HYPH	punct	O
regulating	VBG	dep	O
growth	NN	compound	O
factor	NN	compound	O
TGFbeta	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
for	IN	case	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
enzymes	NNS	nmod	O
or	CC	cc	O
enzyme	NN	compound	O
inhibitors	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
putative	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
rho	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
from	IN	case	O
Aplysia	NN	compound	B-Organism
californica	NN	nmod	I-Organism
as	IN	case	O
transforming	VBG	amod	O
GTPases	NNS	nmod	B-Gene_or_gene_product
utilizing	VBG	acl	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
and	CC	cc	O
a	DT	det	O
Val	NN	compound	B-Organism
-	HYPH	punct	I-Organism
14	CD	nummod	I-Organism
mutant	JJ	conj	I-Organism
,	,	punct	O
equivalent	JJ	advcl	O
to	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
Val	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
mutation	NN	nmod	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
found	VBN	acl	O
in	IN	case	O
animal	NN	nmod	O
and	CC	cc	O
human	JJ	conj	B-Organism
tumors	NNS	dep	B-Cancer
.	.	punct	O

What	WP	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	case	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
was	VBD	cop	O
the	DT	det	O
multistep	NN	compound	O
acquisition	NN	ROOT	O
of	IN	case	O
aberrant	JJ	amod	O
cellular	JJ	amod	B-Cell
genetic	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
marrow	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transformed	VBD	acl:relcl	O
,	,	punct	O
including	VBG	case	O
activating	VBG	amod	O
ras	NN	compound	B-Gene_or_gene_product
oncogene	NN	compound	O
mutations	NNS	nmod	O
,	,	punct	O
clonal	JJ	amod	O
cytogenetic	JJ	amod	O
abnormalities	NNS	conj	O
,	,	punct	O
and	CC	cc	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mutations	NNS	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
medium	NN	nsubjpass	O
from	IN	case	O
TFs	NN	nmod	B-Cell
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
able	JJ	xcomp	O
to	TO	mark	O
promote	VB	xcomp	O
ESCC	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Adenomatoid	JJ	amod	B-Cancer
tumour	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
neutralizing	VBG	amod	O
antibody	NN	dobj	O
,	,	punct	O
1B3	NN	appos	B-Simple_chemical
,	,	punct	O
directed	VBN	acl	O
against	IN	case	O
mouse	NN	compound	B-Organism
PDGFRbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
that	IN	mark	O
adult	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
participate	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
called	VBN	conj	O
neoangiogenesis	NN	xcomp	O
or	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O

In	IN	case	O
transgenic	JJ	amod	O
embryos	NNS	nmod	B-Developing_anatomical_structure
,	,	punct	O
RPE	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
proliferated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
anterior	JJ	amod	B-Multi-tissue_structure
part	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
eye	NN	nmod	B-Organ
and	CC	cc	O
near	IN	conj	O
the	DT	det	O
optic	JJ	amod	B-Multi-tissue_structure
nerve	NN	pobj	I-Multi-tissue_structure
.	.	punct	O

For	IN	case	O
distraction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
mandible	NN	nmod	B-Organ
in	IN	case	O
elderly	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
distraction	NN	compound	O
rate	NN	appos	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mm	NN	nsubj	O
/	HYPH	punct	O
day	NN	nsubj	O
seems	VBZ	ROOT	O
beneficial	JJ	xcomp	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
this	DT	det	O
decreased	VBN	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
myeloproliferative	JJ	amod	O
disorders	NNS	nmod	O
,	,	punct	O
polycythemia	NN	nsubj	O
rubra	NN	compound	O
vera	NN	nmod	O
(	-LRB-	punct	O
PRV	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
essential	JJ	amod	O
thrombocythemia	NN	conj	O
(	-LRB-	punct	O
ET	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
Tie1	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
exposed	VBN	acl	O
to	TO	case	O
shear	VB	compound	O
stress	NN	nmod	O
,	,	punct	O
and	CC	cc	O
more	RBR	advmod	O
so	RB	advmod	O
to	TO	mark	O
shear	VB	conj	O
stress	NN	compound	O
changes	NNS	dobj	O
.	.	punct	O

Boyden	NN	compound	O
double	JJ	amod	O
-	HYPH	punct	O
membrane	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
chemotaxis	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
chemotactic	JJ	ccomp	O
for	IN	case	O
chicken	NN	compound	B-Organism
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
mononuclear	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	case	O
heterophils	NNS	conj	B-Cell
.	.	punct	O

Thrombin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	ROOT	O
the	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
serves	VBZ	conj	O
as	IN	case	O
a	DT	det	O
ligand	NN	nmod	O
to	TO	case	O
this	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

Solid	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
must	MD	aux	O
establish	VB	ROOT	O
a	DT	det	O
blood	NN	compound	B-Organism_substance
supply	NN	dobj	O
in	IN	mark	O
order	NN	pobj	O
to	TO	aux	O
proliferate	VB	advcl	O
and	CC	cc	O
grow	VB	conj	O
.	.	punct	O

We	PRP	nsubj	O
screened	VBD	ROOT	O
200	CD	nummod	O
RTK	NN	compound	O
target	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
compounds	NNS	dobj	O
and	CC	cc	O
identified	VBD	conj	O
one	CD	dobj	O
(	-LRB-	punct	O
TKI	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
31	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
that	WDT	nsubj	O
potently	RB	advmod	O
inhibited	VBD	ccomp	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	dobj	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	advcl	O
0	CD	dobj	O
.	.	punct	O
596	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IGF	NNP	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
are	VBP	auxpass	O
mediated	VBN	ROOT	O
principally	RB	advmod	O
through	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1R	NN	nmod	I-Gene_or_gene_product
but	CC	cc	O
are	VBP	auxpass	O
modulated	VBN	conj	O
by	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
multiple	JJ	amod	O
IGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
that	WDT	mark	O
themselves	PRP	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
,	,	punct	O
proteolysis	NN	conj	O
,	,	punct	O
polymerization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
or	CC	cc	O
matrix	NN	conj	B-Cellular_component
association	NN	conj	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
hCAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
was	VBD	aux	O
localized	JJ	ROOT	O
to	TO	case	O
immune	JJ	amod	B-Cell
and	CC	cc	O
granulosa	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
normal	JJ	amod	B-Tissue
ovarian	JJ	amod	I-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

In	IN	case	O
immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
,	,	punct	O
rk	RB	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
reduced	VBD	amod	O
expression	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
activator	NN	acl:relcl	O
and	CC	cc	O
neovascularization	NN	conj	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
N1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
N2	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
could	MD	aux	O
transform	VB	ccomp	O
E1A	NN	compound	B-Gene_or_gene_product
immortalized	JJ	amod	O
baby	NN	compound	O
rat	NN	compound	B-Organism
kidney	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
RKE	NN	appos	B-Cell
)	-RRB-	punct	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Onconase	RB	nsubj	B-Simple_chemical
similarly	RB	advmod	O
inhibited	VBD	ROOT	O
proliferation	NN	dobj	O
in	IN	case	O
all	DT	det	O
three	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
3	CD	nummod	O
-	SYM	punct	O
1	CD	ROOT	O
.	.	punct	O
0	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
while	IN	mark	O
(	-LRB-	punct	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	LS	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
rhEDN	NN	nsubj	I-Simple_chemical
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	dep	O
on	IN	case	O
immortalized	VBN	amod	O
HUVEC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
02	CD	compound	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
06	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
than	IN	case	O
on	IN	case	O
primary	JJ	amod	O
HUVECs	NNS	nmod	B-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
>	NN	dep	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	ROOT	O
multivariate	JJ	amod	O
analysis	NN	dobj	O
the	DT	det	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nummod	I-Gene_or_gene_product
level	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
prognostic	JJ	amod	O
indicator	NN	dobj	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
metastatic	JJ	amod	O
profile	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
significant	JJ	xcomp	O
after	IN	case	O
exclusion	NN	nmod	O
of	IN	case	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
proportion	NN	nsubj	O
of	IN	case	O
SMCs	NNS	nmod	B-Cell
surviving	VBG	acl	O
in	IN	case	O
the	DT	det	O
implanted	VBN	amod	O
region	NN	nmod	O
was	VBD	cop	O
greater	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
group	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
vector	NN	nmod	O
or	CC	cc	O
cell	NN	compound	B-Cell
controls	NNS	conj	O
.	.	punct	O

Semaphorins	NNS	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
their	PRP$	nmod:poss	O
cognate	JJ	amod	O
receptors	NNS	conj	O
,	,	punct	O
Plexins	NNS	appos	B-Gene_or_gene_product
and	CC	cc	O
neuropilins	NNS	conj	B-Gene_or_gene_product
,	,	punct	O
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
pathfinding	NN	nmod	O
,	,	punct	O
immune	JJ	amod	O
function	NN	conj	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
through	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
migration	NN	conj	O
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
linomide	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
revealed	VBD	ROOT	O
marked	JJ	amod	O
avascularity	NN	dobj	O
.	.	punct	O

Medical	JJ	amod	O
therapy	NN	nsubj	O
to	TO	mark	O
improve	VB	acl	O
symptoms	NNS	dobj	O
,	,	punct	O
stabilise	JJ	ROOT	O
the	DT	det	O
underlying	VBG	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disease	NN	dobj	O
and	CC	cc	O
improve	VB	conj	O
lower	JJR	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
outcomes	NNS	dobj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
and	CC	cc	O
effective	JJ	conj	O
adjunct	NN	conj	O
to	TO	case	O
lifestyle	NN	compound	O
modification	NN	nmod	O
and	CC	cc	O
surgical	JJ	amod	O
or	CC	cc	O
endovascular	JJ	conj	B-Immaterial_anatomical_entity
interventions	NNS	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
IC	NN	nmod	O
.	.	punct	O

The	DT	det	O
hybrid	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibited	VBD	ROOT	O
normal	JJ	amod	O
morphology	NN	dobj	O
,	,	punct	O
anchorage	JJ	amod	O
requirement	NN	conj	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
largely	RB	advmod	O
extended	VBD	conj	O
latency	NN	compound	O
periods	NNS	dobj	O
of	IN	case	O
tumorigenicity	NN	nmod	O
in	IN	case	O
newborn	JJ	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Myofibroblasts	NNS	nsubj	B-Cell
represent	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	dobj	O
for	IN	case	O
invasive	JJ	amod	O
growth	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
translated	VBN	acl:relcl	O
into	IN	case	O
a	DT	det	O
poor	JJ	amod	O
clinical	JJ	amod	O
prognosis	NN	nmod	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

p63	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
homologue	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
myoepithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
marker	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
but	CC	cc	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
neoplastic	JJ	amod	O
cells	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
up	RB	advmod	O
to	TO	dep	O
11	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	ROOT	I-Cancer
,	,	punct	O
with	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
unrelated	JJ	acl	O
to	TO	case	O
cytotoxicity	NN	nmod	O
for	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
two	CD	nummod	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
hexokinase	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcripts	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
previously	RB	advmod	O
that	IN	mark	O
the	DT	det	O
55	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	amod	I-Gene_or_gene_product
polypeptide	NN	nsubj	O
abrogates	VBZ	ccomp	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
mutants	NNS	nsubj	O
defective	JJ	amod	O
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
are	VBP	cop	O
unable	JJ	conj	O
to	TO	mark	O
cooperate	VB	xcomp	O
with	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
transformation	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cytolytic	JJ	amod	O
effectors	NNS	compound	O
perforin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
granule	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
protein	NN	compound	O
TIA1	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
24	CD	nummod	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
,	,	punct	O
18	CD	nummod	O
postthymic	JJ	amod	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	appos	I-Cancer
(	-LRB-	punct	O
one	CD	nummod	O
case	NN	compound	O
CD8	NN	dep	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
and	CC	cc	O
three	CD	nummod	O
anaplastic	JJ	amod	B-Cancer
large	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
(	-LRB-	punct	O
ALCL	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
three	CD	nummod	O
T	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
lymphomas	NNS	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
20	CD	nummod	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
.	.	punct	O

Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
nuclear	JJ	amod	B-Simple_chemical
factor	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
kappaB	NN	compound	I-Simple_chemical
essential	JJ	amod	I-Simple_chemical
modulator	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
binding	NN	compound	I-Simple_chemical
domain	NN	compound	I-Simple_chemical
peptide	NN	nmod	I-Simple_chemical
suppresses	VBZ	ROOT	O
the	DT	det	O
metastasis	NN	dobj	O
of	IN	case	O
highly	RB	advmod	O
metastatic	JJ	amod	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
migration	NN	nsubjpass	O
and	CC	cc	O
invasion	NN	conj	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activities	NNS	conj	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
examined	VBN	conj	O
.	.	punct	O

With	IN	case	O
this	DT	det	O
retrovirus	NN	nmod	B-Organism
,	,	punct	O
LMP1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
MEF	NN	compound	B-Cell
cells	NNS	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

When	WRB	advmod	O
MDV	NN	nsubjpass	B-Organism
was	VBD	auxpass	O
reactivated	VBN	advcl	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
lymphoblastoid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
25	CD	nummod	O
micrograms	NNS	nmod	O
of	IN	case	O
iododeoxyuridine	NN	nmod	B-Simple_chemical
per	IN	case	O
ml	NN	nmod	O
,	,	punct	O
the	DT	det	O
relative	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transcripts	NNS	nmod	O
decreased	VBD	ROOT	O
.	.	punct	O

From	IN	case	O
these	DT	det	O
data	NNS	ROOT	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
earlier	JJR	amod	O
evidence	NN	conj	O
demonstrating	VBG	acl	O
that	IN	mark	O
the	DT	det	O
reduced	VBN	amod	O
nicotinamide	NN	compound	B-Simple_chemical
adenine	NN	compound	I-Simple_chemical
dinucleotide	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
NADH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
shuttle	NN	nsubj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
requires	VBZ	ccomp	O
a	DT	det	O
transaminase	NN	compound	O
step	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
thus	RB	advmod	O
identified	VBN	conj	O
as	IN	case	O
the	DT	det	O
malate	NN	compound	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
(	-LRB-	punct	O
W	NN	dep	O
.	.	punct	O
V	NN	ROOT	O
.	.	punct	O
V	NN	ROOT	O
.	.	punct	O
Greenhouse	NN	ROOT	O
and	CC	cc	O
A	NN	conj	O
.	.	punct	O
L	NN	ROOT	O
.	.	punct	O
Lehninger	NNP	nsubjpass	O
,	,	punct	O
Cancer	NNP	compound	O
Res	NNP	appos	O
.	NNP	punct	O
,	,	punct	O
36	CD	appos	O
:	:	punct	O
1392	CD	nummod	O
-	SYM	punct	O
1396	CD	appos	O
,	,	punct	O
1976	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
metabolic	JJ	amod	O
flux	NN	compound	O
diagrams	NNS	nsubjpass	O
were	VBD	auxpass	O
constructed	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
five	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Instead	RB	advmod	O
of	IN	prep	O
a	DT	det	O
traditional	JJ	amod	O
single	JJ	amod	O
-	HYPH	punct	O
gene	NN	compound	O
readout	NN	pobj	O
,	,	punct	O
global	JJ	amod	O
bioinformatics	NNS	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
,	,	punct	O
which	WDT	nsubj	O
revealed	VBD	ccomp	O
that	IN	mark	O
the	DT	det	O
glycolysis	NN	compound	O
pathway	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
significantly	RB	advmod	O
enriched	JJ	amod	O
pathway	NN	ccomp	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
p53	NN	compound	B-Gene_or_gene_product
response	NN	nsubj	O
and	CC	cc	O
immune	JJ	amod	O
reaction	NN	conj	O
underlie	VBP	ROOT	O
highly	RB	advmod	O
effective	JJ	amod	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
radiotherapy	NN	dobj	O
in	IN	case	O
follicular	JJ	amod	B-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

After	IN	case	O
2	CD	nummod	O
h	NN	compound	O
incubation	NN	nsubj	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
the	DT	det	O
drop	NN	dep	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	B-Simple_chemical
level	NN	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
.	.	punct	O

E1A	NN	compound	B-Gene_or_gene_product
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
relevant	JJ	ROOT	O
for	IN	case	O
reendothelialization	NN	nmod	O
by	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
certain	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Interleukins	NNS	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
ILs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
xenografts	NNS	nsubj	B-Cancer
of	IN	case	O
human	JJ	amod	B-Organism
glioblastoma	NN	compound	B-Cancer
U87MG	NN	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	aux	O
decreased	VBN	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
ING4	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
grow	VBP	ROOT	O
significantly	RB	advmod	O
faster	RBR	acomp	O
and	CC	cc	O
have	VBP	conj	O
higher	JJR	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	compound	O
fractions	NNS	dobj	O
than	IN	prep	O
control	NN	compound	O
tumours	NNS	pobj	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
are	VBP	ROOT	O
increasingly	RB	advmod	O
aware	JJ	acomp	O
that	IN	mark	O
cellular	JJ	amod	B-Cell
metabolism	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
vital	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
diseases	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
metabolic	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
targeted	VBD	ROOT	O
M2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
PK	NN	dobj	I-Gene_or_gene_product
by	IN	case	O
synthetic	JJ	amod	O
peptide	NN	compound	O
aptamers	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
specifically	RB	advmod	O
bind	VBP	acl:relcl	O
to	TO	case	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
shift	VB	conj	O
the	DT	det	O
isoenzyme	NN	dobj	O
into	IN	case	O
its	PRP$	nmod:poss	O
low	JJ	amod	O
affinity	NN	compound	O
dimeric	JJ	amod	O
conformation	NN	nmod	O
.	.	punct	O

Reversal	NN	ROOT	O
of	IN	case	O
the	DT	det	O
malignant	JJ	amod	O
phenotype	NN	nmod	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
A2780	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
under	IN	case	O
hypoxia	NN	nmod	O
the	DT	det	O
secreted	VBN	amod	O
sTie2	NN	nsubj	B-Gene_or_gene_product
selectively	RB	advmod	O
inhibited	VBD	ccomp	O
tube	NN	compound	B-Tissue
formation	NN	dobj	O
and	CC	cc	O
migration	NN	compound	O
capacities	NNS	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
animals	NNS	nsubj	O
transfected	VBN	acl	O
with	IN	case	O
LacZ	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
site	NN	nmod:npmod	O
-	:	punct	O
specific	JJ	amod	O
transfection	NN	conj	O
of	IN	case	O
phVEGF	NN	nmod	B-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
augmented	JJ	amod	O
collateral	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	nmod	O
documented	VBN	acl	O
by	IN	case	O
serial	JJ	amod	O
angiography	NN	nmod	O
,	,	punct	O
and	CC	cc	O
improvement	NN	conj	O
in	IN	case	O
calf	NN	compound	B-Organism_subdivision
blood	NN	compound	B-Organism_substance
pressure	NN	compound	O
ratio	NN	nmod	O
(	-LRB-	punct	O
ischemic	JJ	dep	B-Organism_subdivision
to	TO	case	O
normal	JJ	amod	B-Organism_subdivision
limb	NN	nmod	I-Organism_subdivision
)	-RRB-	punct	O
,	,	punct	O
resting	VBG	amod	O
and	CC	cc	O
maximum	NN	conj	O
blood	NN	compound	B-Organism_substance
flow	NN	conj	O
,	,	punct	O
and	CC	cc	O
capillary	JJ	conj	B-Tissue
to	TO	prep	O
myocyte	VB	compound	B-Cell
ratio	NN	pobj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
ECs	NNS	nmod	B-Cell
after	IN	case	O
denudation	NN	nmod	O
was	VBD	auxpass	O
regulated	VBN	ROOT	O
transcriptionally	RB	advmod	O
,	,	punct	O
and	CC	cc	O
humeral	JJ	amod	B-Gene_or_gene_product
factors	NNS	nsubj	I-Gene_or_gene_product
released	VBN	acl	O
from	IN	case	O
injured	JJ	amod	O
ECs	NNS	nmod	B-Cell
might	MD	aux	O
not	RB	neg	O
be	VB	cop	O
responsible	JJ	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
examined	VBD	ROOT	O
islet	NN	compound	B-Tissue
endotheliuml	NNS	dobj	I-Tissue
/	SYM	punct	O
oxidative	JJ	amod	O
stress	NN	compound	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
/	:	punct	O
inflammation	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
,	,	punct	O
islet	NN	compound	B-Multi-tissue_structure
vascularization	NN	conj	O
and	CC	cc	O
fibrosis	NN	conj	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
IL	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
receptor	NN	compound	I-Simple_chemical
antagonist	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
IL	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
1Ra	CD	dep	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
antiapoptotic	JJ	amod	O
protein	NN	compound	O
Bcl	NN	nsubjpass	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
highly	RB	advmod	O
expressed	VBN	dep	O
by	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
of	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
but	CC	cc	O
in	IN	case	O
no	DT	neg	O
cases	NNS	conj	O
of	IN	case	O
reversible	JJ	amod	O
PHT	NN	nmod	O
,	,	punct	O
nor	CC	cc	O
in	IN	case	O
control	JJ	amod	O
patients	NNS	conj	B-Organism
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
injection	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
elicit	VB	ROOT	O
a	DT	det	O
lymphocyte	NN	compound	B-Cell
proliferative	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
provided	VBD	conj	O
significant	JJ	amod	O
improvement	NN	dobj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
hind	NN	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
ischemia	NN	nmod	O
,	,	punct	O
comparable	JJ	conj	O
to	TO	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
.	.	punct	O

Both	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
dietary	JJ	amod	O
CLA	NN	nmod	B-Simple_chemical
showed	VBD	ROOT	O
similar	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
RBC	NN	compound	B-Cell
-	:	punct	O
containing	VBG	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
per	IN	case	O
20x	NN	compound	O
field	NN	nmod	O
decreased	VBD	advcl	O
to	IN	case	O
a	DT	det	O
third	NN	nmod	O
of	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
control	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
DMI	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
FA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
,	,	punct	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
transcription	NN	dobj	O
when	WRB	advmod	O
both	DT	det	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	advcl	O
together	RB	advmod	O
.	.	punct	O

Substantial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
inhibit	VB	ccomp	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
many	JJ	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
hypermethylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
mechanism	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
v	NN	det	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

A	DT	det	O
further	JJ	amod	O
study	NN	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
FGFR2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
fibroblasts	NNS	nsubjpass	O
were	VBD	auxpass	O
only	RB	advmod	O
observed	VBN	ccomp	O
inside	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
not	RB	neg	O
in	IN	case	O
tumor	NN	compound	B-Tissue
-	HYPH	punct	I-Tissue
surrounding	VBG	amod	I-Tissue
stromal	JJ	amod	I-Tissue
tissues	NNS	conj	I-Tissue
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
FGFR2	NN	nsubjpass	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
as	IN	case	O
a	DT	det	O
TF	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
specific	JJ	amod	O
marker	NN	nmod	O
in	IN	case	O
ESCC	NN	nmod	B-Cancer
.	.	punct	O

Because	IN	mark	O
islet	NN	compound	B-Multi-tissue_structure
inflammation	NN	nsubj	O
may	MD	aux	O
originate	VB	advcl	O
from	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
selected	VBN	amod	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
in	IN	case	O
islets	NNS	nmod	B-Multi-tissue_structure
from	IN	case	O
a	DT	det	O
spontaneous	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
,	,	punct	O
the	DT	det	O
Goto	NN	compound	B-Organism
-	HYPH	punct	I-Organism
Kakizaki	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
GK	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rat	NN	dobj	I-Organism
.	.	punct	O

CD40	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
on	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
correlates	VBZ	ROOT	O
with	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O

Decreased	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
CML	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
leukemia	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
raises	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
altered	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
maintenance	NN	conj	O
of	IN	case	O
the	DT	det	O
disease	NN	compound	O
state	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	B-Organ
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	B-Cancer
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
if	IN	mark	O
hypoxic	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
stress	NN	compound	O
activated	VBD	amod	O
protein	NN	compound	O
kinases	NNS	nmod	O
regulated	VBD	ccomp	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
assayed	VBD	ROOT	O
JNK1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
squamous	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
SCC	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
lines	NNS	nmod	I-Cell
grown	VBN	acl	O
under	IN	case	O
normoxic	JJ	amod	O
or	CC	cc	O
hypoxic	JJ	conj	O
conditions	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
facilitates	VBZ	ROOT	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Solid	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
are	VBP	cop	O
frequently	RB	advmod	O
necrotic	JJ	ROOT	O
and	CC	cc	O
hypoxic	RB	conj	O
due	JJ	case	O
to	TO	mwe	O
poor	JJ	amod	O
vascularization	NN	nmod	O
.	.	punct	O

The	DT	det	O
proinflammatory	JJ	amod	O
activities	NNS	nsubj	O
link	VBP	ROOT	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	dobj	I-Gene_or_gene_product
with	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
psoriasis	NN	nmod	O
,	,	punct	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
disease	NN	conj	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	conj	O
,	,	punct	O
multiple	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
diabetes	NNS	conj	O
and	CC	cc	O
ankylosing	VBG	conj	O
spondylitis	NN	dobj	O
.	.	punct	O

Ang1	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Src	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
upstream	JJ	amod	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
pathway	NN	nmod	O
linking	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	dobj	O
to	TO	case	O
VE	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
internalization	NN	nmod	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
transformants	NNS	nmod	B-Cell
,	,	punct	O
mitogen	NN	compound	O
depletion	NN	nsubj	O
elicited	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
comparable	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
C2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
;	:	punct	O
wt	IN	case	O
SVLT	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
promoted	VBD	parataxis	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
large	JJ	amod	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
induced	VBN	amod	O
Rb	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Most	JJS	amod	O
Group	NNP	compound	O
I	CD	nummod	O
compounds	VBZ	ROOT	O
except	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
which	WDT	nsubj	O
induced	VBD	acl:relcl	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	dobj	O
less	RBR	advmod	O
effectively	RB	advmod	O
than	IN	case	O
others	NNS	nmod	O
)	-RRB-	punct	O
activated	VBN	amod	O
caspase	NN	appos	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
more	RBR	advmod	O
efficiently	RB	advmod	O
than	IN	case	O
Group	NN	compound	O
II	CD	nummod	O
compounds	NNS	nmod	O
.	.	punct	O

The	DT	det	O
pathophysiology	NN	nsubj	O
involves	VBZ	ROOT	O
inflammation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
perivascular	JJ	amod	B-Cell
inflammatory	JJ	amod	I-Cell
T	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
more	RBR	amod	O
antiapoptotic	JJ	amod	O
proteins	NNS	dobj	O
in	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
MTSS1	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	acl:relcl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
methylation	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
many	JJ	amod	O
other	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Dss1	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
TPA	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
treated	VBN	amod	O
hyperplastic	JJ	amod	O
skins	NNS	nmod	B-Organ
and	CC	cc	O
in	IN	case	O
JB6	NN	compound	B-Cell
Cl	NN	compound	I-Cell
41	CD	nummod	I-Cell
-	HYPH	punct	I-Cell
5a	NN	dep	I-Cell
epidermal	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Adenoviral	JJ	amod	B-Organism
transduction	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
Survivin	NNP	nmod	I-Gene_or_gene_product
inhibited	VBD	appos	O
growth	NN	compound	O
factor	NN	compound	O
deprivation	NN	dobj	O
-	:	punct	O
or	CC	cc	O
ceramide	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	conj	O
,	,	punct	O
reduced	VBN	amod	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
generation	NN	conj	O
,	,	punct	O
and	CC	cc	O
stabilized	VBD	conj	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
capillary	JJ	compound	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
a	DT	det	O
small	JJ	amod	O
ear	NN	amod	B-Cancer
tumor	NN	dobj	I-Cancer
with	IN	case	O
a	DT	det	O
humanized	JJ	amod	O
antivascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
prevented	VBD	ROOT	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
inside	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
nontreated	JJ	amod	O
group	NN	advcl	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
major	JJ	amod	O
cellular	JJ	amod	B-Cell
protein	NN	nmod	O
of	IN	case	O
Mr	NN	nmod	O
36	CD	nummod	O
,	,	punct	O
000	CD	appos	O
in	IN	case	O
cells	NNS	nmod	B-Cell
infected	VBN	acl	O
with	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
partially	RB	advmod	O
transforming	VBG	amod	O
mutants	NNS	nmod	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
CNS	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
portion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-Cellular_component
responsible	JJ	amod	O
for	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
was	VBD	auxpass	O
mapped	VBN	ROOT	O
by	IN	case	O
deletions	NNS	nmod	O
to	TO	mark	O
lie	VB	acl	O
within	IN	case	O
the	DT	det	O
U3	NN	compound	O
region	NN	nmod	O
.	.	punct	O

A	DT	det	O
transcript	NN	ROOT	O
from	IN	case	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeats	NNS	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
retrovirus	NN	nmod	I-Organism
associated	VBN	acl	O
with	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
genes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
protein	NN	compound	O
c	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
FLIP	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
cellular	JJ	dep	B-Gene_or_gene_product
Flice	NNP	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
inhibitory	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubjpass	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
inhibit	VB	xcomp	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	dobj	O
at	IN	case	O
the	DT	det	O
DISC	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
was	VBD	cop	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
following	VBG	case	O
AdGFPFasL	NN	compound	B-Organism
(	-LRB-	punct	I-Organism
TET	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
treatment	NN	nmod	O
prompting	VBG	acl	O
us	PRP	dobj	O
to	TO	mark	O
investigate	VB	xcomp	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	mark	O
inhibiting	VBG	advcl	O
CH	NN	compound	O
-	:	punct	O
11	CD	nummod	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
chronic	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
high	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
promotes	VBZ	ccomp	O
the	DT	det	O
spontaneous	JJ	amod	O
neoplastic	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
process	NN	nsubj	O
may	MD	aux	O
represent	VB	conj	O
one	CD	dobj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
adaptation	NN	nmod	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
multidrug	NN	nmod:npmod	O
-	HYPH	punct	O
resistant	JJ	amod	O
phenotype	NN	nmod	O
during	IN	case	O
the	DT	det	O
carcinogenesis	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Through	IN	case	O
morphological	JJ	amod	O
and	CC	cc	O
biochemical	JJ	conj	O
analyses	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
NCI	NN	compound	B-Cell
-	HYPH	punct	I-Cell
H1299	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
treated	VBN	acl	O
with	IN	case	O
BV	NN	nmod	B-Organism_substance
exhibit	VBP	ccomp	O
several	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
resistant	JJ	amod	O
cells	NNS	nsubj	B-Cell
also	RB	advmod	O
exhibited	VBD	ROOT	O
progressively	RB	advmod	O
increasing	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
and	CC	cc	O
myc	NN	compound	B-Gene_or_gene_product
mRNA	NN	conj	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
resistance	NN	conj	O
to	TO	case	O
the	DT	det	O
cytotoxicity	NN	nmod	O
of	IN	case	O
Adriamycin	NN	nmod	B-Simple_chemical
and	CC	cc	O
melphalan	NN	conj	B-Simple_chemical
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
lymphomatous	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
,	,	punct	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
uptake	NN	compound	O
rates	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	dep	O
in	IN	prep	O
overnight	JJ	amod	O
fasting	NN	intj	O
and	CC	cc	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	conj	O
(	-LRB-	punct	O
38	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
versus	CC	cc	O
41	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	dep	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	nmod	O
/	SYM	punct	O
minute	NN	dep	O
,	,	punct	O
not	RB	neg	O
significant	JJ	amod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nsubjpass	O
in	IN	case	O
skeletal	JJ	amod	B-Organ
muscle	NN	nmod	I-Organ
was	VBD	auxpass	O
increased	VBN	parataxis	O
by	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
1	CD	dep	O
.	.	punct	O
7	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nmod	O
.	.	punct	O
2	CD	dep	O
versus	CC	cc	O
3	CD	conj	O
.	.	punct	O
8	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	dep	O
/	SYM	punct	O
minute	NN	ROOT	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
012	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoted	VBD	ROOT	O
filopodia	NN	compound	B-Cellular_component
formation	NN	dobj	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
protein	NN	compound	O
expression	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
Cdc42	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
Rho	NN	compound	B-Gene_or_gene_product
GTPase	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
promote	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	prep	O
filopodia	NN	pobj	B-Cellular_component
.	.	punct	O

PTTG	NN	nsubj	B-Gene_or_gene_product
activated	VBD	ROOT	O
E	NN	compound	O
-	HYPH	punct	O
box	NN	compound	O
transcription	NN	dobj	O
and	CC	cc	O
induced	VBD	conj	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
EC9706	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
may	MD	aux	O
act	VB	ccomp	O
on	IN	case	O
an	DT	det	O
E	NNP	compound	O
-	HYPH	punct	O
box	NN	compound	O
motif	NN	nmod	O
within	IN	case	O
the	DT	det	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

To	TO	aux	O
grow	VB	advcl	O
,	,	punct	O
invade	NN	conj	O
and	CC	cc	O
metastasize	NN	conj	O
,	,	punct	O
a	DT	det	O
treacherous	JJ	amod	O
society	NN	nsubjpass	O
between	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
host	NN	compound	B-Cell
cells	NNS	conj	I-Cell
must	MD	aux	O
be	VB	auxpass	O
formed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
association	NN	nsubj	O
provides	VBZ	conj	O
novel	JJ	amod	O
and	CC	cc	O
effective	JJ	conj	O
clinical	JJ	dep	O
targets	NNS	dobj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
control	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
.	.	punct	O

The	DT	det	O
corresponding	JJ	amod	O
transcripts	NNS	nsubj	O
in	IN	case	O
KE	NN	nmod	B-Cell
and	CC	cc	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
1235	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
contain	VBP	ROOT	O
1053	CD	nummod	O
additional	JJ	amod	O
nucleotides	NNS	dobj	O
representing	VBG	acl	O
an	DT	det	O
in	IN	amod	O
-	HYPH	punct	O
frame	NN	compound	O
duplication	NN	dobj	O
of	IN	case	O
exons	NNS	nmod	O
18	CD	nummod	O
through	IN	case	O
25	CD	nmod	O
which	WDT	nsubj	O
encode	VBP	acl:relcl	O
the	DT	det	O
entire	JJ	amod	O
TK	NN	compound	O
region	NN	dobj	O
and	CC	cc	O
a	DT	det	O
portion	NN	conj	O
of	IN	case	O
the	DT	det	O
CAIN	NN	compound	O
domain	NN	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
and	CC	cc	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	conj	O
of	IN	case	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
in	IN	case	O
hybrids	NNS	nmod	O
of	IN	case	O
HA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
early	JJ	amod	O
-	HYPH	punct	O
passage	NN	conj	O
rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	conj	I-Cell
.	.	punct	O

Of	IN	case	O
the	DT	det	O
14	CD	nummod	O
tumors	NNS	nsubj	B-Cancer
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
CD40	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
all	DT	appos	O
but	CC	cc	O
1	CD	conj	O
(	-LRB-	punct	O
93	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
either	CC	cc:preconj	O
nodal	JJ	dobj	B-Multi-tissue_structure
or	CC	cc	O
systemic	JJ	conj	O
metastasis	NN	dep	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
indication	NN	nsubjpass	O
for	IN	case	O
surgery	NN	nmod	O
was	VBD	auxpass	O
established	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
pathologic	JJ	amod	O
calcitonin	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
seven	CD	nummod	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
on	IN	case	O
the	DT	det	O
basis	NN	conj	O
of	IN	case	O
detected	VBN	amod	O
RET	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	compound	O
mutation	NN	nmod	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
eight	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Furthermore	RB	advmod	O
melanoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
uPA	NN	amod	B-Gene_or_gene_product
variant	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
had	VBD	acl:relcl	O
an	DT	det	O
impaired	JJ	amod	O
interaction	NN	dobj	O
with	IN	case	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
were	VBD	cop	O
not	RB	neg	O
invasive	JJ	ROOT	O
and	CC	cc	O
had	VBD	conj	O
impaired	JJ	amod	O
binding	NN	dobj	O
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Mutations	NNS	nsubj	O
affecting	VBG	acl	O
nuclear	JJ	amod	B-Cellular_component
transport	NN	dobj	O
were	VBD	cop	O
far	RB	advmod	O
more	RBR	advmod	O
critical	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
ability	NN	nmod	O
to	TO	mark	O
interfere	VB	acl	O
with	IN	case	O
myogenic	JJ	amod	O
differentiation	NN	nmod	O
than	IN	mark	O
were	VBD	cop	O
those	DT	advcl	O
affecting	VBG	acl	O
the	DT	det	O
transforming	VBG	amod	O
potential	NN	dobj	O
;	:	punct	O
cytoplasmic	JJ	amod	B-Organism_substance
SVLT	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
fully	RB	advmod	O
compatible	JJ	parataxis	O
with	IN	case	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
C2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
despite	IN	mark	O
enabling	VBG	advcl	O
them	PRP	dobj	O
to	TO	aux	O
grow	VB	xcomp	O
in	IN	prep	O
semisolid	JJ	amod	O
medium	NN	pobj	O
,	,	punct	O
thus	RB	advmod	O
showing	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
myogenesis	NN	npadvmod	O
-	HYPH	punct	O
inhibiting	VBG	amod	O
property	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
dissociated	VBN	ccomp	O
from	IN	case	O
transforming	VBG	amod	O
competence	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TNFalpha	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
alone	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
suppressed	VBN	acl:relcl	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O

The	DT	det	O
graft	NN	compound	B-Tissue
size	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
suspension	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
dependent	JJ	conj	O
on	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
number	NN	nmod	O
of	IN	mark	O
passages	NNS	acl	O
the	DT	det	O
cells	NNS	dobj	B-Cell
are	VBP	auxpass	O
taken	VBN	conj	O
through	IN	case	O
in	IN	case	O
culture	NN	nmod	O
prior	RB	case	O
to	TO	aux	O
grafting	VBG	advcl	O
or	CC	cc	O
on	IN	case	O
the	DT	det	O
postoperative	JJ	amod	O
survival	NN	compound	O
period	NN	conj	O
.	.	punct	O

Further	JJ	amod	O
deletions	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
sequence	NN	dobj	O
within	IN	case	O
the	DT	det	O
carboxy	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
domain	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
responsible	JJ	acl:relcl	O
for	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
bundle	NN	compound	O
formation	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
function	NN	nsubj	O
of	IN	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
unknown	JJ	advcl	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
on	IN	case	O
mitogenicity	NN	nmod	O
and	CC	cc	O
chemotaxis	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
,	,	punct	O
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
protein	NN	ROOT	O
with	IN	prep	O
many	JJ	amod	O
talents	NNS	pobj	O
.	.	punct	O

Curcumin	NN	nsubjpass	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
7	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bis	NN	dep	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methoxyphenyl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
heptadiene	NN	compound	I-Simple_chemical
-	,	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dione	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
extracted	VBN	ROOT	O
from	IN	prep	O
the	DT	det	O
plant	NN	compound	O
Curcuma	NNP	compound	B-Organism
longa	NN	pobj	I-Organism
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
,	,	punct	O
the	DT	det	O
Crabtree	NNP	compound	O
effect	NN	nsubj	O
decreased	VBD	ROOT	O
.	.	punct	O

In	IN	prep	O
recent	JJ	amod	O
years	NNS	pobj	O
the	DT	det	O
family	NN	nsubjpass	O
of	IN	case	O
ADAM	NN	compound	B-Gene_or_gene_product
proteases	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
ascribed	VBN	amod	O
important	JJ	amod	O
roles	NNS	ROOT	O
in	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
STAT3	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
by	IN	mark	O
expressing	VBG	acl	O
a	DT	det	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
STAT3	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
or	CC	cc	O
a	DT	det	O
STAT3	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
shRNA	NN	conj	O
prevented	VBD	ROOT	O
the	DT	det	O
OSM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
arrest	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
HeLa	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
demonstrated	VBD	ccomp	O
the	DT	det	O
highest	JJS	amod	O
sensitivity	NN	dobj	O
to	TO	case	O
paclitaxel	NN	nmod	B-Simple_chemical
,	,	punct	O
whereas	IN	dep	O
CaSki	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
showed	VBD	advcl	O
the	DT	det	O
lowest	JJS	dobj	O
.	.	punct	O

AMI	NN	compound	O
control	NN	compound	O
group	NN	nsubj	O
received	VBD	ROOT	O
equal	JJ	amod	O
volume	NN	compound	O
physiological	JJ	amod	O
saline	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
determined	VBD	ROOT	O
whether	IN	mark	O
growth	NN	compound	O
state	NN	nsubj	O
can	MD	aux	O
influence	VB	ccomp	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
by	IN	mark	O
measuring	VBG	advcl	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
growing	VBG	amod	O
and	CC	cc	O
stationary	JJ	conj	O
cultures	NNS	nmod	O
of	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
transformed	VBN	conj	O
cells	NNS	nmod	B-Cell
.	.	punct	O

SOC	NN	compound	O
activation	NN	nsubj	O
in	IN	case	O
rat	NN	compound	B-Organism
pulmonary	JJ	amod	B-Cell
arterial	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
increased	VBD	ROOT	O
free	JJ	amod	O
cytosolic	JJ	amod	B-Organism_substance
Ca2	NN	dobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
that	WDT	nsubj	O
was	VBD	cop	O
dependent	JJ	conj	O
on	IN	case	O
a	DT	det	O
membrane	NN	compound	B-Cellular_component
current	JJ	nmod	O
having	VBG	acl	O
a	DT	det	O
net	JJ	amod	O
inward	JJ	amod	O
component	NN	dobj	O
of	IN	prep	O
5	CD	pobj	O
.	.	punct	O
45	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
90	CD	nummod	O
pA	NN	npadvmod	O
/	:	punct	O
pF	NN	ROOT	O
at	IN	prt	O
-	HYPH	punct	O
80	CD	nummod	O
mV	NN	pobj	O
.	.	punct	O

Similarly	RB	advmod	O
to	TO	case	O
other	JJ	amod	O
members	NNS	advcl	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
Id	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
repression	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
differentiation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cancer
chemopreventive	JJ	amod	O
agent	NN	nmod	O
conjugated	VBD	ROOT	B-Simple_chemical
linoleic	JJ	amod	I-Simple_chemical
acid	NN	dobj	I-Simple_chemical
.	.	punct	O

After	IN	prep	O
7	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
pellets	NNS	nsubj	O
from	IN	prep	O
animals	NNS	pobj	O
fed	VBD	advcl	O
the	DT	det	O
control	JJ	compound	O
diet	NN	nsubjpass	O
were	VBD	auxpass	O
infiltrated	VBN	ROOT	O
by	IN	case	O
abundant	JJ	amod	O
branching	VBG	compound	O
networks	NNS	nmod	B-Multi-tissue_structure
of	IN	case	I-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
with	IN	case	O
patent	JJ	compound	O
lumen	NN	nmod	B-Immaterial_anatomical_entity
-	:	punct	O
containing	VBG	acl	O
RBCs	NNS	dobj	B-Cell
.	.	punct	O

Affymetrix	NNP	compound	O
-	HYPH	punct	O
microarray	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
using	VBG	xcomp	O
T47D	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
over	IN	advmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
RASSF1C	NN	dobj	B-Gene_or_gene_product
to	TO	mark	O
identify	VB	xcomp	O
RASSF1C	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	dobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
dietary	JJ	amod	O
folate	NN	compound	B-Simple_chemical
supplementation	NN	nsubj	O
at	IN	case	O
4x	NN	nmod	O
the	DT	det	O
basal	JJ	amod	O
dietary	NN	amod	O
requirement	NN	nmod	O
significantly	RB	advmod	O
suppresses	VBZ	ccomp	O
UC	NN	nmod:npmod	B-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	dobj	O
in	IN	case	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
inhibitors	NNS	nsubj	O
(	-LRB-	punct	O
HDACi	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
potent	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
agents	NNS	ROOT	O
for	IN	case	O
variety	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Prior	JJ	case	O
to	TO	case	O
this	DT	det	O
cellular	JJ	amod	B-Cell
outcome	NN	nmod	O
,	,	punct	O
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
functionally	RB	advmod	O
activated	VBN	ROOT	O
and	CC	cc	O
mediates	VBZ	conj	O
a	DT	det	O
large	JJ	amod	O
-	HYPH	punct	O
scale	NN	amod	O
transcription	NN	compound	O
program	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
this	DT	det	O
damage	NN	nmod	O
involving	VBG	acl	O
a	DT	det	O
significant	JJ	amod	O
modulation	NN	dobj	O
of	IN	case	O
440	CD	nummod	O
genes	NNS	nmod	O
.	.	punct	O

Green	JJ	compound	B-Gene_or_gene_product
fluorescence	NN	compound	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
transfected	VBN	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Tissue
fat	NN	compound	I-Tissue
pad	NN	nmod	I-Tissue
of	IN	case	O
young	JJ	amod	O
female	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
bradykinin	NN	conj	B-Gene_or_gene_product
B1	NN	compound	I-Gene_or_gene_product
receptors	NNS	dobj	I-Gene_or_gene_product
in	IN	case	O
precursor	NN	compound	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
of	IN	case	O
gallbladder	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

PTHrP	NN	nsubj	B-Gene_or_gene_product
drives	VBZ	ROOT	O
breast	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
initiation	NN	dobj	O
,	,	punct	O
progression	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
therapy	NN	compound	O
target	NN	conj	O
.	.	punct	O

Instead	RB	advmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
therefore	RB	advmod	O
likely	JJ	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
more	RBR	advmod	O
predominant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	mark	O
spontaneously	RB	advmod	O
arising	VBG	acl	O
breast	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	ROOT	B-Cancer
.	.	punct	O

The	DT	det	O
samples	NNS	nsubjpass	O
were	VBD	auxpass	O
transferred	VBN	ROOT	O
to	IN	case	O
Kyushu	NNP	compound	O
University	NNP	compound	O
Hospital	NNP	nmod	O
(	-LRB-	punct	O
Beppu	NNP	dep	O
,	,	punct	O
Japan	NNP	appos	O
)	-RRB-	punct	O
where	WRB	advmod	O
they	PRP	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	acl:relcl	O
by	IN	case	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
reverse	NN	dep	O
transcription	NN	compound	O
-	:	punct	O
PCR	NN	nmod	O
for	IN	case	O
three	CD	nummod	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
markers	NNS	nmod	O
,	,	punct	O
carcinoembryonic	JJ	amod	B-Gene_or_gene_product
antigen	NN	appos	I-Gene_or_gene_product
,	,	punct	O
cytokeratin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
19	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
cytokeratin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
VEGFR	NNP	conj	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
GTPase	NN	compound	O
Arf6	NN	nsubj	B-Gene_or_gene_product
primarily	RB	advmod	O
regulates	VBZ	ROOT	O
recycling	NN	dobj	O
of	IN	case	O
plasma	NN	compound	B-Organism_substance
membrane	NN	compound	B-Cellular_component
components	NNS	nmod	I-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
here	RB	advmod	O
whether	IN	mark	O
6	CD	nummod	O
popular	JJ	amod	O
antitumor	NN	compound	B-Cancer
compounds	NNS	nsubj	O
modify	VBP	ccomp	O
the	DT	det	O
cytotoxic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NaF	NN	nmod	B-Simple_chemical
against	IN	case	O
human	JJ	amod	B-Organism
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
HSC	NN	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
and	CC	cc	O
human	JJ	amod	B-Organism
promyelocytic	JJ	amod	B-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
HL	NN	compound	B-Cell
-	:	punct	I-Cell
60	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

2ME2	NN	nsubj	B-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
decreased	VBN	amod	O
nuclear	JJ	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
affected	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
downstream	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
bid	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proangiogenic	JJ	amod	O
cytokine	NN	appos	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
examines	VBZ	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
HKa	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibition	NN	dep	O
of	IN	case	O
two	CD	nummod	O
potent	JJ	amod	O
stimulators	NNS	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
,	,	punct	O
sphingosine	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
phosphate	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
S1P	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
act	VBP	acl:relcl	O
through	IN	case	O
the	DT	det	O
P13	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
hCAP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
cancerous	JJ	conj	O
ovarian	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
to	TO	mark	O
examine	VB	conj	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
on	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	prep	O
addition	NN	pobj	O
to	TO	prep	O
giving	VBG	pcomp	O
a	DT	det	O
historical	JJ	amod	O
perspective	NN	dobj	O
on	IN	prep	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
and	CC	cc	O
other	JJ	amod	O
retrovirus	NN	compound	O
research	NN	pobj	O
,	,	punct	O
this	DT	det	O
paper	NN	nsubj	O
discusses	VBZ	ROOT	O
the	DT	det	O
origin	NN	dobj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
;	:	punct	O
the	DT	det	O
modes	NNS	dep	O
of	IN	case	O
transmission	NN	nmod	O
and	CC	cc	O
global	JJ	amod	O
epidemiology	NN	conj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
infection	NN	nmod	O
;	:	punct	O
the	DT	det	O
genome	NN	dep	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	nmod	O
;	:	punct	O
the	DT	det	O
role	NN	dep	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
in	IN	case	O
other	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
recent	JJ	amod	O
breakthroughs	NNS	conj	O
in	IN	case	O
ATL	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
determines	VBZ	ROOT	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
preoperative	JJ	amod	O
serum	NN	compound	B-Organism_substance
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
clinicopathological	JJ	amod	O
features	NNS	conj	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
2ME2	NN	nsubj	B-Simple_chemical
exhibited	VBD	ROOT	O
antiproliferative	JJ	amod	O
and	CC	cc	O
cytotoxic	JJ	conj	O
effects	NNS	dobj	O
in	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
five	CD	nummod	O
head	NN	nmod	B-Cell
and	CC	cc	I-Cell
neck	NN	conj	I-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
0	CD	nmod	O
.	.	punct	O
5	CD	compound	O
to	TO	dep	O
10	CD	nummod	O
micromol	NN	compound	O
/	:	punct	O
L	NN	compound	O
range	NN	ROOT	O
,	,	punct	O
including	VBG	case	O
induction	NN	nmod	O
of	IN	case	O
G2	NN	compound	O
-	HYPH	punct	O
M	NN	compound	O
blockade	NN	nmod	O
,	,	punct	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
7	CD	nummod	B-Gene_or_gene_product
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
at	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

OSCC	NN	compound	B-Cell
sublines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
established	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
GFP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
parental	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
GSAS	NN	appos	B-Cell
,	,	punct	O
and	CC	cc	O
designated	VBN	conj	O
GSAS	NN	compound	B-Cell
/	:	punct	I-Cell
N3	NN	dobj	I-Cell
and	CC	cc	O
N5	NN	conj	B-Cell
according	VBG	case	O
to	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
passage	NN	compound	O
number	NN	nmod	O
after	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
by	IN	case	O
a	DT	det	O
serial	JJ	amod	O
orthotopic	JJ	amod	O
transplantation	NN	compound	O
model	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
gastrointestinal	JJ	amod	B-Cancer
stromal	JJ	amod	I-Cancer
tumor	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

DNA	NN	nsubj	B-Cellular_component
of	IN	case	O
the	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	amod	O
cell	NN	compound	B-Cell
hybrids	NNS	nmod	I-Cell
transformed	VBD	ROOT	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
anchorage	VB	xcomp	O
-	HYPH	punct	O
independent	JJ	amod	O
proliferation	NN	dobj	O
as	IN	mark	O
expected	VBN	advcl	O
for	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
human	JJ	amod	B-Organism
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
donor	NN	amod	O
DNA	NN	nmod	B-Cellular_component
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
reduced	VBD	ccomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
glutathione	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
mouse	NN	compound	B-Organism
epidermal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
JB6	NN	compound	B-Cell
P	NN	dep	I-Cell
+	CC	cc	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
caused	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
AP	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	B-Tissue
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
mandible	NN	nmod	B-Organ
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

HTPB	NN	nsubj	B-Simple_chemical
delayed	VBD	ROOT	O
lung	NN	compound	B-Organ
metastasis	NN	dobj	O
of	IN	case	O
4T1	NN	compound	O
mouse	NN	compound	B-Organism
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

Subsequently	RB	advmod	O
this	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGFalpha	NN	conj	B-Gene_or_gene_product
an	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	O
ligand	NN	dep	O
.	.	punct	O

Mechanistically	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
reduced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
molecular	JJ	amod	O
markers	NNS	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
(	-LRB-	punct	O
Ki67	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
(	-LRB-	punct	O
factor	NN	compound	B-Gene_or_gene_product
VIII	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
antiapoptotic	JJ	amod	O
factor	NN	compound	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
progression	NN	nsubj	O
regulator	NN	parataxis	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
survival	NN	compound	O
factor	NN	compound	O
AKT1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	compound	I-Simple_chemical
agonist	NN	nsubj	O
markedly	RB	advmod	O
increased	VBD	ROOT	O
superoxide	NN	compound	B-Simple_chemical
formation	NN	dobj	O
as	IN	mark	O
reflected	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
dihydroethidium	NN	compound	B-Simple_chemical
staining	NN	nmod	O
of	IN	case	O
EC	NN	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
this	DT	det	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
PEG	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
SOD	NN	nmod	I-Simple_chemical
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
apocynin	NN	conj	B-Simple_chemical
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
induced	VBD	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
an	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	compound	O
model	NN	dobj	O
to	TO	mark	O
illustrate	VB	acl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
recruit	VB	acl	O
mononuclear	JJ	amod	B-Cell
phagocytes	NNS	dobj	I-Cell
,	,	punct	O
increase	VBP	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
enhance	VB	conj	O
angiogenesis	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
antigens	NNS	nmod	I-Gene_or_gene_product
also	RB	advmod	O
can	MD	aux	O
be	VB	auxpass	O
modulated	VBN	ccomp	O
post	JJ	dobj	O
-	HYPH	punct	O
transcriptionally	RB	advmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
aimed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
whether	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
selective	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cytolytic	JJ	amod	O
markers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
and	CC	cc	O
whether	IN	mark	O
there	EX	expl	O
is	VBZ	conj	O
correlation	NN	nsubj	O
with	IN	case	O
zonal	JJ	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
apoptosis	NN	compound	O
characteristics	NNS	nsubjpass	O
of	IN	case	O
MSCs	NNS	nmod	B-Cell
were	VBD	auxpass	O
observed	VBN	ROOT	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
anoxia	NN	conj	O
.	.	punct	O

Irreversible	JJ	amod	O
PHT	NN	compound	O
cases	NNS	nsubj	O
were	VBD	cop	O
also	RB	advmod	O
more	RBR	advmod	O
likely	JJ	ROOT	O
to	TO	mark	O
show	VB	xcomp	O
compensatory	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
new	JJ	amod	O
small	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
at	IN	case	O
the	DT	det	O
sites	NNS	nmod	O
of	IN	case	O
native	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
stenosis	NN	nmod	O
or	CC	cc	O
occlusion	NN	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

Pthrp	JJ	compound	B-Gene_or_gene_product
ablation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
of	IN	case	O
the	DT	det	O
PyMT	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
MMTV	NN	compound	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
mouse	NN	compound	B-Organism
model	NN	nmod	O
caused	VBD	ROOT	O
a	DT	det	O
delay	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
inhibited	VBD	conj	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
reduced	VBN	conj	O
metastasis	NN	dobj	O
to	TO	case	O
distal	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
stimulates	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
the	DT	det	O
angiogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
total	JJ	amod	O
nm23	NN	compound	B-Gene_or_gene_product
messenger	NN	compound	O
RNA	NN	dep	O
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ccomp	O
to	TO	case	O
similar	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
of	IN	case	O
both	CC	cc:preconj	O
high	JJ	amod	O
and	CC	cc	O
low	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

An	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	nsubj	O
containing	VBG	acl	O
the	DT	det	O
first	JJ	amod	O
127	CD	nummod	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
amino	NN	compound	B-Amino_acid
acids	NNS	dobj	I-Amino_acid
(	-LRB-	punct	O
T1	NN	compound	O
-	:	punct	O
127	CD	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
.	.	punct	O

After	IN	ROOT	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	pobj	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
1	CD	appos	O
.	.	punct	O
2	CD	nummod	O
-	:	punct	O
to	TO	prep	O
2	CD	pobj	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
increase	NN	nsubjpass	O
in	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
nine	CD	nmod	O
of	IN	case	O
14	CD	nummod	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
seven	CD	nummod	O
of	IN	case	O
11	CD	nummod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
cases	NNS	conj	O
.	.	punct	O

TEL	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
biallelically	RB	advmod	O
disrupted	VBN	ROOT	O
in	IN	case	O
acute	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
loss	NN	nsubjpass	O
of	IN	case	O
heterozygosity	NN	nmod	O
at	IN	case	O
the	DT	det	O
TEL	NN	compound	B-Gene_or_gene_product
locus	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	conj	O
in	IN	case	O
various	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	B-Cancer
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

Autotaxin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
ATX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
tumor	NN	compound	B-Cancer
motogen	NN	appos	O
,	,	punct	O
augments	VBZ	ROOT	O
invasive	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
potential	NN	dobj	O
of	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
unchallenged	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
fibrillar	JJ	amod	B-Gene_or_gene_product
collagen	NN	nsubj	I-Gene_or_gene_product
induced	VBD	ROOT	O
robust	JJ	amod	O
capillary	JJ	amod	B-Tissue
morphogenesis	NN	dobj	O
.	.	punct	O

Neuroblastoma	NN	nmod	B-Cancer
and	CC	cc	O
hepatocyte	NN	conj	B-Cell
coculture	NN	nsubj	O
conditioned	VBD	ROOT	O
media	NNS	compound	O
alter	VBP	compound	O
apoptosis	NN	dobj	O
.	.	punct	O

Recombinant	JJ	amod	O
EBV	NN	nsubj	B-Organism
containing	VBG	acl	O
LMP1	NN	dobj	B-Gene_or_gene_product
with	IN	case	O
TES2	NN	nmod	O
deleted	VBN	nsubj	O
induces	VBZ	ROOT	O
a	DT	det	O
limited	JJ	amod	O
proliferation	NN	dobj	O
of	IN	case	O
B	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
define	NN	ROOT	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dobj	I-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
integrator	NN	nmod	O
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	O
process	NN	nmod	O
in	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
reveal	VBP	conj	O
an	DT	det	O
essential	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
for	IN	case	O
procaspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
did	VBD	parataxis	O
cell	NN	compound	B-Cell
viability	NN	dobj	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	conj	O
,	,	punct	O
tube	NN	compound	B-Tissue
formation	NN	compound	O
assay	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
Matrigel	NNP	compound	O
plug	NN	compound	O
assay	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
allograft	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
specifically	RB	advmod	O
AKT2	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O

Tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ROOT	O
the	DT	det	O
glycolytic	JJ	amod	O
regulator	NN	dobj	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
subtype	NN	compound	I-Gene_or_gene_product
M2	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
M2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
PK	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
occur	VB	acl:relcl	O
in	IN	case	O
a	DT	det	O
tetrameric	JJ	amod	O
form	NN	nmod	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
substrate	JJ	compound	O
phosphoenolpyruvate	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
PEP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
dimeric	JJ	amod	O
form	NN	conj	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
PEP	NN	compound	B-Simple_chemical
affinity	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	B-Tissue
origin	NN	conj	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
was	VBD	auxpass	O
negatively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
plant	NN	compound	O
based	VBN	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
The	DT	det	O
phytochemistry	NN	nmod	O
and	CC	cc	O
pharmacological	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
all	DT	det	O
Punica	NNP	compound	B-Organism
granatum	NN	compound	I-Organism
components	NNS	nmod	O
suggest	VBP	conj	O
a	DT	det	O
wide	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
clinical	JJ	amod	O
applications	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
diseases	NNS	conj	O
where	WRB	advmod	O
chronic	JJ	amod	O
inflammation	NN	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
essential	JJ	amod	O
etiologic	JJ	amod	O
role	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
endogenous	JJ	amod	O
gene	NN	compound	O
regulation	NN	dobj	O
by	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	dep	I-Gene_or_gene_product
by	IN	mark	O
potentiating	VBG	advcl	O
nuclear	JJ	amod	B-Gene_or_gene_product
hormone	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
function	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
24	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
hydroxylase	NN	compound	I-Gene_or_gene_product
regulation	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	B-Simple_chemical
D	NN	compound	I-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	B-Cell
response	NN	conj	O
of	IN	case	O
oral	JJ	amod	B-Cell
keratinocytes	NNS	nmod	I-Cell
to	TO	case	O
1alpha	NN	compound	B-Simple_chemical
,	,	punct	I-Simple_chemical
25	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dihydroxyvitamin	NN	compound	I-Simple_chemical
D3	NN	nmod	I-Simple_chemical
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	dep	O
accumulation	NN	nmod	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
delayed	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

AIMS	NNS	ROOT	O
:	:	punct	O
As	IN	mark	O
one	CD	pobj	O
of	IN	case	O
the	DT	det	O
five	CD	nummod	O
lactate	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
LDH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
isoenzymes	NNS	nmod	O
,	,	punct	O
LDH5	NN	nsubj	B-Gene_or_gene_product
has	VBZ	dep	O
the	DT	det	O
highest	JJS	amod	O
efficiency	NN	dobj	O
to	TO	mark	O
catalyze	VB	acl	O
pyruvate	NN	compound	B-Simple_chemical
transformation	NN	dobj	O
to	TO	aux	O
lactate	VB	xcomp	B-Simple_chemical
.	.	punct	O

Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
transformed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
from	IN	case	O
human	JJ	amod	B-Organism
EJ	NN	compound	B-Cell
bladder	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
fused	VBN	ROOT	O
with	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
down	RB	pcomp	O
modulated	VBN	amod	O
growing	VBG	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
PDBu	NNS	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
almost	RB	advmod	O
complete	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
down	RB	amod	O
modulated	VBN	amod	O
stationary	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
minimal	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
by	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
observed	VBN	parataxis	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubj	I-Multi-tissue_structure
initiated	VBD	appos	O
growth	NN	dobj	O
and	CC	cc	O
elongated	VBN	conj	O
from	IN	case	O
the	DT	det	O
fat	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
fragments	NNS	nmod	O
over	IN	case	O
15	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

The	DT	det	O
sequential	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	compound	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
/	SYM	punct	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
cleavage	NN	conj	O
of	IN	case	O
poly	NN	amod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ADP	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ribose	NN	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
polymerase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PARP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
behind	IN	case	O
those	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
events	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
curcumin	NN	compound	B-Simple_chemical
dose	NN	nsubj	O
-	:	punct	O
dependently	RB	advmod	O
inhibited	VBN	ccomp	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
the	DT	det	O
proliferation	NN	dep	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
CD2	NN	compound	O
/	:	punct	O
F	NN	compound	O
(	-LRB-	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
placed	VBN	ROOT	O
on	IN	case	O
synthetic	JJ	amod	O
diets	NNS	nmod	O
containing	VBG	acl	O
0	CD	nummod	O
,	,	punct	O
1	CD	conj	O
,	,	punct	O
or	CC	cc	O
2	CD	compound	O
%	NN	compound	O
CLA	NN	dobj	B-Simple_chemical
for	IN	case	O
6	CD	nummod	O
weeks	NNS	nmod	O
,	,	punct	O
before	IN	case	O
angiogenic	JJ	amod	O
challenge	NN	nmod	O
by	IN	case	O
s	NNS	nmod	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
injection	NN	ROOT	O
with	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
gel	NN	compound	O
substrate	NN	nmod	O
(	-LRB-	punct	O
Matrigel	NN	compound	O
pellet	NN	compound	O
assay	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
energy	NN	nsubj	O
expended	VBN	ROOT	O
by	IN	agent	O
the	DT	det	O
host	NN	pobj	O
to	TO	aux	O
synthesize	VB	xcomp	O
substrate	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
utilized	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
cause	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Organism_substance
cachexia	NN	nmod	I-Organism_substance
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
shark	NN	amod	B-Organism
cartilage	NN	npadvmod	B-Tissue
-	HYPH	punct	O
derived	VBN	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
on	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenesis	NN	nmod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activities	NNS	conj	O
.	.	punct	O

After	IN	ROOT	O
the	DT	det	O
completion	NN	pobj	O
of	IN	prep	O
skin	NN	compound	B-Organ
development	NN	pobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	npadvmod	O
.	.	punct	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
of	IN	prep	O
new	JJ	amod	O
capillaries	NNS	pobj	B-Tissue
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	pobj	I-Multi-tissue_structure
,	,	punct	O
is	VBZ	auxpass	O
held	VBN	ROOT	O
to	TO	aux	O
occur	VB	xcomp	O
in	IN	prep	O
the	DT	det	O
skin	NN	pobj	B-Organ
only	RB	advmod	O
under	IN	prep	O
pathologic	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O

We	PRP	nsubj	O
reported	VBD	ROOT	O
earlier	RBR	advmod	O
on	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
Grm1	NN	nmod	B-Gene_or_gene_product
by	IN	mark	O
demonstrating	VBG	advcl	O
that	IN	mark	O
stable	JJ	amod	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mouse	NN	compound	B-Organism
-	HYPH	punct	O
melanocytic	JJ	amod	B-Cell
clones	NNS	nsubj	I-Cell
proliferate	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
supplement	NN	nmod	O
and	CC	cc	O
anchorage	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Counteracting	VBG	csubj	O
islet	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
inflammation	NN	dobj	O
might	MD	aux	O
be	VB	ROOT	O
one	CD	nummod	O
way	NN	attr	O
to	TO	aux	O
ameliorate	VB	relcl	O
/	SYM	punct	O
prevent	VBP	amod	O
beta	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
dysfunction	NN	dobj	O
in	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
.	.	punct	O

Bone	NN	compound	B-Tissue
destruction	NN	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
osteoclastic	JJ	amod	B-Cell
bone	NN	compound	B-Tissue
resorption	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
stimulate	VBP	conj	O
the	DT	det	O
formation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	B-Cell
next	RB	case	O
to	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	B-Cell
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Ang	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
cellular	JJ	amod	B-Cell
interaction	NN	nsubj	O
was	VBD	cop	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	ROOT	O
,	,	punct	O
although	IN	mark	O
isolated	VBN	amod	O
granules	NNS	nsubj	B-Organism_substance
could	MD	aux	O
enhance	VB	advcl	O
fibroblast	NN	compound	B-Cell
proliferation	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
TEL	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
inhibits	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
in	IN	case	O
normal	JJ	amod	O
cultures	NNS	conj	O
.	.	punct	O

Electrical	JJ	amod	O
stimulation	NN	nsubjpass	O
(	-LRB-	punct	O
ES	NN	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
recommended	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
optimal	JJ	amod	O
treatment	NN	compound	O
paradigms	NNS	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
established	VBN	parataxis	O
.	.	punct	O

The	DT	det	O
EGFR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
GEP100	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Arf6	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
AMAP1	NN	dep	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	ROOT	O
specific	JJ	amod	O
to	TO	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
did	VBD	ROOT	O
immunoblotting	VBG	dobj	O
,	,	punct	O
immunoprecipitation	NN	conj	O
,	,	punct	O
and	CC	cc	O
immunofluorescence	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

The	DT	det	O
latent	JJ	amod	O
membrane	NN	compound	O
protein	NN	nsubj	O
LMP1	NN	dep	B-Gene_or_gene_product
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nmod	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
is	VBZ	cop	O
often	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
EBV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
associated	VBN	amod	O
malignancies	NNS	nmod	B-Cancer
including	VBG	case	O
nasopharyngeal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
Hodgkin	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	conj	I-Cancer
.	.	punct	O

Vinculin	NN	compound	B-Gene_or_gene_product
staining	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
leading	JJ	amod	O
edge	NN	nsubj	O
of	IN	case	O
ECs	NNS	nmod	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ccomp	O
focal	JJ	amod	O
adhesions	NNS	dobj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
oriented	VBN	acl:relcl	O
with	IN	case	O
their	PRP$	nmod:poss	O
lamellipodial	JJ	amod	O
protrusion	NN	nmod	O
and	CC	cc	O
the	DT	det	O
direction	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
;	:	punct	O
this	DT	det	O
arrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	O
adhesions	NNS	nmod	O
may	MD	aux	O
promote	VB	parataxis	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
altered	JJ	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
therefore	RB	advmod	O
indicate	VBP	ROOT	O
a	DT	det	O
specific	JJ	dobj	O
and	CC	cc	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dep	O
of	IN	case	O
the	DT	det	O
PKCalpha	NN	compound	B-Gene_or_gene_product
isoform	NN	nmod	O
in	IN	case	O
three	CD	nummod	O
major	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
functions	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
maintenance	NN	nmod	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
homeostasis	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
of	IN	case	O
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
vascular	JJ	amod	B-Multi-tissue_structure
physiology	NN	dobj	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
distinct	JJ	amod	O
subdomains	NNS	nmod	O
within	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
bind	VB	acl	O
adhesion	NN	compound	O
proteins	NNS	dobj	O
and	CC	cc	O
induce	VBP	conj	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
bundling	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
protein	NN	nsubj	O
could	MD	aux	O
function	VB	ccomp	O
in	IN	case	O
the	DT	det	O
aggregation	NN	nmod	O
and	CC	cc	O
tethering	NN	conj	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
filaments	NNS	nmod	O
during	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cellular_component
cell	NN	compound	I-Cellular_component
-	HYPH	punct	I-Cellular_component
substrate	NN	nmod	I-Cellular_component
and	CC	cc	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
cell	NN	compound	I-Cellular_component
contacts	NNS	conj	I-Cellular_component
.	.	punct	O

A	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
Km	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
type	NN	appos	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	appos	I-Gene_or_gene_product
is	VBZ	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
hepatomas	NNS	nmod	B-Cancer
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
in	IN	case	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
increases	VBZ	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
neurogenesis	NN	conj	O
in	IN	case	O
culture	NN	nmod	O
but	CC	cc	O
has	VBZ	conj	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
these	DT	det	O
functions	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Several	JJ	amod	O
Notch	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
clearly	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
proto	JJ	compound	O
-	HYPH	punct	O
oncogenes	NNS	xcomp	O
in	IN	case	O
mammalian	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Antiangiogenic	JJ	amod	O
therapy	NN	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	dep	O
as	IN	case	O
an	DT	det	O
effective	JJ	amod	O
strategy	NN	nmod	O
for	IN	mark	O
controlling	VBG	acl	O
the	DT	det	O
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Several	JJ	amod	O
such	JJ	amod	O
agents	NNS	nsubj	O
are	VBP	cop	O
currently	RB	advmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	ROOT	O
,	,	punct	O
and	CC	cc	O
many	JJ	amod	O
others	NNS	nsubj	O
are	VBP	conj	O
under	IN	prep	O
development	NN	pobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
reported	VBD	dep	O
here	RB	advmod	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
,	,	punct	O
particularly	RB	advmod	O
in	IN	case	O
familial	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
,	,	punct	O
suggesting	VBG	advcl	O
this	DT	det	O
epigenetic	JJ	amod	O
alteration	NN	dobj	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
pathomechanism	NN	nmod	O
of	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Chang	NN	compound	B-Cell
hepatocytes	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	prep	O
the	DT	det	O
coculture	NN	pobj	O
conditioned	JJ	amod	O
media	NNS	npadvmod	O
have	VBP	appos	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Ets	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	appos	O
,	,	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Treatment	NN	ROOT	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
recombinant	JJ	amod	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nummod	I-Gene_or_gene_product
stimulated	VBN	amod	O
proliferation	NN	nmod	O
,	,	punct	O
chemotaxis	NN	conj	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

By	IN	prep	O
live	JJ	amod	O
videomicroscopy	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
vessels	NNS	nsubj	B-Multi-tissue_structure
were	VBD	cop	O
largely	RB	advmod	O
nonfunctional	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
alpha2beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

To	TO	mark	O
explore	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
oncogenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
Evi	NNP	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
affects	VBZ	ccomp	O
the	DT	det	O
signaling	NN	dobj	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
proliferation	NN	dobj	O
of	IN	case	O
a	DT	det	O
wide	JJ	amod	O
range	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
types	NNS	nmod	I-Cell
and	CC	cc	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
studied	VBN	amod	O
growth	NN	compound	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
composition	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
by	IN	case	O
low	JJ	amod	B-Gene_or_gene_product
density	NN	compound	I-Gene_or_gene_product
lipoprotein	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
:	:	punct	O
activities	NNS	dep	O
based	VBN	case	O
on	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Mitochondrial	JJ	amod	B-Cellular_component
apoptosis	NN	ROOT	O
and	CC	cc	O
FAK	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
disruption	NN	conj	O
by	IN	case	O
a	DT	det	O
novel	JJ	amod	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
,	,	punct	O
HTPB	NN	appos	B-Simple_chemical
,	,	punct	O
in	IN	case	O
antitumor	NN	nmod	B-Cancer
and	CC	cc	O
antimetastatic	JJ	conj	O
mouse	NN	compound	B-Organism
models	NNS	conj	O
.	.	punct	O

Folate	JJ	compound	B-Simple_chemical
supplementation	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	B-Pathological_formation
dysplasia	NN	nmod	I-Pathological_formation
and	CC	cc	O
cancer	NN	conj	B-Cancer
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
UC	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
.	.	punct	O

Silencing	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
significantly	RB	advmod	O
reduced	VBD	ROOT	O
cell	NN	compound	B-Cell
adhesion	NN	dobj	O
to	TO	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

a	DT	det	O
pilot	NN	compound	O
study	NN	ROOT	O
.	.	punct	O

Grossly	RB	advmod	O
,	,	punct	O
these	DT	det	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
small	JJ	ROOT	O
and	CC	cc	O
had	VBD	conj	O
few	JJ	amod	O
feeding	VBG	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

This	DT	det	O
metastatic	JJ	amod	O
ability	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
remarkably	RB	advmod	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
(	-LRB-	punct	O
subcutaneous	JJ	amod	O
tumor	NN	compound	B-Cancer
formation	NN	dep	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
)	-RRB-	punct	O
accompanied	VBN	acl	O
by	IN	case	O
increased	VBN	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
gene	NN	compound	O
amplification	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
-	HYPH	punct	O
derived	VBN	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
,	,	punct	O
while	IN	mark	O
it	PRP	nsubj	O
declined	VBD	advcl	O
gradually	RB	advmod	O
as	IN	mark	O
the	DT	det	O
passage	NN	compound	O
number	NN	nsubj	O
increased	VBD	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
with	IN	case	O
corresponding	JJ	amod	O
decreases	NNS	nmod	O
of	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
promotion	NN	nsubj	O
is	VBZ	cop	O
due	JJ	acomp	O
to	TO	case	O
induction	NN	ROOT	O
of	IN	case	O
inflammation	NN	nmod	B-Pathological_formation
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
enhanced	VBN	amod	O
pneumocyte	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
abrogated	VBN	conj	O
by	IN	case	O
IKKbeta	NN	compound	B-Gene_or_gene_product
ablation	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
JNK1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
head	NN	amod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
using	VBG	acl	O
UM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
SCC	NN	compound	I-Cell
-	:	punct	I-Cell
11A	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
2ME2	NN	nsubj	B-Simple_chemical
exhibited	VBD	ROOT	O
antitumor	NN	dobj	B-Cancer
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	B-Gene_or_gene_product
immunostaining	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
inhibits	VBZ	ccomp	O
adenosine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
accumulation	NN	dobj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
AQP5	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
cellular	JJ	amod	B-Cell
differentiation	NN	nmod	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
clinicopathological	JJ	amod	O
staging	NN	conj	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
mutation	NN	nsubj	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
GIST	NN	nmod	B-Cancer
and	CC	cc	O
also	RB	advmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
prognostic	JJ	amod	O
marker	NN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
for	IN	case	O
its	PRP$	nmod:poss	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
on	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O

However	RB	advmod	O
many	JJ	amod	O
human	JJ	amod	B-Organism
carcinomas	NNS	nsubj	B-Cancer
overexpress	VBP	ROOT	O
TGFbeta1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
this	DT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
poor	JJ	amod	O
patient	NN	compound	B-Organism
prognosis	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
frequency	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
disparate	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
enhancing	VBG	nmod	O
or	CC	cc	O
inhibiting	VBG	conj	O
apoptosis	NN	conj	O
exist	VBP	ccomp	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
related	JJ	amod	O
to	TO	case	O
environmental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
HGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
cellular	JJ	amod	B-Cell
synthesis	NN	nmod	O
of	IN	case	O
distinct	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
mRNA	NN	conj	O
.	.	punct	O

Platelets	NNS	nsubj	B-Cell
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
potential	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
heterozygous	JJ	amod	O
disruption	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
increases	VBZ	ccomp	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
and	CC	cc	O
accelerates	VBZ	conj	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	npadvmod	I-Organism
-	:	punct	O
induced	VBN	amod	O
premalignant	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
.	.	punct	O

Parathyroid	JJ	amod	B-Gene_or_gene_product
hormone	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
PTHrP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
secreted	VBN	amod	O
factor	NN	ROOT	O
expressed	VBN	acl	O
in	IN	case	O
almost	RB	advmod	O
all	DT	amod	O
normal	JJ	amod	O
fetal	JJ	amod	B-Tissue
and	CC	cc	O
adult	JJ	conj	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubjpass	O
whereby	WRB	advmod	O
RNA	NN	compound	B-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nsubj	I-Organism
cause	VBP	acl:relcl	O
lymphoid	JJ	amod	B-Cancer
neoplasia	NN	dobj	I-Cancer
after	IN	case	O
a	DT	det	O
long	JJ	amod	O
latent	JJ	amod	O
period	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
extensively	RB	advmod	O
studied	VBN	ROOT	O
but	CC	cc	O
are	VBP	auxpass	O
only	RB	advmod	O
partially	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

All	DT	det	O
courses	NNS	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
safety	NN	nmod	O
and	CC	cc	O
31	CD	conj	O
for	IN	case	O
efficacy	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Dependence	NN	nsubj	O
on	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	appos	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
decreased	VBD	ROOT	O
as	IN	mark	O
ECs	NNS	compound	B-Cell
migration	NN	nsubj	O
slowed	VBD	advcl	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
Coincidental	NN	dep	O
with	IN	case	O
SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
mRNA	NN	compound	O
expression	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
target	NN	compound	O
genes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
low	JJ	amod	B-Gene_or_gene_product
density	NN	compound	I-Gene_or_gene_product
lipoprotein	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
HMG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
CoA	NN	compound	I-Gene_or_gene_product
reductase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
fatty	JJ	amod	B-Gene_or_gene_product
acid	NN	compound	I-Gene_or_gene_product
synthase	NN	conj	I-Gene_or_gene_product
also	RB	advmod	O
increased	VBD	parataxis	O
in	IN	mark	O
migrating	VBG	advcl	O
ECs	NNS	compound	B-Cell
population	NN	dobj	O
as	IN	mark	O
detected	VBN	advcl	O
by	IN	case	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
Migration	NN	nsubj	O
induced	VBD	parataxis	O
SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nsubjpass	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
SREBP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
acting	VBG	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
RNAi	NNS	nmod	O
and	CC	cc	O
pharmacologically	RB	advmod	O
by	IN	case	O
25	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxycholesterol	NN	conj	I-Simple_chemical
;	:	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
SREBP	NN	nmod	B-Gene_or_gene_product
led	VBD	parataxis	O
to	TO	case	O
decreased	VBN	amod	O
ECs	NNS	compound	B-Cell
migration	NN	nmod	O
in	IN	case	O
various	JJ	amod	O
models	NNS	nmod	O
;	:	punct	O
(	-LRB-	punct	O
5	LS	dep	O
)	-RRB-	punct	O
Cells	NNS	nsubj	B-Cell
genetically	RB	advmod	O
deficient	JJ	amod	O
in	IN	case	O
SREBP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
acting	VBG	amod	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
S1P	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
S2P	NN	conj	B-Gene_or_gene_product
,	,	punct	O
phenotypically	RB	advmod	O
exhibited	VBD	parataxis	O
impaired	JJ	amod	O
migration	NN	dobj	O
;	:	punct	O
(	-LRB-	punct	O
6	LS	dep	O
)	-RRB-	punct	O
SREBP	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubj	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
suppressed	VBD	parataxis	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
small	JJ	amod	O
GTPase	NN	compound	O
Cdc42	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
molecule	NN	appos	O
for	IN	case	O
ECs	NNS	compound	B-Cell
motility	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
modulate	VB	ROOT	O
cellular	JJ	amod	B-Cell
energy	NN	compound	O
metabolism	NN	dobj	O
or	CC	cc	O
be	VB	cop	O
a	DT	det	O
substrate	NN	conj	O
in	IN	case	O
a	DT	det	O
chemical	JJ	amod	O
reaction	NN	nmod	O
generating	VBG	acl	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	dobj	I-Simple_chemical
.	.	punct	O

sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
assayed	VBN	ROOT	O
by	IN	case	O
enzyme	NN	nmod:npmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
RASSF1C	NN	compound	B-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
enhances	VBZ	ccomp	O
T47D	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
/	:	punct	O
migration	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	aux	O
investigate	VB	xcomp	O
in	IN	case	O
more	JJR	advmod	O
detail	NN	nmod	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
apoptotic	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
in	IN	case	O
cell	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
free	JJ	amod	O
extracts	NNS	conj	B-Organism_substance
of	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
to	TO	case	O
long	RB	advmod	O
-	HYPH	punct	O
term	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
was	VBD	cop	O
significantly	RB	advmod	O
different	JJ	ROOT	O
depending	VBG	case	O
upon	IN	case	O
the	DT	det	O
initial	JJ	amod	O
growth	NN	compound	O
state	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
increased	VBN	amod	O
active	JJ	amod	O
form	NN	compound	O
SREBP	NN	dobj	B-Gene_or_gene_product
in	IN	mark	O
migrating	VBG	advcl	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
migrating	VBG	amod	O
ECs	NNS	compound	B-Cell
population	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
"	``	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
resistant	JJ	dep	O
"	``	punct	O
phenotype	NN	nmod	O
in	IN	case	O
a	DT	det	O
clonal	JJ	amod	O
strain	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
passage	NN	compound	O
WB	NN	compound	B-Cell
-	HYPH	punct	I-Cell
F344	NN	compound	I-Cell
normal	JJ	amod	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
proliferation	NN	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
was	VBD	auxpass	O
markedly	RB	advmod	O
inhibited	VBN	parataxis	O
by	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Prognostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
resected	JJ	amod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HDAc	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	B-Simple_chemical
A	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
TSA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

RNA	NN	compound	O
damage	NN	ROOT	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
neoplastic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
growth	NN	nmod	O
:	:	punct	O
effects	NNS	dep	O
of	IN	case	O
human	JJ	amod	B-Organism
and	CC	cc	O
amphibian	JJ	conj	O
ribonucleases	NNS	nmod	B-Gene_or_gene_product
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
phenotypic	JJ	amod	O
traits	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
null	JJ	amod	O
mutant	NN	nmod	O
could	MD	aux	O
result	VB	ROOT	O
partly	RB	advmod	O
from	IN	case	O
reduced	VBN	amod	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
expression	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Since	IN	mark	O
ras	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
frequently	RB	advmod	O
activated	VBN	xcomp	O
in	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
sera	NN	nmod	B-Organism_substance
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
intravenously	RB	advmod	B-Immaterial_anatomical_entity
injected	JJ	amod	O
lipoplexes	NNS	nsubj	B-Simple_chemical
migrated	VBD	advcl	O
within	IN	case	O
seconds	NNS	nmod	O
to	IN	case	O
lungs	NNS	xcomp	B-Organ
,	,	punct	O
we	PRP	nsubj	O
checked	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
immediate	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
serum	NN	nmod	B-Organism_substance
correlate	VBP	ccomp	O
with	IN	case	O
lung	NN	compound	B-Organ
lipofection	NN	compound	O
efficiency	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
DOTAP	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
formulations	NNS	nmod	O
.	.	punct	O

Over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
either	CC	det	O
rho	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
anchorage	NN	amod	O
-	HYPH	punct	O
and	CC	cc	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
identity	NN	nsubj	O
of	IN	case	O
pulmonary	JJ	amod	O
endothelial	JJ	amod	B-Cell
SOCs	NNS	nmod	O
is	VBZ	cop	O
unknown	JJ	advcl	O
,	,	punct	O
but	CC	cc	O
mammalian	JJ	amod	O
homologues	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-Organism
melanogaster	FW	compound	I-Organism
transient	JJ	amod	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
potential	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
trp	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	conj	O
to	TO	mark	O
form	VB	xcomp	O
Ca2	NN	dobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	compound	O
channels	NNS	conj	O
in	IN	case	O
nonexcitable	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
we	PRP	nsubj	O
performed	VBD	ROOT	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
using	VBG	xcomp	O
Trp	NN	compound	B-Gene_or_gene_product
oligonucleotide	NN	compound	O
primers	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
rat	NN	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
pulmonary	JJ	amod	B-Cell
arterial	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
thus	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
on	IN	case	O
hemostasis	NN	nmod	O
of	IN	case	O
the	DT	det	O
drugs	NNS	nmod	O
examined	VBN	acl	O
can	MD	aux	O
contribute	VB	ccomp	O
only	RB	advmod	O
marginally	RB	advmod	O
to	TO	case	O
their	PRP$	nmod:poss	O
antimetastatic	JJ	amod	O
action	NN	nmod	O
,	,	punct	O
since	IN	case	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubjpass	O
on	IN	case	O
hemostasis	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
to	TO	mark	O
significantly	RB	advmod	O
affect	VB	xcomp	O
metastasis	NN	compound	O
formation	NN	dobj	O
.	.	punct	O

Chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	ROOT	I-Cell
and	CC	cc	O
hamster	NN	compound	B-Cell
BHK	NN	compound	I-Cell
cells	NNS	conj	I-Cell
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
RSV	NN	appos	B-Organism
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEF	NN	appos	B-Cell
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	B-Organism
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

HKa	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
reduce	VBP	ROOT	O
the	DT	det	O
localization	NN	dobj	O
of	IN	case	O
paxillin	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
after	IN	case	O
S1P	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
stimulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
clinicopathologic	JJ	amod	O
features	NNS	conj	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Administration	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
at	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	nummod	O
microM	NN	nsubj	O
increased	VBD	ROOT	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
,	,	punct	O
while	IN	mark	O
at	IN	case	O
10	CD	nummod	O
microM	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
decreased	VBD	advcl	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
applied	VBD	ROOT	O
a	DT	det	O
proteomics	NNS	compound	O
strategy	NN	dobj	O
to	TO	mark	O
identify	VB	advcl	O
novel	JJ	amod	O
proteins	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
ECM	NN	compound	B-Cellular_component
modeling	NN	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
LRP	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	nsubjpass	O
:	:	punct	O
The	DT	det	O
parameters	NNS	nsubj	O
associated	VBN	acl	O
with	IN	prep	O
locating	VBG	pobj	O
and	CC	cc	O
then	RB	advmod	O
photocoagulating	VBG	dep	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
were	VBD	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
optimized	VBN	conj	O
using	VBG	xcomp	O
published	VBN	amod	O
data	NNS	dobj	O
and	CC	cc	O
data	NNS	conj	O
derived	VBN	acl	O
from	IN	mark	O
modeling	VBG	advcl	O
the	DT	det	O
choroidal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	dobj	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
hypothesis	NN	nsubj	O
was	VBD	ROOT	O
that	IN	mark	O
therapy	NN	nsubj	O
with	IN	case	O
NH	NN	nmod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
-	:	punct	O
terminally	RB	advmod	O
truncated	VBN	amod	O
form	NN	conj	O
of	IN	prep	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
will	MD	aux	O
be	VB	cop	O
efficacious	JJ	ccomp	O
for	IN	case	O
reduction	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
for	IN	case	O
inhibition	NN	conj	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
agreement	NN	nmod	O
between	IN	prep	O
pediatric	JJ	amod	O
dentists	NNS	pobj	O
and	CC	cc	O
endodontists	NNS	conj	O
at	IN	case	O
a	DT	det	O
pulp	JJ	amod	B-Tissue
therapy	NN	compound	O
symposium	NN	nmod	O
conjointly	RB	advmod	O
sponsored	VBN	acl	O
by	IN	agent	O
the	DT	det	O
American	NNP	compound	O
Association	NNP	pobj	O
of	IN	prep	O
Endodontists	NNPS	pobj	O
(	-LRB-	punct	O
AAE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
American	NNP	compound	O
Academy	NNP	conj	O
of	IN	prep	O
Pediatric	NNP	compound	O
Dentistry	NNP	pobj	O
(	-LRB-	punct	O
AAPD	NN	appos	O
)	-RRB-	punct	O
on	IN	prep	O
November	NNP	pobj	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
,	,	punct	O
2007	CD	nummod	O
.	.	punct	O

After	IN	case	O
decapitation	NN	nmod	O
of	IN	prep	O
the	DT	det	O
rats	NNS	pobj	B-Organism
,	,	punct	O
trunk	NN	compound	B-Organism_substance
blood	NN	nsubjpass	I-Organism_substance
was	VBD	auxpass	O
obtained	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ileum	NN	nsubjpass	B-Multi-tissue_structure
,	,	punct	O
liver	NN	conj	B-Organ
,	,	punct	O
and	CC	cc	O
kidney	NN	nsubjpass	B-Organ
were	VBD	auxpass	O
removed	VBN	conj	O
for	IN	case	O
histological	JJ	amod	O
examination	NN	nmod	O
and	CC	cc	O
for	IN	case	O
the	DT	det	O
measurement	NN	conj	O
of	IN	case	O
malondialdehyde	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
MDA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
glutathione	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
levels	NNS	conj	O
,	,	punct	O
myeloperoxidase	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
MPO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
activity	NN	conj	O
,	,	punct	O
and	CC	cc	O
collagen	NN	compound	B-Gene_or_gene_product
content	NN	conj	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Fifteen	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
with	IN	case	O
MEN	NN	compound	B-Cancer
II	CD	nummod	I-Cancer
A	NN	nmod	I-Cancer
(	-LRB-	punct	O
aged	JJ	amod	O
4	CD	compound	O
-	SYM	punct	O
24	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
who	WP	nsubj	O
had	VBD	aux	O
undergone	VBN	acl:relcl	O
prophylactic	JJ	amod	O
thyroidectomy	NN	dobj	O
since	IN	case	O
1990	CD	nmod	O
were	VBD	auxpass	O
included	VBN	dep	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
retrospectively	RB	advmod	O
analyzed	VBD	ROOT	O
the	DT	det	O
coagulation	NN	compound	O
function	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
platelet	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
/	:	punct	O
thymidine	NN	compound	B-Gene_or_gene_product
phosphorylase	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
tumor	NN	compound	B-Cancer
behavior	NN	nmod	O
.	.	punct	O

Intriguingly	RB	advmod	O
,	,	punct	O
two	CD	nummod	O
recent	JJ	amod	O
papers	NNS	nsubj	O
have	VBP	aux	O
shed	VBN	ROOT	O
new	JJ	amod	O
light	NN	dobj	O
into	IN	prep	O
this	DT	det	O
unexplored	JJ	amod	O
field	NN	pobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
growth	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
,	,	punct	O
unexpectedly	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
developmental	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
early	JJ	amod	O
embryos	NNS	nmod	B-Developing_anatomical_structure
.	.	punct	O

Glucose	NNP	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	B-Amino_acid
utilization	NN	nmod	O
by	IN	case	O
34	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Mutation	NN	compound	O
positive	JJ	amod	O
GIST	NN	nsubj	B-Cancer
showed	VBD	ROOT	O
higher	JJR	amod	O
frequency	NN	dobj	O
of	IN	case	O
adjacent	JJ	amod	O
tissue	NN	compound	B-Tissue
invasion	NN	nmod	O
,	,	punct	O
metastasis	NN	conj	O
and	CC	cc	O
recurrence	NN	conj	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
mutation	NN	compound	O
negative	JJ	amod	O
ones	NNS	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
tobacco	NN	compound	B-Organism
smoke	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
over	IN	advmod	O
60	CD	nummod	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
initiating	VBG	amod	O
carcinogens	NNS	dobj	O
,	,	punct	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
risk	NN	compound	O
factor	NN	ROOT	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
accounting	VBG	advcl	O
for	IN	case	O
a	DT	det	O
large	JJ	amod	O
portion	NN	nmod	O
of	IN	prep	O
cancer	NN	npadvmod	B-Cancer
-	HYPH	punct	O
related	JJ	amod	O
deaths	NNS	npadvmod	O
worldwide	VBP	pobj	O
.	.	punct	O

DMI	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
to	TO	mark	O
affect	VB	conj	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
.	.	punct	O

HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
hypoxic	JJ	nmod	O
and	CC	cc	O
in	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
oxygenized	VBN	amod	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
tissue	NN	conj	B-Tissue
,	,	punct	O
presumably	RB	advmod	O
reflecting	VBG	advcl	O
their	PRP$	nmod:poss	O
embryonic	JJ	amod	B-Developing_anatomical_structure
features	NNS	dobj	O
.	.	punct	O

Urokinase	NN	compound	B-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
molecular	JJ	amod	O
organizer	NN	dep	O
in	IN	case	O
cellular	JJ	amod	B-Cell
communication	NN	nmod	O
.	.	punct	O

Store	NNP	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
calcium	NN	compound	B-Simple_chemical
entry	NN	nsubj	O
promotes	VBZ	ROOT	O
shape	NN	compound	O
change	NN	dobj	O
in	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
Trp1	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Using	VBG	advcl	O
recombinant	JJ	amod	O
viruses	NNS	dobj	O
that	WDT	nsubj	O
lack	VBP	acl:relcl	O
only	RB	advmod	O
one	CD	nummod	O
member	NN	dobj	O
of	IN	case	O
the	DT	det	O
cluster	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
all	DT	det	O
three	CD	nummod	O
BHRF1	NN	compound	B-Gene_or_gene_product
miRNAs	NNS	nsubj	O
contribute	VBP	ccomp	O
to	TO	case	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
.	.	punct	O

A	DT	det	O
two	CD	nsubj	O
sided	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
TKTL1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LDH5	NN	conj	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
shown	VBN	ROOT	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
002	CD	dep	O
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
overall	JJ	amod	O
cohort	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	prep	O
each	DT	det	O
grading	NN	nmod	O
and	CC	cc	O
pN	NN	conj	O
group	NN	pobj	O
.	.	punct	O

Antibodies	NNS	nsubj	O
to	TO	case	O
PA	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
dose	NN	nmod	O
-	HYPH	punct	O
dependently	RB	advmod	O
,	,	punct	O
and	CC	cc	O
significantly	RB	advmod	O
,	,	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
and	CC	cc	O
migratory	JJ	conj	O
potential	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
HT1080	NN	compound	B-Cell
fibrosarcoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
did	VBD	advcl	O
an	DT	det	O
antibody	NN	dobj	O
to	TO	case	O
uPA	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
plasmin	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
aprotinin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Human	JJ	amod	B-Organism
pituitary	JJ	amod	B-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
transforming	NN	compound	I-Gene_or_gene_product
gene	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PTTG	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
overexpression	NN	nsubj	O
correlates	VBZ	ROOT	O
with	IN	case	O
metastasis	NN	nmod	O
in	IN	case	O
multiple	JJ	amod	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
yet	RB	advmod	O
its	PRP$	nmod:poss	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
action	NN	nmod	O
remain	VBP	conj	O
elusive	JJ	xcomp	O
.	.	punct	O

Since	IN	mark	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nsubj	I-Gene_or_gene_product
are	VBP	cop	O
key	JJ	amod	O
elements	NNS	advcl	O
in	IN	mark	O
controlling	VBG	acl	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
cytokine	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
supernatants	NNS	nmod	O
were	VBD	auxpass	O
measured	VBN	conj	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O

Abilities	NNS	nsubjpass	O
of	IN	case	O
adhesion	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cell	NN	nmod	I-Cell
were	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signal	NN	compound	O
pathway	NN	nsubj	O
plays	VBZ	appos	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
drug	NN	compound	O
-	HYPH	punct	O
resistance	NN	nmod	O
.	.	punct	O

VDAs	NNS	nsubj	B-Simple_chemical
specifically	RB	advmod	O
target	NN	ROOT	O
and	CC	cc	O
destroy	VB	conj	O
well	RB	advmod	O
-	HYPH	punct	O
established	JJ	amod	O
tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	conj	I-Multi-tissue_structure
with	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
destruction	NN	conj	O
of	IN	case	O
large	JJ	amod	O
masses	NNS	nmod	B-Cancer
with	IN	case	O
central	JJ	amod	O
hemorrhagic	JJ	amod	O
necrosis	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
a	DT	det	O
thin	JJ	amod	O
peripheral	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
layer	NN	nmod	I-Cancer
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
association	NN	nsubjpass	O
of	IN	case	O
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
with	IN	case	O
clinical	JJ	amod	O
/	SYM	punct	O
pathological	JJ	dep	O
findings	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
outcome	NN	conj	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Preoperative	JJ	amod	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
retrospectively	RB	advmod	O
examined	VBN	ROOT	O
in	IN	case	O
405	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
surgery	NN	dobj	O
for	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Chondrocyte	NNP	compound	B-Cell
-	HYPH	punct	O
DegraPol	NNP	nsubj	O
in	IN	prep	O
Oxygent	JJ	amod	B-Simple_chemical
group	NN	pobj	O
presented	VBD	ROOT	O
lower	JJR	amod	O
glycosaminoglycan	JJ	amod	B-Simple_chemical
value	NN	dobj	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
03	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	npadvmod	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
13	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	dep	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
;	:	punct	O
histology	NN	compound	O
slides	NNS	nsubj	O
showed	VBD	ROOT	O
poor	JJ	amod	O
acid	NN	compound	O
mucopolysaccharides	VBZ	compound	B-Simple_chemical
formation	NN	dobj	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
basis	NN	pobj	O
of	IN	case	O
earlier	JJR	amod	O
findings	NNS	nmod	O
that	IN	mark	O
ERK5	NN	compound	B-Gene_or_gene_product
deficiency	NN	nsubj	O
in	IN	case	O
mouse	NN	compound	B-Organism
EC	NN	nmod	B-Cell
results	VBZ	ccomp	O
in	IN	case	O
massive	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
architecture	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
we	PRP	nsubj	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
impact	NN	nmod	O
of	IN	case	O
the	DT	det	O
MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
on	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
All	DT	det	O
patients	NNS	nsubj	B-Organism
completed	VBD	dep	O
therapy	NN	dobj	O
and	CC	cc	O
tolerability	NN	conj	O
was	VBD	ROOT	O
good	JJ	acomp	O
.	.	punct	O

These	DT	nsubj	O
are	VBP	aux	O
exciting	VBG	ROOT	O
new	JJ	amod	O
functions	NNS	dobj	O
of	IN	prep	O
vitamins	NNS	pobj	B-Simple_chemical
that	IN	mark	O
nobody	NN	nsubj	O
could	MD	aux	O
have	VB	aux	O
predicted	VBN	relcl	O
only	RB	advmod	O
a	DT	quantmod	O
few	JJ	nummod	O
years	NNS	npadvmod	O
ago	RB	advmod	O
.	.	punct	O

Lactoferrin	NN	nsubj	B-Gene_or_gene_product
enhances	VBZ	ROOT	O
Fas	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
azoxymethane	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
experiments	NNS	nmod	O
,	,	punct	O
the	DT	det	O
metastasis	NN	nsubjpass	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
engrafted	VBN	amod	O
mice	NNS	nmod	B-Organism
were	VBD	auxpass	O
monitored	VBN	ROOT	O
.	.	punct	O

Arteriogenesis	NN	ROOT	O
:	:	punct	O
the	DT	det	O
development	NN	appos	O
and	CC	cc	O
growth	NN	conj	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
arteries	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Cytotoxic	JJ	amod	O
chemotherapy	NN	compound	O
resistance	NN	nsubjpass	O
is	VBZ	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
limited	JJ	amod	O
therapeutic	JJ	amod	O
options	NNS	nmod	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
.	.	punct	O

The	DT	det	O
differences	NNS	nsubj	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
were	VBD	cop	O
unremarkable	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
synchronized	JJ	amod	O
cultures	NNS	nmod	B-Cell
at	IN	case	O
the	DT	det	O
beginning	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitotic	JJ	amod	O
cycle	NN	nmod	O
,	,	punct	O
the	DT	det	O
bulk	NN	nsubjpass	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
resynthesized	VBD	acl	O
via	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	auxpass	O
utilized	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
synthesis	NN	nmod	O
of	IN	case	O
biopolymers	NNS	nmod	O
,	,	punct	O
whereas	IN	mark	O
that	DT	mark	O
at	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
S	NNP	compound	O
-	HYPH	punct	O
phase	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
G2	NN	compound	O
-	HYPH	punct	O
phase	NN	conj	O
is	VBZ	auxpass	O
utilized	VBN	advcl	O
for	IN	case	O
cation	NN	compound	B-Simple_chemical
transport	NN	nmod	O
across	IN	case	O
plasma	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
.	.	punct	O

Bilateral	JJ	amod	O
central	JJ	amod	O
lymphadenectomy	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
thyroidectomy	NN	nmod	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
the	DT	det	O
grafts	NNS	nsubj	B-Tissue
maintain	VBP	ROOT	O
a	DT	det	O
constant	JJ	amod	O
volume	NN	dobj	O
between	IN	prep	O
3	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
weeks	NNS	pobj	O
,	,	punct	O
thereby	RB	advmod	O
indicating	VBG	advcl	O
that	IN	mark	O
primary	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
do	VBP	aux	O
not	RB	neg	O
produce	VB	ccomp	O
tumors	NNS	dobj	B-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Members	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
superfamily	NN	nmod	O
play	VBP	dep	O
critical	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
important	JJ	amod	O
benefits	NNS	dobj	O
and	CC	cc	O
survival	NN	conj	O
with	IN	case	O
an	DT	det	O
immunotherapy	NN	compound	O
schedule	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
endocrine	JJ	nmod:npmod	B-Anatomical_system
-	HYPH	punct	O
dependent	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
distant	JJ	amod	O
metastases	NNS	conj	O
.	.	punct	O

Placed	VBN	ROOT	O
in	IN	prep	O
the	DT	det	O
framework	NN	pobj	O
of	IN	prep	O
other	JJ	amod	O
recently	RB	advmod	O
published	VBN	amod	O
work	NN	pobj	O
,	,	punct	O
the	DT	det	O
observations	NNS	appos	O
of	IN	prep	O
Villani	NNP	pobj	O
et	FW	cc	O
al	FW	conj	O
.	.	punct	O
both	DT	det	O
raise	NN	amod	O
questions	NNS	ROOT	O
about	IN	case	O
the	DT	det	O
cell	NN	nmod	B-Cell
of	IN	case	O
origin	NN	nmod	O
for	IN	case	O
basal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
define	VB	conj	O
additional	JJ	amod	O
putative	JJ	amod	O
therapeutic	JJ	amod	O
and	CC	cc	O
preventive	JJ	conj	O
targets	NNS	dobj	O
for	IN	case	O
this	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
increased	VBD	ROOT	O
in	IN	case	O
33	CD	compound	O
of	IN	advmod	O
41	CD	nummod	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
was	VBD	auxpass	O
elevated	JJ	conj	O
in	IN	case	O
28	CD	compound	O
of	IN	advmod	O
41	CD	nummod	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
relative	JJ	case	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
matched	VBN	amod	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
also	RB	advmod	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
maturation	NN	nmod	O
.	.	punct	O

The	DT	det	O
rationale	NN	nsubjpass	O
for	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
,	,	punct	O
together	RB	advmod	O
with	IN	prep	O
the	DT	det	O
most	RBS	advmod	O
recent	JJ	amod	O
results	NNS	pobj	O
from	IN	case	O
randomised	VBN	amod	O
trials	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

p53	NN	compound	B-Gene_or_gene_product
up	RB	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
proliferation	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
were	VBD	auxpass	O
substantiated	VBN	ROOT	O
using	VBG	xcomp	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
intrinsic	JJ	nmod	O
and	CC	cc	O
the	DT	det	O
extrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O

Ischemic	JJ	amod	O
cardiac	JJ	amod	B-Tissue
muscle	NN	nsubj	I-Tissue
is	VBZ	ROOT	O
additionally	RB	advmod	O
vulnerable	JJ	acomp	O
because	IN	mark	O
reperfusion	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	advcl	O
for	IN	case	O
survival	NN	nmod	O
but	CC	cc	O
reperfusion	NN	conj	O
itself	PRP	nsubj	O
poses	VBZ	advcl	O
additional	JJ	amod	O
stress	NN	dobj	O
principally	RB	advmod	O
from	IN	case	O
increased	VBN	amod	O
production	NN	nmod	O
of	IN	case	O
free	JJ	amod	O
radicals	NNS	nmod	O
during	IN	case	O
reoxygenation	NN	nmod	O
.	.	punct	O

This	DT	det	O
activation	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
activity	NN	conj	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
p38	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
SB203580	NN	nmod	B-Simple_chemical
.	.	punct	O

In	IN	case	O
20	CD	nummod	O
RCC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
serum	NN	compound	B-Organism_substance
samples	NNS	nsubjpass	I-Organism_substance
were	VBD	auxpass	O
obtained	VBN	ROOT	O
separately	RB	advmod	O
from	IN	case	O
the	DT	det	O
bilateral	JJ	amod	B-Multi-tissue_structure
renal	JJ	amod	I-Multi-tissue_structure
veins	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Islet	NN	amod	B-Cell
endothelial	JJ	amod	I-Cell
activation	NN	nsubjpass	O
and	CC	cc	O
oxidative	JJ	amod	O
stress	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
is	VBZ	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	JJ	nummod	I-Simple_chemical
treatment	NN	nmod	O
in	IN	case	O
the	DT	det	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
GK	NN	compound	B-Organism
rat	NN	nmod	I-Organism
.	.	punct	O

The	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
MEFs	NNS	nsubj	B-Cell
deficient	JJ	amod	O
in	IN	case	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	aux	O
grow	VB	xcomp	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
while	IN	mark	O
those	DT	nsubj	O
expressing	VBG	acl	O
SWAP70	NN	dobj	B-Gene_or_gene_product
readily	RB	advmod	O
formed	VBD	advcl	O
colonies	NNS	dobj	B-Cell
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
SWAP	NNP	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
anchorage	JJ	amod	O
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	compound	I-Gene_or_gene_product
transformed	VBD	amod	O
MEFs	NNS	nmod	B-Cell
.	.	punct	O

When	WRB	advmod	O
injected	VBN	advcl	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenografts	NNS	dep	I-Cancer
,	,	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	nsubj	I-Gene_or_gene_product
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
triggered	VBD	conj	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	compound	I-Cell
(	-LRB-	punct	O
MSCs	NNS	appos	B-Cell
)	-RRB-	punct	O
transplantation	NN	nsubj	O
is	VBZ	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
potential	NN	appos	O
after	IN	case	O
ischemic	JJ	amod	O
injury	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
herein	RB	advmod	O
report	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
,	,	punct	O
efficient	JJ	dep	O
method	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	compound	O
inhibitors	NNS	dobj	O
and	CC	cc	O
introduce	VB	conj	O
one	CD	dobj	O
,	,	punct	O
TKI	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
31	CD	conj	I-Simple_chemical
,	,	punct	O
that	WDT	nsubj	O
may	MD	aux	O
prove	VB	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
new	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	xcomp	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rates	NNS	nsubj	O
of	IN	case	O
oxygen	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
,	,	punct	O
the	DT	det	O
CO2	NN	compound	B-Simple_chemical
evolution	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
changes	NNS	conj	O
in	IN	case	O
the	DT	det	O
redox	NN	compound	O
states	NNS	nmod	O
of	IN	case	O
cytochromes	NNS	nmod	B-Gene_or_gene_product
indicate	VBP	ROOT	O
that	IN	mark	O
glucose	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
preferred	VBN	ccomp	O
by	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	xcomp	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
as	IN	case	O
energy	NN	compound	O
substrate	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
the	DT	det	O
putative	JJ	amod	O
transforming	NN	amod	O
protein	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nmod	I-Organism
HTLV	NN	dep	I-Organism
-	:	punct	I-Organism
I	CD	dep	I-Organism
and	CC	cc	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
II	CD	conj	I-Organism
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
regulate	VB	acl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
factors	NNS	nmod	O
identified	VBN	acl	O
here	RB	advmod	O
suggests	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	mark	O
determining	VBG	acl	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
structure	NN	dobj	O
and	CC	cc	O
in	IN	case	O
angiogenesis	NN	conj	O
.	.	punct	O

Rofecoxib	NNP	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
eight	CD	nummod	O
acute	JJ	amod	O
haemarthrosis	NN	nmod	O
,	,	punct	O
four	CD	nummod	O
target	NN	compound	O
joints	NNS	appos	B-Multi-tissue_structure
,	,	punct	O
seven	CD	nummod	O
cases	NNS	appos	O
of	IN	case	O
synovitis	NN	nmod	O
and	CC	cc	O
12	CD	nummod	O
episodes	NNS	conj	O
of	IN	case	O
pain	NN	nmod	O
.	.	punct	O

For	IN	case	O
efficacy	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
nude	JJ	amod	B-Organism
mice	NNS	nsubjpass	I-Organism
bearing	VBG	acl	O
orthotopically	RB	advmod	O
implanted	VBN	amod	O
tumors	NNS	dobj	B-Cancer
derived	VBN	acl	O
from	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
MDA	NN	compound	I-Cell
-	:	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
435	CD	dep	I-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	prep	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	pobj	I-Gene_or_gene_product
or	CC	cc	O
a	DT	det	O
vehicle	NN	conj	O
control	NN	conj	O
i	LS	dobj	O
.	.	punct	O
m	LS	ROOT	O
.	.	punct	O
twice	RB	advmod	O
daily	RB	ROOT	O
for	IN	prep	O
90	CD	nummod	O
days	NNS	pobj	O
.	.	punct	O

v	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nsubj	I-Gene_or_gene_product
morphologically	RB	advmod	O
transformed	VBD	ROOT	O
MEFs	NNS	dobj	B-Cell
lacking	VBG	acl	O
SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	dobj	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
growth	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
was	VBD	cop	O
slower	JJR	conj	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
supplemented	VBN	acl	O
with	IN	case	O
exogenous	JJ	amod	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
scope	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
review	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
discuss	VB	xcomp	O
from	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
point	NN	nmod	O
of	IN	case	O
view	NN	acl	O
the	DT	det	O
potential	JJ	amod	O
interactions	NNS	dobj	O
between	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
angiopoietins	VBZ	conj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
asthmatic	JJ	amod	O
airways	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
focus	VBP	conj	O
on	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
implications	NNS	nmod	O
targeting	VBG	acl	O
for	IN	case	O
these	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
directly	RB	advmod	O
address	VB	ROOT	O
whether	IN	mark	O
pericyte	NN	compound	B-Cell
dysfunction	NN	nsubj	O
increases	VBZ	ccomp	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	parataxis	O
beta	NN	compound	B-Cell
cell	NN	compound	I-Cell
tumorigenesis	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
deficient	JJ	amod	O
Pdgfb	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
ret	VB	compound	O
/	SYM	punct	O
ret	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
skin	NN	compound	B-Tissue
microvasculature	NN	compound	I-Tissue
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Proprotein	NN	compound	O
convertases	NNS	nsubj	O
are	VBP	cop	O
serine	NN	amod	B-Amino_acid
endoproteases	NNS	ROOT	O
implicated	VBN	acl	O
in	IN	case	O
the	DT	det	O
proteolytic	JJ	amod	O
processing	NN	nmod	O
of	IN	case	O
a	DT	det	O
large	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
regulatory	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
,	,	punct	O
possibly	RB	advmod	O
via	IN	case	O
its	PRP$	nmod:poss	O
free	JJ	amod	O
radical	NN	amod	O
scavenging	NN	nmod	O
and	CC	cc	O
antioxidant	JJ	amod	O
properties	NNS	conj	O
,	,	punct	O
ameliorates	VBZ	ccomp	O
MTX	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
organ	NN	compound	B-Organ
injury	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
leukocyte	NN	compound	B-Cell
apoptosis	NN	dobj	O
.	.	punct	O

